"","Study_id_f","first author","publication_date","semester","study design","population_category","historyofCOVID","country_clean","Country.Code","continent","Income group","GNI_per_c_WB","year_GNI","variant_clean","clean_vaccine","vac_type","dose_number","timing_of_dose_days","outcome_final","min_period_days","max_period_days","min_vac_intro","owid_vac_F40","owid_vac_F70","VE","LCL","UCL","include","justification","sensitivity","VE1","LCL.1","UCL.1","RR","RR.LCL","RR.UCL","ln.RR","SE.ln.RR"
"1",43,"Stowe",2021-06-14,"2021 (Jan-Jun)","Test-negative case-control","general pop","included","UK","GBR","Europe","High income",49370,2019,"alpha","BioNTech/Pfizer BNT162b2","mRNA","1","21+","severe",NA,NA,2020-12-21,2021-06-04,2021-12-23,83,62,93,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"2",43,"Stowe",2021-06-14,"2021 (Jan-Jun)","Test-negative case-control","general pop","included","UK","GBR","Europe","High income",49370,2019,"alpha","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",NA,NA,2020-12-21,2021-06-04,2021-12-23,95,78,99,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"3",43,"Stowe",2021-06-14,"2021 (Jan-Jun)","Test-negative case-control","general pop","included","UK","GBR","Europe","High income",49370,2019,"alpha","Oxford/AstraZeneca ChAdOx1-S","Vectored","1","21+","severe",NA,NA,2020-12-21,2021-06-04,2021-12-23,76,61,85,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"4",43,"Stowe",2021-06-14,"2021 (Jan-Jun)","Test-negative case-control","general pop","included","UK","GBR","Europe","High income",49370,2019,"alpha","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","severe",NA,NA,2020-12-21,2021-06-04,2021-12-23,86,53,96,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"5",43,"Stowe",2021-06-14,"2021 (Jan-Jun)","Test-negative case-control","general pop","included","UK","GBR","Europe","High income",49370,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","1","21+","severe",NA,NA,2020-12-21,2021-06-04,2021-12-23,94,46,99,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"6",43,"Stowe",2021-06-14,"2021 (Jan-Jun)","Test-negative case-control","general pop","included","UK","GBR","Europe","High income",49370,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",14,140,2020-12-21,2021-06-04,2021-12-23,96,86,99,"yes",NA,0,96,86,99,0.04,0.01,0.14,-3.2188758248682,0.673228910616137
"7",43,"Stowe",2021-06-14,"2021 (Jan-Jun)","Test-negative case-control","general pop","included","UK","GBR","Europe","High income",49370,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","1","21+","severe",NA,NA,2020-12-21,2021-06-04,2021-12-23,71,51,83,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"8",43,"Stowe",2021-06-14,"2021 (Jan-Jun)","Test-negative case-control","general pop","included","UK","GBR","Europe","High income",49370,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","severe",14,140,2020-12-21,2021-06-04,2021-12-23,92,75,97,"yes",NA,0,92,75,97,0.08,0.03,0.25,-2.52572864430826,0.540883555153084
"9",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"original","BioNTech/Pfizer BNT162b2","mRNA","1","14+","symptomatic",NA,NA,2020-12-14,2021-07-09,2021-09-28,63,56,68,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"original","BioNTech/Pfizer BNT162b2","mRNA","2","14+","symptomatic",NA,NA,2020-12-14,2021-07-09,2021-09-28,92,87,95,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"11",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"original","BioNTech/Pfizer BNT162b2","mRNA","1","14+","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,77,67,84,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"12",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"original","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,97,88,99,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"13",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"original","Moderna mRNA-1273","mRNA","1","14+","symptomatic",NA,NA,2020-12-14,2021-07-09,2021-09-28,63,47,74,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"14",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"original","Moderna mRNA-1273","mRNA","2","14+","symptomatic",NA,NA,2020-12-14,2021-07-09,2021-09-28,98,83,100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"15",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"original","Moderna mRNA-1273","mRNA","1","14+","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,66,43,80,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"16",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"original","Moderna mRNA-1273","mRNA","2","14+","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"17",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"original","Oxford/AstraZeneca ChAdOx1-S","Vectored","1","14+","symptomatic",NA,NA,2020-12-14,2021-07-09,2021-09-28,67,44,81,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"18",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"original","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","symptomatic",NA,NA,2020-12-14,2021-07-09,2021-09-28,100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"19",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"original","Oxford/AstraZeneca ChAdOx1-S","Vectored","1","14+","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,92,45,99,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"20",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"original","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"21",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"alpha","BioNTech/Pfizer BNT162b2","mRNA","1","14+","symptomatic",NA,NA,2020-12-14,2021-07-09,2021-09-28,67,65,68,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"22",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"alpha","BioNTech/Pfizer BNT162b2","mRNA","2","14+","symptomatic",NA,NA,2020-12-14,2021-07-09,2021-09-28,88,86,90,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"23",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"alpha","BioNTech/Pfizer BNT162b2","mRNA","1","14+","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,82,81,84,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"24",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"alpha","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,96,94,97,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"25",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"alpha","Moderna mRNA-1273","mRNA","1","14+","symptomatic",NA,NA,2020-12-14,2021-07-09,2021-09-28,82,80,84,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"26",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"alpha","Moderna mRNA-1273","mRNA","2","14+","symptomatic",NA,NA,2020-12-14,2021-07-09,2021-09-28,92,87,95,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"27",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"alpha","Moderna mRNA-1273","mRNA","1","14+","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,80,76,84,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"28",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"alpha","Moderna mRNA-1273","mRNA","2","14+","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,95,92,97,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"29",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"alpha","Oxford/AstraZeneca ChAdOx1-S","Vectored","1","14+","symptomatic",NA,NA,2020-12-14,2021-07-09,2021-09-28,63,59,66,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"30",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"alpha","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","symptomatic",NA,NA,2020-12-14,2021-07-09,2021-09-28,87,47,97,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"31",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"alpha","Oxford/AstraZeneca ChAdOx1-S","Vectored","1","14+","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,87,83,90,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"32",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"alpha","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,92,41,99,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"33",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"beta","BioNTech/Pfizer BNT162b2","mRNA","1","14+","symptomatic",NA,NA,2020-12-14,2021-07-09,2021-09-28,50,15,70,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"34",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"beta","BioNTech/Pfizer BNT162b2","mRNA","2","14+","symptomatic",NA,NA,2020-12-14,2021-07-09,2021-09-28,86,0,98,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"35",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"beta","BioNTech/Pfizer BNT162b2","mRNA","1","14+","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,64,31,82,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"36",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"beta","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,92,39,99,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"37",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"beta","Moderna mRNA-1273","mRNA","2","14+","symptomatic",NA,NA,2020-12-14,2021-07-09,2021-09-28,100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"38",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"beta","Moderna mRNA-1273","mRNA","1","14+","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,59,-77,90,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"39",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"beta","Moderna mRNA-1273","mRNA","2","14+","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"40",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"beta","Oxford/AstraZeneca ChAdOx1-S","Vectored","1","14+","symptomatic",NA,NA,2020-12-14,2021-07-09,2021-09-28,84,-13,98,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"41",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"beta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","symptomatic",NA,NA,2020-12-14,2021-07-09,2021-09-28,100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"42",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"beta","Oxford/AstraZeneca ChAdOx1-S","Vectored","1","14+","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,61,-64,91,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"43",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"gamma","BioNTech/Pfizer BNT162b2","mRNA","1","14+","symptomatic",NA,NA,2020-12-14,2021-07-09,2021-09-28,63,54,70,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"44",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"gamma","BioNTech/Pfizer BNT162b2","mRNA","2","14+","symptomatic",NA,NA,2020-12-14,2021-07-09,2021-09-28,90,76,96,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"45",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"gamma","BioNTech/Pfizer BNT162b2","mRNA","1","14+","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,80,70,87,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"46",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"gamma","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,94,59,99,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"47",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"gamma","Moderna mRNA-1273","mRNA","1","14+","symptomatic",NA,NA,2020-12-14,2021-07-09,2021-09-28,89,76,95,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"48",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"gamma","Moderna mRNA-1273","mRNA","2","14+","symptomatic",NA,NA,2020-12-14,2021-07-09,2021-09-28,100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"49",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"gamma","Moderna mRNA-1273","mRNA","1","14+","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,88,63,96,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"50",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"gamma","Moderna mRNA-1273","mRNA","2","14+","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"51",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"gamma","Oxford/AstraZeneca ChAdOx1-S","Vectored","1","14+","symptomatic",NA,NA,2020-12-14,2021-07-09,2021-09-28,41,12,60,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"52",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"gamma","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","symptomatic",NA,NA,2020-12-14,2021-07-09,2021-09-28,100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"53",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"gamma","Oxford/AstraZeneca ChAdOx1-S","Vectored","1","14+","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,76,40,90,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"54",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"gamma","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"55",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","1","14+","symptomatic",NA,NA,2020-12-14,2021-07-09,2021-09-28,57,53,61,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"56",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14+","symptomatic",NA,NA,2020-12-14,2021-07-09,2021-09-28,92,89,94,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"57",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","1","14+","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,81,76,85,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"58",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",14,196,2020-12-14,2021-07-09,2021-09-28,98,96,99,"yes",NA,0,98,96,99,0.02,0.01,0.04,-3.91202300542815,0.35364652069385
"59",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"delta","Moderna mRNA-1273","mRNA","1","14+","symptomatic",NA,NA,2020-12-14,2021-07-09,2021-09-28,70,64,76,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"60",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"delta","Moderna mRNA-1273","mRNA","2","14+","symptomatic",NA,NA,2020-12-14,2021-07-09,2021-09-28,94,90,97,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"61",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"delta","Moderna mRNA-1273","mRNA","1","14+","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,90,82,94,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"62",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"delta","Moderna mRNA-1273","mRNA","2","14+","severe",14,175,2020-12-14,2021-07-09,2021-09-28,98,93,100,"yes",NA,0,98,93,99.9,0.02,0.00099999999999989,0.07,-3.91202300542815,1.08379980664527
"63",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","1","14+","symptomatic",NA,NA,2020-12-14,2021-07-09,2021-09-28,68,57,76,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"64",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","symptomatic",NA,NA,2020-12-14,2021-07-09,2021-09-28,88,68,96,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"65",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","1","14+","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,91,82,96,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"66",49,"Nasreen",2022-02-07,"2022 (Jan-Jun)","Test-negative case-control","general pop","unknown","Canada","CAN","North America","High income",49140,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","severe",14,21,2020-12-14,2021-07-09,2021-09-28,90,67,97,"yes",NA,0,90,67,97,0.1,0.03,0.33,-2.30258509299405,0.611707977754686
"67",74,"Tang",2021-11-02,"2021 (Jul-Dec)","Test-negative case-control","general pop","included","Qatar","QAT","Asia","High income",92300,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","1","14+","infection",NA,NA,2021-01-28,2021-05-31,2021-08-16,42.8,18.2,60.1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"68",74,"Tang",2021-11-02,"2021 (Jul-Dec)","Test-negative case-control","general pop","included","Qatar","QAT","Asia","High income",92300,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14+","infection",NA,NA,2021-01-28,2021-05-31,2021-08-16,50.6,45.4,55.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"69",74,"Tang",2021-11-02,"2021 (Jul-Dec)","Test-negative case-control","general pop","included","Qatar","QAT","Asia","High income",92300,2019,"delta","Moderna mRNA-1273","mRNA","1","14+","infection",NA,NA,2021-01-28,2021-05-31,2021-08-16,73.2,57.3,83.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"70",74,"Tang",2021-11-02,"2021 (Jul-Dec)","Test-negative case-control","general pop","included","Qatar","QAT","Asia","High income",92300,2019,"delta","Moderna mRNA-1273","mRNA","2","14+","infection",NA,NA,2021-01-28,2021-05-31,2021-08-16,72,66.1,76.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"71",74,"Tang",2021-11-02,"2021 (Jul-Dec)","Test-negative case-control","general pop","included","Qatar","QAT","Asia","High income",92300,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","1","14+","severe",NA,NA,2021-01-28,2021-05-31,2021-08-16,84.5,-25.2,98.1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"72",74,"Tang",2021-11-02,"2021 (Jul-Dec)","Test-negative case-control","general pop","included","Qatar","QAT","Asia","High income",92300,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",14,175,2021-01-28,2021-05-31,2021-08-16,94.1,85.9,97.6,"yes",NA,0,94.1,85.9,97.6,0.0590000000000001,0.024,0.141,-2.83021783507642,0.451710729599546
"73",74,"Tang",2021-11-02,"2021 (Jul-Dec)","Test-negative case-control","general pop","included","Qatar","QAT","Asia","High income",92300,2019,"delta","Moderna mRNA-1273","mRNA","1","14+","severe",NA,NA,2021-01-28,2021-05-31,2021-08-16,87.5,23.4,95.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"74",74,"Tang",2021-11-02,"2021 (Jul-Dec)","Test-negative case-control","general pop","included","Qatar","QAT","Asia","High income",92300,2019,"delta","Moderna mRNA-1273","mRNA","2","14+","severe",14,175,2021-01-28,2021-05-31,2021-08-16,96.1,71.4,99.5,"yes",NA,0,96.1,71.4,99.5,0.039,0.005,0.286,-3.24419363285249,1.03228415775147
"75",74,"Tang",2021-11-02,"2021 (Jul-Dec)","Test-negative case-control","general pop","included","Qatar","QAT","Asia","High income",92300,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","1","14+","symptomatic",NA,NA,2021-01-28,2021-05-31,2021-08-16,56.2,30.6,72.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"76",74,"Tang",2021-11-02,"2021 (Jul-Dec)","Test-negative case-control","general pop","included","Qatar","QAT","Asia","High income",92300,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14+","symptomatic",NA,NA,2021-01-28,2021-05-31,2021-08-16,44.4,37,50.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"77",74,"Tang",2021-11-02,"2021 (Jul-Dec)","Test-negative case-control","general pop","included","Qatar","QAT","Asia","High income",92300,2019,"delta","Moderna mRNA-1273","mRNA","1","14+","symptomatic",NA,NA,2021-01-28,2021-05-31,2021-08-16,82.5,65.2,91.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"78",74,"Tang",2021-11-02,"2021 (Jul-Dec)","Test-negative case-control","general pop","included","Qatar","QAT","Asia","High income",92300,2019,"delta","Moderna mRNA-1273","mRNA","2","14+","symptomatic",NA,NA,2021-01-28,2021-05-31,2021-08-16,73.9,65.9,79.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"79",74,"Tang",2021-11-02,"2021 (Jul-Dec)","Test-negative case-control","general pop","included","Qatar","QAT","Asia","High income",92300,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","1","14+","infection",NA,NA,2021-01-28,2021-05-31,2021-08-16,46.7,-56.2,81.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"80",74,"Tang",2021-11-02,"2021 (Jul-Dec)","Test-negative case-control","general pop","included","Qatar","QAT","Asia","High income",92300,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14+","infection",NA,NA,2021-01-28,2021-05-31,2021-08-16,46,32.3,56.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"81",74,"Tang",2021-11-02,"2021 (Jul-Dec)","Test-negative case-control","general pop","included","Qatar","QAT","Asia","High income",92300,2019,"delta","Moderna mRNA-1273","mRNA","1","14+","infection",NA,NA,2021-01-28,2021-05-31,2021-08-16,61.8,-9.6,86.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"82",74,"Tang",2021-11-02,"2021 (Jul-Dec)","Test-negative case-control","general pop","included","Qatar","QAT","Asia","High income",92300,2019,"delta","Moderna mRNA-1273","mRNA","2","14+","infection",NA,NA,2021-01-28,2021-05-31,2021-08-16,53.6,33.4,67.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"83",74,"Tang",2021-11-02,"2021 (Jul-Dec)","Test-negative case-control","general pop","included","Qatar","QAT","Asia","High income",92300,2019,"beta","BioNTech/Pfizer BNT162b2","mRNA","1","14+","infection",NA,NA,2021-01-28,2021-05-31,2021-08-16,18.9,-1.8,35.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"84",74,"Tang",2021-11-02,"2021 (Jul-Dec)","Test-negative case-control","general pop","included","Qatar","QAT","Asia","High income",92300,2019,"beta","BioNTech/Pfizer BNT162b2","mRNA","2","14+","infection",NA,NA,2021-01-28,2021-05-31,2021-08-16,74.3,70.3,77.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"85",74,"Tang",2021-11-02,"2021 (Jul-Dec)","Test-negative case-control","general pop","included","Qatar","QAT","Asia","High income",92300,2019,"beta","Moderna mRNA-1273","mRNA","1","14+","infection",NA,NA,2021-01-28,2021-05-31,2021-08-16,66.3,55.8,74.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"86",74,"Tang",2021-11-02,"2021 (Jul-Dec)","Test-negative case-control","general pop","included","Qatar","QAT","Asia","High income",92300,2019,"beta","Moderna mRNA-1273","mRNA","2","14+","infection",NA,NA,2021-01-28,2021-05-31,2021-08-16,80.8,69,88.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"87",74,"Tang",2021-11-02,"2021 (Jul-Dec)","Test-negative case-control","general pop","included","Qatar","QAT","Asia","High income",92300,2019,"beta","BioNTech/Pfizer BNT162b2","mRNA","1","14+","severe",NA,NA,2021-01-28,2021-05-31,2021-08-16,74.8,-7.6,94.1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"88",74,"Tang",2021-11-02,"2021 (Jul-Dec)","Test-negative case-control","general pop","included","Qatar","QAT","Asia","High income",92300,2019,"beta","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",NA,NA,2021-01-28,2021-05-31,2021-08-16,92.7,81.5,97.1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"89",74,"Tang",2021-11-02,"2021 (Jul-Dec)","Test-negative case-control","general pop","included","Qatar","QAT","Asia","High income",92300,2019,"beta","Moderna mRNA-1273","mRNA","1","14+","severe",NA,NA,2021-01-28,2021-05-31,2021-08-16,72.5,7.7,91.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"90",74,"Tang",2021-11-02,"2021 (Jul-Dec)","Test-negative case-control","general pop","included","Qatar","QAT","Asia","High income",92300,2019,"beta","Moderna mRNA-1273","mRNA","2","14+","severe",NA,NA,2021-01-28,2021-05-31,2021-08-16,100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"91",80,"Tartof",2021-10-16,"2021 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"other combinations","BioNTech/Pfizer BNT162b2","mRNA","1","14+","infection",NA,NA,2020-12-13,2021-05-14,NA,58,54,61,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"92",80,"Tartof",2021-10-16,"2021 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"other combinations","BioNTech/Pfizer BNT162b2","mRNA","2","7+","infection",NA,NA,2020-12-13,2021-05-14,NA,73,72,74,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"93",80,"Tartof",2021-10-16,"2021 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"other combinations","BioNTech/Pfizer BNT162b2","mRNA","2","7-36","infection",NA,NA,2020-12-13,2021-05-14,NA,88,86,89,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"94",80,"Tartof",2021-10-16,"2021 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"other combinations","BioNTech/Pfizer BNT162b2","mRNA","2","157+","infection",NA,NA,2020-12-13,2021-05-14,NA,47,43,51,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"95",80,"Tartof",2021-10-16,"2021 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"other combinations","BioNTech/Pfizer BNT162b2","mRNA","1","14+","severe",NA,NA,2020-12-13,2021-05-14,NA,54,43,63,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"96",80,"Tartof",2021-10-16,"2021 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"other combinations","BioNTech/Pfizer BNT162b2","mRNA","2","7+","severe",NA,NA,2020-12-13,2021-05-14,NA,90,89,92,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"97",80,"Tartof",2021-10-16,"2021 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"other combinations","BioNTech/Pfizer BNT162b2","mRNA","2","7-36","severe",NA,NA,2020-12-13,2021-05-14,NA,87,82,91,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"98",80,"Tartof",2021-10-16,"2021 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"other combinations","BioNTech/Pfizer BNT162b2","mRNA","2","157+","severe",NA,NA,2020-12-13,2021-05-14,NA,88,82,92,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"99",80,"Tartof",2021-10-16,"2021 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","1","14+","infection",NA,NA,2020-12-13,2021-05-14,NA,74,55,85,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"100",80,"Tartof",2021-10-16,"2021 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","7+","infection",NA,NA,2020-12-13,2021-05-14,NA,75,71,78,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"101",80,"Tartof",2021-10-16,"2021 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","7-36","infection",NA,NA,2020-12-13,2021-05-14,NA,93,85,97,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"102",80,"Tartof",2021-10-16,"2021 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","127+","infection",NA,NA,2020-12-13,2021-05-14,NA,53,39,65,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"103",80,"Tartof",2021-10-16,"2021 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","1","14+","severe",NA,NA,2020-12-13,2021-05-14,NA,79,-49,97,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"104",80,"Tartof",2021-10-16,"2021 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","7+","severe",7,203,2020-12-13,2021-05-14,NA,93,84,96,"yes",NA,0,93,84,96,0.07,0.04,0.16,-2.65926003693278,0.353646520693849
"105",80,"Tartof",2021-10-16,"2021 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"other combinations","BioNTech/Pfizer BNT162b2","mRNA","1","14+","infection",NA,NA,2020-12-13,2021-05-14,NA,74,64,81,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"106",80,"Tartof",2021-10-16,"2021 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"other combinations","BioNTech/Pfizer BNT162b2","mRNA","2","7+","infection",NA,NA,2020-12-13,2021-05-14,NA,91,88,92,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"107",80,"Tartof",2021-10-16,"2021 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"other combinations","BioNTech/Pfizer BNT162b2","mRNA","2","7-36","infection",NA,NA,2020-12-13,2021-05-14,NA,97,95,99,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"108",80,"Tartof",2021-10-16,"2021 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"other combinations","BioNTech/Pfizer BNT162b2","mRNA","2","127+","infection",NA,NA,2020-12-13,2021-05-14,NA,67,45,80,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"109",80,"Tartof",2021-10-16,"2021 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"other combinations","BioNTech/Pfizer BNT162b2","mRNA","1","14+","severe",NA,NA,2020-12-13,2021-05-14,NA,75,21,92,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"110",80,"Tartof",2021-10-16,"2021 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"other combinations","BioNTech/Pfizer BNT162b2","mRNA","2","7+","severe",NA,NA,2020-12-13,2021-05-14,NA,95,90,98,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"111",81,"Golberg",2021-10-27,"2021 (Jul-Dec)","Retrospective cohort","16-39 years","excluded","Israel","ISR","Asia","High income",40250,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","168-203","infection",NA,NA,2020-12-16,2021-03-07,NA,55,50,60,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"112",81,"Golberg",2021-10-27,"2021 (Jul-Dec)","Retrospective cohort","16-39 years","excluded","Israel","ISR","Asia","High income",40250,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","55-98","infection",NA,NA,2020-12-16,2021-03-07,NA,80,75,84,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"113",81,"Golberg",2021-10-27,"2021 (Jul-Dec)","Retrospective cohort","40-59 years","excluded","Israel","ISR","Asia","High income",40250,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","168-203","infection",NA,NA,2020-12-16,2021-03-07,NA,57,53,61,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"114",81,"Golberg",2021-10-27,"2021 (Jul-Dec)","Retrospective cohort","40-59 years","excluded","Israel","ISR","Asia","High income",40250,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","55-98","infection",NA,NA,2020-12-16,2021-03-07,NA,83,75,88,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"115",81,"Golberg",2021-10-27,"2021 (Jul-Dec)","Retrospective cohort",">= 60 years","excluded","Israel","ISR","Asia","High income",40250,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","168-203","infection",NA,NA,2020-12-16,2021-03-07,NA,57,52,62,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"116",81,"Golberg",2021-10-27,"2021 (Jul-Dec)","Retrospective cohort",">= 60 years","excluded","Israel","ISR","Asia","High income",40250,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","55-98","infection",NA,NA,2020-12-16,2021-03-07,NA,82,70,89,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"117",81,"Golberg",2021-10-27,"2021 (Jul-Dec)","Retrospective cohort","40-59 years","excluded","Israel","ISR","Asia","High income",40250,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","168-203","severe",NA,NA,2020-12-16,2021-03-07,NA,98,94,99,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"118",81,"Golberg",2021-10-27,"2021 (Jul-Dec)","Retrospective cohort",">= 60 years","excluded","Israel","ISR","Asia","High income",40250,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","168-203","severe",NA,NA,2020-12-16,2021-03-07,NA,93,86,97,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"119",81,"Golberg",2021-10-27,"2021 (Jul-Dec)","Retrospective cohort","40-59 years","excluded","Israel","ISR","Asia","High income",40250,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","109-159","severe",109,159,2020-12-16,2021-03-07,NA,92,87,95,"yes",NA,0,92,87,95,0.08,0.05,0.13,-2.52572864430826,0.243752919649856
"120",81,"Golberg",2021-10-27,"2021 (Jul-Dec)","Retrospective cohort",">= 60 years","excluded","Israel","ISR","Asia","High income",40250,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","109-159","severe",109,159,2020-12-16,2021-03-07,NA,85,81,88,"yes",NA,1,85,81,88,0.15,0.12,0.19,-1.89711998488588,0.11722763504552
"121",92,"Grannis",2021-09-10,"2021 (Jul-Dec)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",14,28,2020-12-13,2021-05-14,NA,80,73,85,"yes",NA,0,80,73,85,0.2,0.15,0.27,-1.6094379124341,0.149945577781153
"122",92,"Grannis",2021-09-10,"2021 (Jul-Dec)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14+","symptomatic",NA,NA,2020-12-13,2021-05-14,NA,77,74,80,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"123",92,"Grannis",2021-09-10,"2021 (Jul-Dec)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"delta","Moderna mRNA-1273","mRNA","2","14+","severe",14,28,2020-12-13,2021-05-14,NA,95,92,97,"yes",NA,0,95,92,97,0.05,0.03,0.08,-2.99573227355399,0.250211544135644
"124",92,"Grannis",2021-09-10,"2021 (Jul-Dec)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"delta","Moderna mRNA-1273","mRNA","2","14+","symptomatic",NA,NA,2020-12-13,2021-05-14,NA,92,89,93,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"125",92,"Grannis",2021-09-10,"2021 (Jul-Dec)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"delta","Janssen Ad26.COV2.S","Vectored","1","14+","severe",14,28,2020-12-13,2021-05-14,NA,60,31,77,"yes",NA,0,60,31,77,0.4,0.23,0.69,-0.916290731874155,0.28025823690513
"126",92,"Grannis",2021-09-10,"2021 (Jul-Dec)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"delta","Janssen Ad26.COV2.S","Vectored","1","14+","symptomatic",NA,NA,2020-12-13,2021-05-14,NA,65,56,72,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"127",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"alpha","BioNTech/Pfizer BNT162b2","mRNA","1","28+","symptomatic",NA,NA,2020-12-21,2021-06-04,2021-12-23,45.9,44.2,47.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"128",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"alpha","BioNTech/Pfizer BNT162b2","mRNA","2","14+","symptomatic",NA,NA,2020-12-21,2021-06-04,2021-12-23,94.9,93.6,95.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"129",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"alpha","BioNTech/Pfizer BNT162b2","mRNA","2","70+","symptomatic",NA,NA,2020-12-21,2021-06-04,2021-12-23,94.8,88.4,97.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"130",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"alpha","BioNTech/Pfizer BNT162b2","mRNA","1","28+","severe",NA,NA,2020-12-21,2021-06-04,2021-12-23,85.2,81.6,88.1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"131",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"alpha","BioNTech/Pfizer BNT162b2","mRNA","2","14-63","severe",NA,NA,2020-12-21,2021-06-04,2021-12-23,97.7,90.8,99.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"132",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"alpha","BioNTech/Pfizer BNT162b2","mRNA","1","28+","death",NA,NA,2020-12-21,2021-06-04,2021-12-23,73.1,65,79.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"133",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"alpha","BioNTech/Pfizer BNT162b2","mRNA","2","14+","death",NA,NA,2020-12-21,2021-06-04,2021-12-23,96.6,94.4,96.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"134",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"alpha","Oxford/AstraZeneca ChAdOx1-S","Vectored","1","28+","symptomatic",NA,NA,2020-12-21,2021-06-04,2021-12-23,45.1,43.3,46.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"135",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"alpha","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","symptomatic",NA,NA,2020-12-21,2021-06-04,2021-12-23,82.1,79.4,84.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"136",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"alpha","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14-63","symptomatic",NA,NA,2020-12-21,2021-06-04,2021-12-23,82.4,79.6,84.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"137",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"alpha","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","70+","symptomatic",NA,NA,2020-12-21,2021-06-04,2021-12-23,76.2,49.8,88.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"138",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"alpha","Oxford/AstraZeneca ChAdOx1-S","Vectored","1","28+","severe",NA,NA,2020-12-21,2021-06-04,2021-12-23,82.5,78.7,85.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"139",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"alpha","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14-63","severe",NA,NA,2020-12-21,2021-06-04,2021-12-23,95.1,86.7,98.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"140",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"alpha","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","70+","severe",NA,NA,2020-12-21,2021-06-04,2021-12-23,100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"141",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"alpha","Oxford/AstraZeneca ChAdOx1-S","Vectored","1","28+","death",NA,NA,2020-12-21,2021-06-04,2021-12-23,79.1,68.8,86,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"142",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"alpha","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","death",NA,NA,2020-12-21,2021-06-04,2021-12-23,100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"143",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"alpha","Moderna mRNA-1273","mRNA","1","28+","symptomatic",NA,NA,2020-12-21,2021-06-04,2021-12-23,58.1,11.7,80.1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"144",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","1","28+","symptomatic",NA,NA,2020-12-21,2021-06-04,2021-12-23,51.2,50.7,51.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"145",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14+","symptomatic",NA,NA,2020-12-21,2021-06-04,2021-12-23,83.3,83.1,83.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"146",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14-69","symptomatic",NA,NA,2020-12-21,2021-06-04,2021-12-23,89.8,89.6,90,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"147",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","140+","symptomatic",NA,NA,2020-12-21,2021-06-04,2021-12-23,69.7,68.7,70.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"148",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","1","28+","severe",NA,NA,2020-12-21,2021-06-04,2021-12-23,91.1,89.7,92.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"149",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",14,234.5,2020-12-21,2021-06-04,2021-12-23,96.6,96.2,96.9,"yes",NA,0,96.6,96.2,96.9,0.034,0.0309999999999999,0.0379999999999999,-3.38139475436597,0.0519385089901123
"150",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14-69","severe",NA,NA,2020-12-21,2021-06-04,2021-12-23,98.4,97.9,98.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"151",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","140+","severe",NA,NA,2020-12-21,2021-06-04,2021-12-23,92.7,90.3,94.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"152",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","1","28+","death",NA,NA,2020-12-21,2021-06-04,2021-12-23,88.6,78.8,93.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"153",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14+","death",NA,NA,2020-12-21,2021-06-04,2021-12-23,95.6,94.4,96.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"154",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14-69","death",NA,NA,2020-12-21,2021-06-04,2021-12-23,98.2,95.9,99.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"155",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","140+","death",NA,NA,2020-12-21,2021-06-04,2021-12-23,90.4,85.1,93.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"156",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","1","28+","symptomatic",NA,NA,2020-12-21,2021-06-04,2021-12-23,45.1,43.4,46.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"157",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","symptomatic",NA,NA,2020-12-21,2021-06-04,2021-12-23,64.2,63.9,64.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"158",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14-69","symptomatic",NA,NA,2020-12-21,2021-06-04,2021-12-23,66.7,66.3,67,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"159",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","140+","symptomatic",NA,NA,2020-12-21,2021-06-04,2021-12-23,47.3,45,49.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"160",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","1","28+","severe",NA,NA,2020-12-21,2021-06-04,2021-12-23,80.7,78,83,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"161",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","severe",14,143.5,2020-12-21,2021-06-04,2021-12-23,92.5,92,93,"yes",NA,0,92.5,92,93,0.075,0.07,0.08,-2.59026716544583,0.0340641307715619
"162",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14-69","severe",NA,NA,2020-12-21,2021-06-04,2021-12-23,95.2,94.6,95.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"163",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","140+","severe",NA,NA,2020-12-21,2021-06-04,2021-12-23,77,70.3,82.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"164",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","1","28+","death",NA,NA,2020-12-21,2021-06-04,2021-12-23,86.9,77.5,92.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"165",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","death",NA,NA,2020-12-21,2021-06-04,2021-12-23,93.2,91.7,94.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"166",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14-69","death",NA,NA,2020-12-21,2021-06-04,2021-12-23,94.1,91.8,95.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"167",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","140+","death",NA,NA,2020-12-21,2021-06-04,2021-12-23,78.7,52.7,90.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"168",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"delta","Moderna mRNA-1273","mRNA","1","28+","symptomatic",NA,NA,2020-12-21,2021-06-04,2021-12-23,64.9,64,65.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"169",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"delta","Moderna mRNA-1273","mRNA","2","14+","symptomatic",NA,NA,2020-12-21,2021-06-04,2021-12-23,94.8,94.4,95.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"170",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"delta","Moderna mRNA-1273","mRNA","2","14-63","symptomatic",NA,NA,2020-12-21,2021-06-04,2021-12-23,93.8,93.4,94.1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"171",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"delta","Moderna mRNA-1273","mRNA","2","70-104","symptomatic",NA,NA,2020-12-21,2021-06-04,2021-12-23,85.6,83.8,87.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"172",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"delta","Moderna mRNA-1273","mRNA","1","28+","severe",NA,NA,2020-12-21,2021-06-04,2021-12-23,93.7,89.9,96,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"173",95,"Andrews",2022-01-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"delta","Moderna mRNA-1273","mRNA","2","14-69","severe",NA,NA,2020-12-21,2021-06-04,2021-12-23,100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"174",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"other combinations","BioNTech/Pfizer BNT162b2","mRNA","2","14+","infection",NA,NA,2020-12-14,2021-07-09,2021-09-28,89,89,89,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"175",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"other combinations","BioNTech/Pfizer BNT162b2","mRNA","2","14-27","infection",NA,NA,2020-12-14,2021-07-09,2021-09-28,93,92,94,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"176",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"other combinations","BioNTech/Pfizer BNT162b2","mRNA","2","252-279","infection",NA,NA,2020-12-14,2021-07-09,2021-09-28,80,75,83,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"177",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"other combinations","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,97,97,98,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"178",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"other combinations","BioNTech/Pfizer BNT162b2","mRNA","2","14-27","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,98,96,99,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"179",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"other combinations","BioNTech/Pfizer BNT162b2","mRNA","2","252-279","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,96,86,99,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"180",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"other combinations","Moderna mRNA-1273","mRNA","2","14+","infection",NA,NA,2020-12-14,2021-07-09,2021-09-28,90,89,90,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"181",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"other combinations","Moderna mRNA-1273","mRNA","2","14-27","infection",NA,NA,2020-12-14,2021-07-09,2021-09-28,95,94,96,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"182",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"other combinations","Moderna mRNA-1273","mRNA","2","252-279","infection",NA,NA,2020-12-14,2021-07-09,2021-09-28,55,40,66,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"183",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"other combinations","Moderna mRNA-1273","mRNA","2","14+","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,97,97,98,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"184",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"other combinations","Moderna mRNA-1273","mRNA","2","14-27","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,99,95,100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"185",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"other combinations","Moderna mRNA-1273","mRNA","2","252-279","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,95,65,99,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"186",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"other combinations","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","infection",NA,NA,2020-12-14,2021-07-09,2021-09-28,74,72,76,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"187",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"other combinations","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14-27","infection",NA,NA,2020-12-14,2021-07-09,2021-09-28,77,57,87,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"188",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"other combinations","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","168-195","infection",NA,NA,2020-12-14,2021-07-09,2021-09-28,67,48,80,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"189",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"other combinations","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,95,94,97,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"190",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"other combinations","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","28-55","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,97,71,97,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"191",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"other combinations","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","168-195","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,91,35,99,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"192",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"other combinations","Multiple or heterologous RNA","mRNA","2","14+","infection",NA,NA,2020-12-14,2021-07-09,2021-09-28,90,89,90,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"193",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"other combinations","Multiple or heterologous RNA","mRNA","2","14-27","infection",NA,NA,2020-12-14,2021-07-09,2021-09-28,95,91,97,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"194",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"other combinations","Multiple or heterologous RNA","mRNA","2","168-195","infection",NA,NA,2020-12-14,2021-07-09,2021-09-28,96,73,99,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"195",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"other combinations","Multiple or heterologous RNA","mRNA","2","14+","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,98,97,98,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"196",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"other combinations","Multiple or heterologous RNA","mRNA","2","14-27","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,96,75,100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"197",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"other combinations","Multiple or heterologous RNA","mRNA","2","140-167","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,96,92,98,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"198",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"other combinations","Heterologous platforms","Multiple","2","14+","infection",NA,NA,2020-12-14,2021-07-09,2021-09-28,89,88,89,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"199",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"other combinations","Heterologous platforms","Multiple","2","14-27","infection",NA,NA,2020-12-14,2021-07-09,2021-09-28,94,89,97,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"200",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"other combinations","Heterologous platforms","Multiple","2","140-167","infection",NA,NA,2020-12-14,2021-07-09,2021-09-28,82,78,85,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"201",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"other combinations","Heterologous platforms","Multiple","2","14+","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,99,99,100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"202",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"other combinations","Heterologous platforms","Multiple","2","14-27","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,93,48,99,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"203",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"other combinations","Heterologous platforms","Multiple","2","140-167","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,98,91,99,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"204",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14+","infection",NA,NA,2020-12-14,2021-07-09,2021-09-28,89,89,89,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"205",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14-27","infection",NA,NA,2020-12-14,2021-07-09,2021-09-28,93,93,94,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"206",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","252-279","infection",NA,NA,2020-12-14,2021-07-09,2021-09-28,79,75,83,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"207",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",14,266,2020-12-14,2021-07-09,2021-09-28,98,97,98,"yes",NA,0,98,97,98,0.02,0.02,0.03,-3.91202300542815,0.103434976558205
"208",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14-27","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,98,95,99,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"209",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","196-223","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,94,87,97,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"210",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"delta","Moderna mRNA-1273","mRNA","2","14+","infection",NA,NA,2020-12-14,2021-07-09,2021-09-28,90,89,90,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"211",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"delta","Moderna mRNA-1273","mRNA","2","14-27","infection",NA,NA,2020-12-14,2021-07-09,2021-09-28,95,94,96,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"212",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"delta","Moderna mRNA-1273","mRNA","2","196-223","infection",NA,NA,2020-12-14,2021-07-09,2021-09-28,55,41,66,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"213",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"delta","Moderna mRNA-1273","mRNA","2","14+","severe",14,266,2020-12-14,2021-07-09,2021-09-28,97,97,98,"yes",NA,0,97,97,98,0.03,0.02,0.03,-3.50655789731998,0.103434976558205
"214",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"delta","Moderna mRNA-1273","mRNA","2","14-27","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,98,94,100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"215",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"delta","Moderna mRNA-1273","mRNA","2","196-223","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,95,80,99,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"216",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","infection",NA,NA,2020-12-14,2021-07-09,2021-09-28,73,72,75,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"217",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14-27","infection",NA,NA,2020-12-14,2021-07-09,2021-09-28,70,39,86,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"218",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","168-195","infection",NA,NA,2020-12-14,2021-07-09,2021-09-28,67,48,80,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"219",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","severe",14,266,2020-12-14,2021-07-09,2021-09-28,95,93,97,"yes",NA,0,95,93,97,0.05,0.03,0.07,-2.99573227355399,0.216147413364082
"220",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","28-55","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,89,67,97,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"221",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","168-195","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,91,34,99,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"222",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"delta","Multiple or heterologous RNA","mRNA","2","14+","infection",NA,NA,2020-12-14,2021-07-09,2021-09-28,90,89,90,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"223",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"delta","Multiple or heterologous RNA","mRNA","2","14-27","infection",NA,NA,2020-12-14,2021-07-09,2021-09-28,94,90,97,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"224",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"delta","Multiple or heterologous RNA","mRNA","2","168-195","infection",NA,NA,2020-12-14,2021-07-09,2021-09-28,96,73,99,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"225",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"delta","Multiple or heterologous RNA","mRNA","2","14+","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,98,97,98,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"226",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"delta","Multiple or heterologous RNA","mRNA","2","28-55","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,97,93,99,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"227",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"delta","Multiple or heterologous RNA","mRNA","2","140-167","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,96,92,98,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"228",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"delta","Heterologous platforms","Multiple","2","14+","infection",NA,NA,2020-12-14,2021-07-09,2021-09-28,88,88,89,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"229",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"delta","Heterologous platforms","Multiple","2","14-27","infection",NA,NA,2020-12-14,2021-07-09,2021-09-28,94,88,97,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"230",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"delta","Heterologous platforms","Multiple","2","140-167","infection",NA,NA,2020-12-14,2021-07-09,2021-09-28,82,77,85,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"231",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"delta","Heterologous platforms","Multiple","2","14+","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,99,99,100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"232",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"delta","Heterologous platforms","Multiple","2","14-27","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,91,33,99,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"233",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"delta","Heterologous platforms","Multiple","2","140-167","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,98,91,99,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"234",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"alpha","BioNTech/Pfizer BNT162b2","mRNA","2","14+","infection",NA,NA,2020-12-14,2021-07-09,2021-09-28,96,92,98,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"235",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"alpha","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,96,83,99,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"236",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"alpha","Moderna mRNA-1273","mRNA","2","14+","infection",NA,NA,2020-12-14,2021-07-09,2021-09-28,95,84,98,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"237",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"alpha","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","infection",NA,NA,2020-12-14,2021-07-09,2021-09-28,75,33,91,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"238",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"alpha","Multiple or heterologous RNA","mRNA","2","14+","infection",NA,NA,2020-12-14,2021-07-09,2021-09-28,96,73,99,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"239",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"gamma","BioNTech/Pfizer BNT162b2","mRNA","2","14+","infection",NA,NA,2020-12-14,2021-07-09,2021-09-28,92,88,95,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"240",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"gamma","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",NA,NA,2020-12-14,2021-07-09,2021-09-28,95,82,98,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"241",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"gamma","Moderna mRNA-1273","mRNA","2","14+","infection",NA,NA,2020-12-14,2021-07-09,2021-09-28,95,85,98,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"242",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"gamma","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","infection",NA,NA,2020-12-14,2021-07-09,2021-09-28,91,63,98,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"243",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"gamma","Multiple or heterologous RNA","mRNA","2","14+","infection",NA,NA,2020-12-14,2021-07-09,2021-09-28,94,76,99,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"244",114,"Skowronski",2022-04-19,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Canada","CAN","North America","High income",49140,2019,"gamma","Heterologous platforms","Multiple","2","14+","infection",NA,NA,2020-12-14,2021-07-09,2021-09-28,96,69,99,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"245",151,"Collie",2021-12-29,"2021 (Jul-Dec)","Test-negative case-control","general pop","included","South Africa","ZAF","Africa","Upper middle income",14080,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",14,168,2021-02-17,NA,NA,70,62,76,"yes",NA,0,70,62,76,0.3,0.24,0.38,-1.20397280432594,0.11722763504552
"246",151,"Collie",2021-12-29,"2021 (Jul-Dec)","Test-negative case-control","general pop","included","South Africa","ZAF","Africa","Upper middle income",14080,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",14,133,2021-02-17,NA,NA,93,90,94,"yes",NA,0,93,90,94,0.07,0.0600000000000001,0.1,-2.65926003693278,0.130312659123977
"247",165,"Tartof",2022-04-22,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","USA","USA","North America","High income",66120,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","7+","symptomatic",NA,NA,2020-12-13,2021-05-14,NA,47,40,54,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"248",165,"Tartof",2022-04-22,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","USA","USA","North America","High income",66120,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","7 to <3 months","symptomatic",NA,NA,2020-12-13,2021-05-14,NA,64,51,73,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"249",165,"Tartof",2022-04-22,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","USA","USA","North America","High income",66120,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2",">=9 months","symptomatic",NA,NA,2020-12-13,2021-05-14,NA,31,16,43,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"250",165,"Tartof",2022-04-22,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","USA","USA","North America","High income",66120,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","7+","severe",7,329,2020-12-13,2021-05-14,NA,62,53,69,"yes",NA,0,62,53,69,0.38,0.31,0.47,-0.967584026261706,0.106163366639008
"251",165,"Tartof",2022-04-22,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","USA","USA","North America","High income",66120,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","7 to <3 months","severe",NA,NA,2020-12-13,2021-05-14,NA,68,48,80,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"252",165,"Tartof",2022-04-22,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","USA","USA","North America","High income",66120,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2",">=9 months","severe",NA,NA,2020-12-13,2021-05-14,NA,41,21,55,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"253",165,"Tartof",2022-04-22,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","USA","USA","North America","High income",66120,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","7+","symptomatic",NA,NA,2020-12-13,2021-05-14,NA,61,55,66,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"254",165,"Tartof",2022-04-22,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","USA","USA","North America","High income",66120,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","7 to <3 months","symptomatic",NA,NA,2020-12-13,2021-05-14,NA,78,69,85,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"255",165,"Tartof",2022-04-22,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","USA","USA","North America","High income",66120,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2",">=9 months","symptomatic",NA,NA,2020-12-13,2021-05-14,NA,57,45,66,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"256",165,"Tartof",2022-04-22,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","USA","USA","North America","High income",66120,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","7+","severe",7,329,2020-12-13,2021-05-14,NA,76,69,82,"yes",NA,0,76,69,82,0.24,0.18,0.31,-1.42711635564015,0.138677409844128
"257",165,"Tartof",2022-04-22,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","USA","USA","North America","High income",66120,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","7 to <3 months","severe",NA,NA,2020-12-13,2021-05-14,NA,78,55,89,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"258",165,"Tartof",2022-04-22,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","USA","USA","North America","High income",66120,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2",">=9 months","severe",NA,NA,2020-12-13,2021-05-14,NA,73,58,83,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"259",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort","15-59 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",14,336,2020-12-23,2021-07-09,2022-01-24,98.1,97.5,98.6,"yes",NA,0,98.1,97.5,98.6,0.019,0.014,0.025,-3.9633162998157,0.147912881442077
"260",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort","15-59 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","6 months","severe",NA,NA,2020-12-23,2021-07-09,2022-01-24,95.5,94.3,96.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"261",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort","60-79 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",14,336,2020-12-23,2021-07-09,2022-01-24,96.7,95.9,97.4,"yes",NA,1,96.7,95.9,97.4,0.0329999999999999,0.0259999999999999,0.0409999999999999,-3.41124771751566,0.116192736908884
"262",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort","60-79 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","6 months","severe",NA,NA,2020-12-23,2021-07-09,2022-01-24,92,91,92.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"263",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort",">= 80 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",14,336,2020-12-23,2021-07-09,2022-01-24,94.2,92,95.7,"yes",NA,1,94.2,92,95.7,0.0579999999999999,0.0429999999999999,0.08,-2.84731226843572,0.158374111984776
"264",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort",">= 80 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","6 months","severe",NA,NA,2020-12-23,2021-07-09,2022-01-24,85.9,83.5,88,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"265",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort","15-59 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14+","death",NA,NA,2020-12-23,2021-07-09,2022-01-24,96.5,94.8,97.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"266",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort","15-59 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","6 months","death",NA,NA,2020-12-23,2021-07-09,2022-01-24,93.8,91,95.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"267",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort","60-79 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14+","death",NA,NA,2020-12-23,2021-07-09,2022-01-24,94.1,92.7,95.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"268",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort","60-79 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","6 months","death",NA,NA,2020-12-23,2021-07-09,2022-01-24,89.4,87.9,90.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"269",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort",">= 80 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14+","death",NA,NA,2020-12-23,2021-07-09,2022-01-24,91,88.4,93,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"270",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort",">= 80 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","6 months","death",NA,NA,2020-12-23,2021-07-09,2022-01-24,84,82.2,85.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"271",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort","15-59 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","Moderna mRNA-1273","mRNA","2","14+","severe",14,336,2020-12-23,2021-07-09,2022-01-24,99.4,98.2,99.8,"yes",NA,0,99.4,98.2,99.8,0.00599999999999989,0.002,0.018,-5.1159958097541,0.56051647381026
"272",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort","15-59 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","Moderna mRNA-1273","mRNA","2","6 months","severe",NA,NA,2020-12-23,2021-07-09,2022-01-24,97.3,93.1,98.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"273",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort","60-79 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","Moderna mRNA-1273","mRNA","2","14+","severe",14,336,2020-12-23,2021-07-09,2022-01-24,98.9,97.3,99.5,"yes",NA,1,98.9,97.3,99.5,0.0109999999999999,0.005,0.027,-4.50986000618378,0.430203814686283
"274",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort","60-79 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","Moderna mRNA-1273","mRNA","2","6 months","severe",NA,NA,2020-12-23,2021-07-09,2022-01-24,95.1,93,96.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"275",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort",">= 80 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","Moderna mRNA-1273","mRNA","2","14+","severe",14,336,2020-12-23,2021-07-09,2022-01-24,97.9,90.2,99.5,"yes",NA,1,97.9,90.2,99.5,0.0209999999999999,0.005,0.098,-3.86323284125872,0.759063664856242
"276",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort",">= 80 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","Moderna mRNA-1273","mRNA","2","6 months","severe",NA,NA,2020-12-23,2021-07-09,2022-01-24,90.6,67,97.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"277",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort","15-59 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","Moderna mRNA-1273","mRNA","2","14+","death",NA,NA,2020-12-23,2021-07-09,2022-01-24,99.3,94.7,99.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"278",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort","15-59 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","Moderna mRNA-1273","mRNA","2","6 months","death",NA,NA,2020-12-23,2021-07-09,2022-01-24,98.3,88.3,99.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"279",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort","60-79 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","Moderna mRNA-1273","mRNA","2","14+","death",NA,NA,2020-12-23,2021-07-09,2022-01-24,98.4,95.5,99.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"280",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort","60-79 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","Moderna mRNA-1273","mRNA","2","6 months","death",NA,NA,2020-12-23,2021-07-09,2022-01-24,96.2,93.6,97.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"281",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort",">= 80 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","Moderna mRNA-1273","mRNA","2","14+","death",NA,NA,2020-12-23,2021-07-09,2022-01-24,96.7,87.9,99.1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"282",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort",">= 80 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","Moderna mRNA-1273","mRNA","2","6 months","death",NA,NA,2020-12-23,2021-07-09,2022-01-24,92,80,96.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"283",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort","15-59 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","severe",14,336,2020-12-23,2021-07-09,2022-01-24,97.8,95.3,99,"yes",NA,0,97.8,95.3,99,0.022,0.01,0.047,-3.81671282562382,0.394786354264289
"284",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort","15-59 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","6 months","severe",NA,NA,2020-12-23,2021-07-09,2022-01-24,92.4,84,96.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"285",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort","60-79 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","severe",14,336,2020-12-23,2021-07-09,2022-01-24,97.2,95.3,98.3,"yes",NA,1,97.2,95.3,98.3,0.028,0.017,0.047,-3.57555076880693,0.259422004503531
"286",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort","60-79 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","6 months","severe",NA,NA,2020-12-23,2021-07-09,2022-01-24,90.3,87.4,92.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"287",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort",">= 80 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","severe",14,336,2020-12-23,2021-07-09,2022-01-24,97.8,91.7,99.4,"yes",NA,1,97.8,91.7,99.4,0.022,0.00599999999999989,0.083,-3.81671282562382,0.670173759838919
"288",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort",">= 80 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","6 months","severe",NA,NA,2020-12-23,2021-07-09,2022-01-24,92.4,72.7,97.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"289",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort","15-59 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","death",NA,NA,2020-12-23,2021-07-09,2022-01-24,97.5,89.7,99.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"290",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort","15-59 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","6 months","death",NA,NA,2020-12-23,2021-07-09,2022-01-24,94.5,77.2,98.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"291",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort","60-79 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","death",NA,NA,2020-12-23,2021-07-09,2022-01-24,95.4,91.2,97.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"292",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort","60-79 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","6 months","death",NA,NA,2020-12-23,2021-07-09,2022-01-24,89.8,85.2,93,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"293",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort",">= 80 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","death",NA,NA,2020-12-23,2021-07-09,2022-01-24,92.6,84.2,96.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"294",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort",">= 80 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","6 months","death",NA,NA,2020-12-23,2021-07-09,2022-01-24,83.4,69.6,90.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"295",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort","15-59 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","Janssen Ad26.COV2.S","Vectored","1","14+","severe",14,336,2020-12-23,2021-07-09,2022-01-24,85,73.9,91.4,"yes",NA,0,85,73.9,91.4,0.15,0.086,0.261,-1.89711998488588,0.28320742629316
"296",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort","15-59 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","Janssen Ad26.COV2.S","Vectored","1","6 months","severe",NA,NA,2020-12-23,2021-07-09,2022-01-24,91.7,84.4,95.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"297",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort","60-79 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","Janssen Ad26.COV2.S","Vectored","1","14+","severe",14,336,2020-12-23,2021-07-09,2022-01-24,79.6,65.2,88,"yes",NA,1,79.6,65.2,88,0.204,0.12,0.348,-1.58963528513792,0.271609881885824
"298",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort","60-79 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","Janssen Ad26.COV2.S","Vectored","1","6 months","severe",NA,NA,2020-12-23,2021-07-09,2022-01-24,88.7,78.7,94,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"299",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort",">= 80 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","Janssen Ad26.COV2.S","Vectored","1","14+","severe",14,336,2020-12-23,2021-07-09,2022-01-24,85,62.3,94,"yes",NA,1,85,62.3,94,0.15,0.0600000000000001,0.377,-1.89711998488588,0.468852200312732
"300",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort",">= 80 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","Janssen Ad26.COV2.S","Vectored","1","6 months","severe",NA,NA,2020-12-23,2021-07-09,2022-01-24,91.7,75.5,97.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"301",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort","15-59 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","Janssen Ad26.COV2.S","Vectored","1","14+","death",NA,NA,2020-12-23,2021-07-09,2022-01-24,81.7,57.5,92.1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"302",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort","15-59 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","Janssen Ad26.COV2.S","Vectored","1","6 months","death",NA,NA,2020-12-23,2021-07-09,2022-01-24,90.7,77.2,96.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"303",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort","60-79 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","Janssen Ad26.COV2.S","Vectored","1","14+","death",NA,NA,2020-12-23,2021-07-09,2022-01-24,69.1,43.2,83.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"304",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort","60-79 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","Janssen Ad26.COV2.S","Vectored","1","6 months","death",NA,NA,2020-12-23,2021-07-09,2022-01-24,84.3,67.9,92.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"305",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort",">= 80 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","Janssen Ad26.COV2.S","Vectored","1","14+","death",NA,NA,2020-12-23,2021-07-09,2022-01-24,61.9,43.2,74.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"306",174,"Lytras",2022-06-14,"2022 (Jan-Jun)","Retrospective cohort",">= 80 years","included","Greece","GRC","Europe","High income",30860,2019,"delta","Janssen Ad26.COV2.S","Vectored","1","6 months","death",NA,NA,2020-12-23,2021-07-09,2022-01-24,80.6,59.7,90.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"307",178,"Lauring",2022-03-09,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","USA","USA","North America","High income",66120,2019,"omicron","Multiple or heterologous RNA","mRNA","2","14+","severe",NA,NA,2020-12-13,2021-05-14,NA,65,51,75,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"308",178,"Lauring",2022-03-09,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","USA","USA","North America","High income",66120,2019,"delta","Multiple or heterologous RNA","mRNA","2","150+","severe",NA,NA,2020-12-13,2021-05-14,NA,85,83,87,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"309",178,"Lauring",2022-03-09,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","USA","USA","North America","High income",66120,2019,"delta","Multiple or heterologous RNA","mRNA","2",">150","severe",NA,NA,2020-12-13,2021-05-14,NA,90,85,93,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"310",178,"Lauring",2022-03-09,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","USA","USA","North America","High income",66120,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",14,189,2020-12-13,2021-05-14,NA,82,80,84,"yes",NA,0,82,80,84,0.18,0.16,0.2,-1.71479842809193,0.0569243753352575
"311",178,"Lauring",2022-03-09,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","USA","USA","North America","High income",66120,2019,"delta","Moderna mRNA-1273","mRNA","2","14+","severe",14,189,2020-12-13,2021-05-14,NA,88,86,90,"yes",NA,0,88,86,90,0.12,0.1,0.14,-2.12026353620009,0.0858347542401054
"312",178,"Lauring",2022-03-09,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","USA","USA","North America","High income",66120,2019,"alpha","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",NA,NA,2020-12-13,2021-05-14,NA,82,77,86,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"313",178,"Lauring",2022-03-09,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","USA","USA","North America","High income",66120,2019,"alpha","Moderna mRNA-1273","mRNA","2","14+","severe",NA,NA,2020-12-13,2021-05-14,NA,90,85,93,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"314",178,"Lauring",2022-03-09,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","USA","USA","North America","High income",66120,2019,"other combinations","Multiple or heterologous RNA","mRNA","1","14+","severe",NA,NA,2020-12-13,2021-05-14,NA,77,71,81,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"315",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","1","14-74","infection",NA,NA,2020-12-23,2021-07-16,NA,31,28,34,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"316",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14-74","infection",NA,NA,2020-12-23,2021-07-16,NA,49,48,50,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"317",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","1","75+","infection",NA,NA,2020-12-23,2021-07-16,NA,53,46,59,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"318",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","135+","infection",NA,NA,2020-12-23,2021-07-16,NA,11,10,12,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"319",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","1","14-74","severe",NA,NA,2020-12-23,2021-07-16,NA,41,-3,66,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"320",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14-74","severe",14,74,2020-12-23,2021-07-16,NA,46,28,60,"yes",NA,0,46,28,60,0.54,0.4,0.72,-0.616186139423817,0.149945577781153
"321",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","1","75+","severe",NA,NA,2020-12-23,2021-07-16,NA,4,-287,76,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"322",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","135+","severe",NA,NA,2020-12-23,2021-07-16,NA,34,24,42,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"323",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"omicron","Moderna mRNA-1273","mRNA","1","14-74","infection",NA,NA,2020-12-23,2021-07-16,NA,49,42,55,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"324",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"omicron","Moderna mRNA-1273","mRNA","2","14-74","infection",NA,NA,2020-12-23,2021-07-16,NA,48,44,52,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"325",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"omicron","Moderna mRNA-1273","mRNA","1","75+","infection",NA,NA,2020-12-23,2021-07-16,NA,60,36,75,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"326",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"omicron","Moderna mRNA-1273","mRNA","2","135+","infection",NA,NA,2020-12-23,2021-07-16,NA,20,17,22,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"327",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"omicron","Moderna mRNA-1273","mRNA","1","14-74","severe",NA,NA,2020-12-23,2021-07-16,NA,56,-78,89,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"328",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"omicron","Moderna mRNA-1273","mRNA","2","14-74","severe",14,74,2020-12-23,2021-07-16,NA,51,-20,80,"yes",NA,0,51,-20,80,0.49,0.2,1.25,-0.713349887877465,0.467495271364365
"329",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"omicron","Moderna mRNA-1273","mRNA","1","75+","severe",NA,NA,2020-12-23,2021-07-16,NA,-160,-1743,64,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"330",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"omicron","Moderna mRNA-1273","mRNA","2","135+","severe",NA,NA,2020-12-23,2021-07-16,NA,31,9,49,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"331",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"omicron","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","75-135","infection",NA,NA,2020-12-23,2021-07-16,NA,51,23,69,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"332",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"omicron","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","135+","infection",NA,NA,2020-12-23,2021-07-16,NA,5,1,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"333",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"omicron","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","75-135","severe",NA,NA,2020-12-23,2021-07-16,NA,-139,-861,41,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"334",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"omicron","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","135+","severe",NA,NA,2020-12-23,2021-07-16,NA,13,-8,30,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"335",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"omicron","Janssen Ad26.COV2.S","Vectored","1","14-74","infection",NA,NA,2020-12-23,2021-07-16,NA,47,45,49,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"336",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"omicron","Janssen Ad26.COV2.S","Vectored","1","135+","infection",NA,NA,2020-12-23,2021-07-16,NA,35,33,38,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"337",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"omicron","Janssen Ad26.COV2.S","Vectored","1","14-74","severe",NA,NA,2020-12-23,2021-07-16,NA,28,-22,57,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"338",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"omicron","Janssen Ad26.COV2.S","Vectored","1","135+","severe",NA,NA,2020-12-23,2021-07-16,NA,38,8,58,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"339",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","1","14-74","infection",NA,NA,2020-12-23,2021-07-16,NA,67,65,69,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"340",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14-74","infection",NA,NA,2020-12-23,2021-07-16,NA,82,81,83,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"341",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","1","75+","infection",NA,NA,2020-12-23,2021-07-16,NA,61,51,69,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"342",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","135+","infection",NA,NA,2020-12-23,2021-07-16,NA,54,53,55,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"343",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","1","14-74","severe",NA,NA,2020-12-23,2021-07-16,NA,53,40,63,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"344",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14-74","severe",14,74,2020-12-23,2021-07-16,NA,80,72,85,"yes",NA,0,80,72,85,0.2,0.15,0.28,-1.6094379124341,0.159223038028825
"345",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","1","75+","severe",NA,NA,2020-12-23,2021-07-16,NA,61,-20,87,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"346",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","135+","severe",NA,NA,2020-12-23,2021-07-16,NA,82,77,86,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"347",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"delta","Moderna mRNA-1273","mRNA","1","14-74","infection",NA,NA,2020-12-23,2021-07-16,NA,68,61,74,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"348",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"delta","Moderna mRNA-1273","mRNA","2","14-74","infection",NA,NA,2020-12-23,2021-07-16,NA,71,65,76,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"349",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"delta","Moderna mRNA-1273","mRNA","1","75+","infection",NA,NA,2020-12-23,2021-07-16,NA,67,34,84,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"350",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"delta","Moderna mRNA-1273","mRNA","2","135+","infection",NA,NA,2020-12-23,2021-07-16,NA,68,66,69,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"351",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"delta","Moderna mRNA-1273","mRNA","1","14-74","severe",NA,NA,2020-12-23,2021-07-16,NA,49,13,71,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"352",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"delta","Moderna mRNA-1273","mRNA","2","14-74","severe",NA,NA,2020-12-23,2021-07-16,NA,100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"353",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"delta","Moderna mRNA-1273","mRNA","1","75+","severe",NA,NA,2020-12-23,2021-07-16,NA,100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"354",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"delta","Moderna mRNA-1273","mRNA","2","135+","severe",NA,NA,2020-12-23,2021-07-16,NA,82,78,85,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"355",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","75-135","infection",NA,NA,2020-12-23,2021-07-16,NA,65,57,72,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"356",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","135+","infection",NA,NA,2020-12-23,2021-07-16,NA,45,43,48,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"357",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","75-135","severe",75,135,2020-12-23,2021-07-16,NA,80,62,89,"yes",NA,0,80,62,89,0.2,0.11,0.38,-1.6094379124341,0.316247675236739
"358",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","135+","severe",NA,NA,2020-12-23,2021-07-16,NA,68,64,71,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"359",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"delta","Janssen Ad26.COV2.S","Vectored","1","14-74","infection",NA,NA,2020-12-23,2021-07-16,NA,60,57,63,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"360",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"delta","Janssen Ad26.COV2.S","Vectored","1","135+","infection",NA,NA,2020-12-23,2021-07-16,NA,54,50,57,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"361",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"delta","Janssen Ad26.COV2.S","Vectored","1","14-74","severe",14,74,2020-12-23,2021-07-16,NA,54,39,65,"yes",NA,0,54,39,65,0.46,0.35,0.61,-0.776528789498996,0.14171576599079
"362",194,"Smid",2022-10-15,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","Czech Republic","CZE","Europe","High income",41530,2019,"delta","Janssen Ad26.COV2.S","Vectored","1","135+","severe",NA,NA,2020-12-23,2021-07-16,NA,61,51,69,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"363",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"other combinations","BioNTech/Pfizer BNT162b2","mRNA","1","21-83","severe",NA,NA,2020-12-23,2021-08-15,2021-10-31,61,49,71,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"364",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"other combinations","BioNTech/Pfizer BNT162b2","mRNA","1","84+","severe",NA,NA,2020-12-23,2021-08-15,2021-10-31,64,49,75,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"365",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"other combinations","BioNTech/Pfizer BNT162b2","mRNA","2","14-90","severe",NA,NA,2020-12-23,2021-08-15,2021-10-31,93,89,95,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"366",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"other combinations","BioNTech/Pfizer BNT162b2","mRNA","2","181+","severe",NA,NA,2020-12-23,2021-08-15,2021-10-31,69,63,74,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"367",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"other combinations","BioNTech/Pfizer BNT162b2","mRNA","1","21-83","severe",NA,NA,2020-12-23,2021-08-15,2021-10-31,84,63,93,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"368",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"other combinations","BioNTech/Pfizer BNT162b2","mRNA","1","84+","severe",NA,NA,2020-12-23,2021-08-15,2021-10-31,69,15,89,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"369",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"other combinations","BioNTech/Pfizer BNT162b2","mRNA","2","14-90","severe",NA,NA,2020-12-23,2021-08-15,2021-10-31,98,92,99,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"370",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"other combinations","BioNTech/Pfizer BNT162b2","mRNA","2","181+","severe",NA,NA,2020-12-23,2021-08-15,2021-10-31,79,65,87,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"371",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"other combinations","Moderna mRNA-1273","mRNA","1","21-83","severe",NA,NA,2020-12-23,2021-08-15,2021-10-31,70,43,84,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"372",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"other combinations","Moderna mRNA-1273","mRNA","1","84+","severe",NA,NA,2020-12-23,2021-08-15,2021-10-31,63,26,82,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"373",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"other combinations","Moderna mRNA-1273","mRNA","2","14-90","severe",NA,NA,2020-12-23,2021-08-15,2021-10-31,93,82,97,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"374",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"other combinations","Moderna mRNA-1273","mRNA","2","181+","severe",NA,NA,2020-12-23,2021-08-15,2021-10-31,73,59,83,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"375",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"other combinations","Moderna mRNA-1273","mRNA","1","21-83","severe",NA,NA,2020-12-23,2021-08-15,2021-10-31,70,-29,93,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"376",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"other combinations","Moderna mRNA-1273","mRNA","1","84+","severe",NA,NA,2020-12-23,2021-08-15,2021-10-31,100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"377",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"other combinations","Moderna mRNA-1273","mRNA","2","14-90","severe",NA,NA,2020-12-23,2021-08-15,2021-10-31,100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"378",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"other combinations","Moderna mRNA-1273","mRNA","2","181+","severe",NA,NA,2020-12-23,2021-08-15,2021-10-31,93,46,99,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"379",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"other combinations","Oxford/AstraZeneca ChAdOx1-S","Vectored","1","21-83","severe",NA,NA,2020-12-23,2021-08-15,2021-10-31,68,-3,90,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"380",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"other combinations","Oxford/AstraZeneca ChAdOx1-S","Vectored","1","84+","severe",NA,NA,2020-12-23,2021-08-15,2021-10-31,37,-95,80,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"381",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"other combinations","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14-90","severe",NA,NA,2020-12-23,2021-08-15,2021-10-31,81,49,93,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"382",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"other combinations","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","181+","severe",NA,NA,2020-12-23,2021-08-15,2021-10-31,48,17,68,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"383",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"other combinations","Oxford/AstraZeneca ChAdOx1-S","Vectored","1","21-83","severe",NA,NA,2020-12-23,2021-08-15,2021-10-31,68,-151,96,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"384",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"other combinations","Oxford/AstraZeneca ChAdOx1-S","Vectored","1","84+","severe",NA,NA,2020-12-23,2021-08-15,2021-10-31,100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"385",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"other combinations","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14-90","severe",NA,NA,2020-12-23,2021-08-15,2021-10-31,78,2,95,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"386",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"other combinations","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","181+","severe",NA,NA,2020-12-23,2021-08-15,2021-10-31,64,-14,89,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"387",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","1","21-83","severe",NA,NA,2020-12-23,2021-08-15,2021-10-31,53,-16,81,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"388",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","1","84+","severe",NA,NA,2020-12-23,2021-08-15,2021-10-31,68,45,81,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"389",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14-90","severe",14,90,2020-12-23,2021-08-15,2021-10-31,90,78,96,"yes",NA,1,90,78,96,0.1,0.04,0.22,-2.30258509299405,0.434884717407761
"390",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","181+","severe",NA,NA,2020-12-23,2021-08-15,2021-10-31,79,71,84,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"391",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"delta","Moderna mRNA-1273","mRNA","1","21-83","severe",NA,NA,2020-12-23,2021-08-15,2021-10-31,60,-189,94,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"392",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"delta","Moderna mRNA-1273","mRNA","1","84+","severe",NA,NA,2020-12-23,2021-08-15,2021-10-31,91,35,99,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"393",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"delta","Moderna mRNA-1273","mRNA","2","14-90","severe",14,90,2020-12-23,2021-08-15,2021-10-31,92,42,99,"yes",NA,1,92,42,99,0.08,0.01,0.58,-2.52572864430826,1.03582729860878
"394",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"delta","Moderna mRNA-1273","mRNA","2","181+","severe",NA,NA,2020-12-23,2021-08-15,2021-10-31,87,70,94,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"395",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","1","84+","severe",NA,NA,2020-12-23,2021-08-15,2021-10-31,62,-171,95,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"396",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","91-180","severe",91,180,2020-12-23,2021-08-15,2021-10-31,79,67,87,"yes",NA,1,79,67,87,0.21,0.13,0.33,-1.56064774826467,0.237642398980853
"397",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","181+","severe",NA,NA,2020-12-23,2021-08-15,2021-10-31,23,-76,67,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"398",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","1","21-83","severe",NA,NA,2020-12-23,2021-08-15,2021-10-31,22,-38,56,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"399",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","1","84+","severe",NA,NA,2020-12-23,2021-08-15,2021-10-31,61,34,77,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"400",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14-90","severe",14,90,2020-12-23,2021-08-15,2021-10-31,91,83,95,"yes",NA,1,91,83,95,0.09,0.05,0.17,-2.40794560865187,0.312187610107682
"401",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","181+","severe",NA,NA,2020-12-23,2021-08-15,2021-10-31,58,48,66,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"402",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"omicron","Moderna mRNA-1273","mRNA","1","21-83","severe",NA,NA,2020-12-23,2021-08-15,2021-10-31,81,-33,97,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"403",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"omicron","Moderna mRNA-1273","mRNA","1","84+","severe",NA,NA,2020-12-23,2021-08-15,2021-10-31,23,-63,64,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"404",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"omicron","Moderna mRNA-1273","mRNA","2","14-90","severe",14,90,2020-12-23,2021-08-15,2021-10-31,79,43,92,"yes",NA,1,79,43,92,0.21,0.08,0.57,-1.56064774826467,0.500920848508856
"405",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"omicron","Moderna mRNA-1273","mRNA","2","181+","severe",NA,NA,2020-12-23,2021-08-15,2021-10-31,60,34,75,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"406",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"omicron","Oxford/AstraZeneca ChAdOx1-S","Vectored","1","84+","severe",NA,NA,2020-12-23,2021-08-15,2021-10-31,100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"407",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"omicron","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","91-180","severe",91,180,2020-12-23,2021-08-15,2021-10-31,37,-154,85,"yes",NA,1,37,NA,85,0.63,0.15,NA,-0.462035459596559,0.732185982290471
"408",203,"Baum",2022-11-05,"2022 (Jul-Dec)","Retrospective cohort",">= 70 years","excluded","Finland","FIN","Europe","High income",52070,2019,"omicron","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","181+","severe",NA,NA,2020-12-23,2021-08-15,2021-10-31,51,12,73,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"409",218,"Starrfelt",2022-03-30,"2022 (Jan-Jun)","Retrospective cohort","general pop","excluded","Norway","NOR","Europe","High income",71400,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","1","21+","infection",NA,NA,2020-12-23,2021-08-12,2021-11-18,15.5,12.9,18,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"410",218,"Starrfelt",2022-03-30,"2022 (Jan-Jun)","Retrospective cohort","general pop","excluded","Norway","NOR","Europe","High income",71400,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","2-9 weeks","infection",NA,NA,2020-12-23,2021-08-12,2021-11-18,77.7,76.8,78.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"411",218,"Starrfelt",2022-03-30,"2022 (Jan-Jun)","Retrospective cohort","general pop","excluded","Norway","NOR","Europe","High income",71400,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2",">33 weeks","infection",NA,NA,2020-12-23,2021-08-12,2021-11-18,8.2,3.4,12.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"412",218,"Starrfelt",2022-03-30,"2022 (Jan-Jun)","Retrospective cohort","general pop","excluded","Norway","NOR","Europe","High income",71400,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","1","21+","severe",NA,NA,2020-12-23,2021-08-12,2021-11-18,75.3,66.4,81.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"413",218,"Starrfelt",2022-03-30,"2022 (Jan-Jun)","Retrospective cohort","general pop","excluded","Norway","NOR","Europe","High income",71400,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","2-9 weeks","severe",14,63,2020-12-23,2021-08-12,2021-11-18,97.5,95.6,98.6,"yes",NA,0,97.5,95.6,98.6,0.025,0.014,0.044,-3.68887945411394,0.292125587832399
"414",218,"Starrfelt",2022-03-30,"2022 (Jan-Jun)","Retrospective cohort","general pop","excluded","Norway","NOR","Europe","High income",71400,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2",">33 weeks","severe",NA,NA,2020-12-23,2021-08-12,2021-11-18,63.9,54.3,71.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"415",218,"Starrfelt",2022-03-30,"2022 (Jan-Jun)","Retrospective cohort","general pop","excluded","Norway","NOR","Europe","High income",71400,2019,"delta","Moderna mRNA-1273","mRNA","1","21+","infection",NA,NA,2020-12-23,2021-08-12,2021-11-18,38.1,34.7,41.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"416",218,"Starrfelt",2022-03-30,"2022 (Jan-Jun)","Retrospective cohort","general pop","excluded","Norway","NOR","Europe","High income",71400,2019,"delta","Moderna mRNA-1273","mRNA","2","2-9 weeks","infection",NA,NA,2020-12-23,2021-08-12,2021-11-18,86.6,85.6,87.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"417",218,"Starrfelt",2022-03-30,"2022 (Jan-Jun)","Retrospective cohort","general pop","excluded","Norway","NOR","Europe","High income",71400,2019,"delta","Moderna mRNA-1273","mRNA","2",">33 weeks","infection",NA,NA,2020-12-23,2021-08-12,2021-11-18,28.6,9.6,43.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"418",218,"Starrfelt",2022-03-30,"2022 (Jan-Jun)","Retrospective cohort","general pop","excluded","Norway","NOR","Europe","High income",71400,2019,"delta","Moderna mRNA-1273","mRNA","1","21+","severe",NA,NA,2020-12-23,2021-08-12,2021-11-18,77.1,58.9,87.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"419",218,"Starrfelt",2022-03-30,"2022 (Jan-Jun)","Retrospective cohort","general pop","excluded","Norway","NOR","Europe","High income",71400,2019,"delta","Moderna mRNA-1273","mRNA","2","18-25 weeks","severe",126,175,2020-12-23,2021-08-12,2021-11-18,95.3,91.5,97.4,"yes",NA,0,95.3,91.5,97.4,0.047,0.0259999999999999,0.085,-3.05760767727208,0.30218232614001
"420",218,"Starrfelt",2022-03-30,"2022 (Jan-Jun)","Retrospective cohort","general pop","excluded","Norway","NOR","Europe","High income",71400,2019,"delta","Moderna mRNA-1273","mRNA","2","26-33 weeks","severe",NA,NA,2020-12-23,2021-08-12,2021-11-18,91.1,84.9,94.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"421",218,"Starrfelt",2022-03-30,"2022 (Jan-Jun)","Retrospective cohort","general pop","excluded","Norway","NOR","Europe","High income",71400,2019,"delta","Multiple or heterologous RNA","mRNA","2","2-9 weeks","infection",NA,NA,2020-12-23,2021-08-12,2021-11-18,84.1,83.2,85,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"422",218,"Starrfelt",2022-03-30,"2022 (Jan-Jun)","Retrospective cohort","general pop","excluded","Norway","NOR","Europe","High income",71400,2019,"delta","Multiple or heterologous RNA","mRNA","2","18-25 weeks","infection",NA,NA,2020-12-23,2021-08-12,2021-11-18,40.7,23.9,53.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"423",230,"Plumb",2022-04-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","Multiple or heterologous RNA","mRNA","1","14+","severe",NA,NA,2020-12-13,2021-05-14,NA,33,15,47.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"424",230,"Plumb",2022-04-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",14,385,2020-12-13,2021-05-14,NA,37.3,25.8,46.9,"yes",NA,0,37.3,25.8,46.9,0.627,0.531,0.742,-0.466808738349216,0.0853538831442453
"425",230,"Plumb",2022-04-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","Moderna mRNA-1273","mRNA","2","14+","severe",14,385,2020-12-13,2021-05-14,NA,35.9,21.7,47.4,"yes",NA,0,35.9,21.7,47.4,0.641,0.526,0.783,-0.444725822061467,0.10148762327885
"426",230,"Plumb",2022-04-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"delta","Multiple or heterologous RNA","mRNA","1","14+","severe",NA,NA,2020-12-13,2021-05-14,NA,58.8,41.3,71.1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"427",230,"Plumb",2022-04-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",14,385,2020-12-13,2021-05-14,NA,50,39,59,"yes",NA,0,50,39,59,0.5,0.41,0.61,-0.693147180559945,0.101352499354338
"428",230,"Plumb",2022-04-12,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"delta","Moderna mRNA-1273","mRNA","2","14+","severe",14,385,2020-12-13,2021-05-14,NA,44,29.9,55.2,"yes",NA,0,44,29.9,55.2,0.56,0.448,0.701,-0.579818495252942,0.114212922096838
"429",235,"Voko",2022-07-22,"2022 (Jul-Dec)","Retrospective cohort","18-64 years","included","Hungary","HUN","Europe","High income",33630,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14-120","infection",NA,NA,2020-12-23,2021-06-05,NA,70.3,69.2,71.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"430",235,"Voko",2022-07-22,"2022 (Jul-Dec)","Retrospective cohort","18-64 years","included","Hungary","HUN","Europe","High income",33630,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","240+","infection",NA,NA,2020-12-23,2021-06-05,NA,0.6,-2.3,3.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"431",235,"Voko",2022-07-22,"2022 (Jul-Dec)","Retrospective cohort","18-64 years","included","Hungary","HUN","Europe","High income",33630,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14-120","severe",14,120,2020-12-23,2021-06-05,NA,82.6,80.1,84.7,"yes",NA,0,82.6,80.1,84.7,0.174,0.153,0.199,-1.74869997976761,0.0670578835030758
"432",235,"Voko",2022-07-22,"2022 (Jul-Dec)","Retrospective cohort","18-64 years","included","Hungary","HUN","Europe","High income",33630,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","240+","severe",NA,NA,2020-12-23,2021-06-05,NA,69.6,64.9,73.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"433",235,"Voko",2022-07-22,"2022 (Jul-Dec)","Retrospective cohort","18-64 years","included","Hungary","HUN","Europe","High income",33630,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14-120","death",NA,NA,2020-12-23,2021-06-05,NA,87.4,81.5,91.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"434",235,"Voko",2022-07-22,"2022 (Jul-Dec)","Retrospective cohort","18-64 years","included","Hungary","HUN","Europe","High income",33630,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","240+","death",NA,NA,2020-12-23,2021-06-05,NA,73.6,61.1,82.1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"435",235,"Voko",2022-07-22,"2022 (Jul-Dec)","Retrospective cohort","18-64 years","included","Hungary","HUN","Europe","High income",33630,2019,"delta","Moderna mRNA-1273","mRNA","2","14-120","infection",NA,NA,2020-12-23,2021-06-05,NA,76.9,73.3,80,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"436",235,"Voko",2022-07-22,"2022 (Jul-Dec)","Retrospective cohort","18-64 years","included","Hungary","HUN","Europe","High income",33630,2019,"delta","Moderna mRNA-1273","mRNA","2","240+","infection",NA,NA,2020-12-23,2021-06-05,NA,22.6,6.1,36.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"437",235,"Voko",2022-07-22,"2022 (Jul-Dec)","Retrospective cohort","18-64 years","included","Hungary","HUN","Europe","High income",33630,2019,"delta","Moderna mRNA-1273","mRNA","2","14-120","severe",14,120,2020-12-23,2021-06-05,NA,84.9,75.4,90.8,"yes",NA,0,84.9,75.4,90.8,0.151,0.0920000000000001,0.246,-1.89047544216721,0.250903816041664
"438",235,"Voko",2022-07-22,"2022 (Jul-Dec)","Retrospective cohort","18-64 years","included","Hungary","HUN","Europe","High income",33630,2019,"delta","Moderna mRNA-1273","mRNA","2","240+","severe",NA,NA,2020-12-23,2021-06-05,NA,42.5,-4,68.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"439",235,"Voko",2022-07-22,"2022 (Jul-Dec)","Retrospective cohort","18-64 years","included","Hungary","HUN","Europe","High income",33630,2019,"delta","Moderna mRNA-1273","mRNA","2","14-120","death",NA,NA,2020-12-23,2021-06-05,NA,77.7,30.7,92.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"440",235,"Voko",2022-07-22,"2022 (Jul-Dec)","Retrospective cohort","18-64 years","included","Hungary","HUN","Europe","High income",33630,2019,"delta","Moderna mRNA-1273","mRNA","2","240+","death",NA,NA,2020-12-23,2021-06-05,NA,100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"441",235,"Voko",2022-07-22,"2022 (Jul-Dec)","Retrospective cohort","18-64 years","included","Hungary","HUN","Europe","High income",33630,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14-120","infection",NA,NA,2020-12-23,2021-06-05,NA,39.2,36.4,41.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"442",235,"Voko",2022-07-22,"2022 (Jul-Dec)","Retrospective cohort","18-64 years","included","Hungary","HUN","Europe","High income",33630,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","240+","infection",NA,NA,2020-12-23,2021-06-05,NA,-14,-20.5,-7.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"443",235,"Voko",2022-07-22,"2022 (Jul-Dec)","Retrospective cohort","18-64 years","included","Hungary","HUN","Europe","High income",33630,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14-120","severe",14,120,2020-12-23,2021-06-05,NA,76.2,70.6,80.7,"yes",NA,0,76.2,70.6,80.7,0.238,0.193,0.294,-1.43548460531066,0.107369790416785
"444",235,"Voko",2022-07-22,"2022 (Jul-Dec)","Retrospective cohort","18-64 years","included","Hungary","HUN","Europe","High income",33630,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","240+","severe",NA,NA,2020-12-23,2021-06-05,NA,48.8,38.2,57.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"445",235,"Voko",2022-07-22,"2022 (Jul-Dec)","Retrospective cohort","18-64 years","included","Hungary","HUN","Europe","High income",33630,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14-120","death",NA,NA,2020-12-23,2021-06-05,NA,90.1,73.5,96.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"446",235,"Voko",2022-07-22,"2022 (Jul-Dec)","Retrospective cohort","18-64 years","included","Hungary","HUN","Europe","High income",33630,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","240+","death",NA,NA,2020-12-23,2021-06-05,NA,57.1,35.2,71.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"447",235,"Voko",2022-07-22,"2022 (Jul-Dec)","Retrospective cohort","18-64 years","included","Hungary","HUN","Europe","High income",33630,2019,"delta","Gamaleya Gam-COVID-Vac/Sputnik V","Vectored","2","14-120","infection",NA,NA,2020-12-23,2021-06-05,NA,38.3,31.8,44.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"448",235,"Voko",2022-07-22,"2022 (Jul-Dec)","Retrospective cohort","18-64 years","included","Hungary","HUN","Europe","High income",33630,2019,"delta","Gamaleya Gam-COVID-Vac/Sputnik V","Vectored","2","240+","infection",NA,NA,2020-12-23,2021-06-05,NA,-4.6,-12.5,2.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"449",235,"Voko",2022-07-22,"2022 (Jul-Dec)","Retrospective cohort","18-64 years","included","Hungary","HUN","Europe","High income",33630,2019,"delta","Gamaleya Gam-COVID-Vac/Sputnik V","Vectored","2","14-120","severe",NA,NA,2020-12-23,2021-06-05,NA,90.4,78.5,95.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"450",235,"Voko",2022-07-22,"2022 (Jul-Dec)","Retrospective cohort","18-64 years","included","Hungary","HUN","Europe","High income",33630,2019,"delta","Gamaleya Gam-COVID-Vac/Sputnik V","Vectored","2","240+","severe",NA,NA,2020-12-23,2021-06-05,NA,78.7,69.1,85.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"451",235,"Voko",2022-07-22,"2022 (Jul-Dec)","Retrospective cohort","18-64 years","included","Hungary","HUN","Europe","High income",33630,2019,"delta","Gamaleya Gam-COVID-Vac/Sputnik V","Vectored","2","121-180","death",NA,NA,2020-12-23,2021-06-05,NA,89.3,79.9,94.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"452",235,"Voko",2022-07-22,"2022 (Jul-Dec)","Retrospective cohort","18-64 years","included","Hungary","HUN","Europe","High income",33630,2019,"delta","Gamaleya Gam-COVID-Vac/Sputnik V","Vectored","2","240+","death",NA,NA,2020-12-23,2021-06-05,NA,79.1,59.8,89.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"453",235,"Voko",2022-07-22,"2022 (Jul-Dec)","Retrospective cohort","18-64 years","included","Hungary","HUN","Europe","High income",33630,2019,"delta","Janssen Ad26.COV2.S","Vectored","1","14-120","infection",NA,NA,2020-12-23,2021-06-05,NA,39.3,36.1,42.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"454",235,"Voko",2022-07-22,"2022 (Jul-Dec)","Retrospective cohort","18-64 years","included","Hungary","HUN","Europe","High income",33630,2019,"delta","Janssen Ad26.COV2.S","Vectored","1","181-240","infection",NA,NA,2020-12-23,2021-06-05,NA,35.9,32.5,39.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"455",235,"Voko",2022-07-22,"2022 (Jul-Dec)","Retrospective cohort","18-64 years","included","Hungary","HUN","Europe","High income",33630,2019,"delta","Janssen Ad26.COV2.S","Vectored","1","14-120","severe",14,120,2020-12-23,2021-06-05,NA,43.2,32.9,52,"yes",NA,0,43.2,32.9,52,0.568,0.48,0.671,-0.565633860260986,0.085454855374935
"456",235,"Voko",2022-07-22,"2022 (Jul-Dec)","Retrospective cohort","18-64 years","included","Hungary","HUN","Europe","High income",33630,2019,"delta","Janssen Ad26.COV2.S","Vectored","1","181-240","severe",NA,NA,2020-12-23,2021-06-05,NA,59.4,50.1,67,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"457",235,"Voko",2022-07-22,"2022 (Jul-Dec)","Retrospective cohort","18-64 years","included","Hungary","HUN","Europe","High income",33630,2019,"delta","Janssen Ad26.COV2.S","Vectored","1","14-120","death",NA,NA,2020-12-23,2021-06-05,NA,59.8,35.2,75.1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"458",235,"Voko",2022-07-22,"2022 (Jul-Dec)","Retrospective cohort","18-64 years","included","Hungary","HUN","Europe","High income",33630,2019,"delta","Janssen Ad26.COV2.S","Vectored","1","181-240","death",NA,NA,2020-12-23,2021-06-05,NA,76.1,56.7,86.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"459",235,"Voko",2022-07-22,"2022 (Jul-Dec)","Retrospective cohort","18-64 years","included","Hungary","HUN","Europe","High income",33630,2019,"delta","Beijing/Sinopharm BBIBP-CorV","Inactivated","2","14-120","infection",NA,NA,2020-12-23,2021-06-05,NA,10.9,6.7,15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"460",235,"Voko",2022-07-22,"2022 (Jul-Dec)","Retrospective cohort","18-64 years","included","Hungary","HUN","Europe","High income",33630,2019,"delta","Beijing/Sinopharm BBIBP-CorV","Inactivated","2","240+","infection",NA,NA,2020-12-23,2021-06-05,NA,-19.9,-31.9,-9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"461",235,"Voko",2022-07-22,"2022 (Jul-Dec)","Retrospective cohort","18-64 years","included","Hungary","HUN","Europe","High income",33630,2019,"delta","Beijing/Sinopharm BBIBP-CorV","Inactivated","2","14-120","severe",NA,NA,2020-12-23,2021-06-05,NA,53.8,43.9,61.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"462",235,"Voko",2022-07-22,"2022 (Jul-Dec)","Retrospective cohort","18-64 years","included","Hungary","HUN","Europe","High income",33630,2019,"delta","Beijing/Sinopharm BBIBP-CorV","Inactivated","2","240+","severe",NA,NA,2020-12-23,2021-06-05,NA,40.9,24.4,53.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"463",235,"Voko",2022-07-22,"2022 (Jul-Dec)","Retrospective cohort","18-64 years","included","Hungary","HUN","Europe","High income",33630,2019,"delta","Beijing/Sinopharm BBIBP-CorV","Inactivated","2","14-120","death",NA,NA,2020-12-23,2021-06-05,NA,67.4,39.2,82.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"464",235,"Voko",2022-07-22,"2022 (Jul-Dec)","Retrospective cohort","18-64 years","included","Hungary","HUN","Europe","High income",33630,2019,"delta","Beijing/Sinopharm BBIBP-CorV","Inactivated","2","240+","death",NA,NA,2020-12-23,2021-06-05,NA,50.7,21.4,69.1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"465",310,"Penayo",2022-06-01,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","Paraguay","PRY","South America","Upper middle income",13770,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",14,266,2021-02-22,2021-12-10,NA,91.9,72.2,97.6,"yes",NA,0,91.9,72.2,97.6,0.081,0.024,0.278,-2.5133061243097,0.624889613097625
"466",310,"Penayo",2022-06-01,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","Paraguay","PRY","South America","Upper middle income",13770,2019,"delta","Moderna mRNA-1273","mRNA","2","14+","severe",14,259,2021-02-22,2021-12-10,NA,76.1,-127.4,97.5,"yes",NA,0,76.1,NA,97.5,0.239,0.025,NA,-1.43129172705063,1.15183047299148
"467",310,"Penayo",2022-06-01,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","Paraguay","PRY","South America","Upper middle income",13770,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","severe",14,231,2021-02-22,2021-12-10,NA,83,66.3,91.5,"yes",NA,0,83,66.3,91.5,0.17,0.085,0.337,-1.77195684193187,0.351385631087257
"468",310,"Penayo",2022-06-01,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","Paraguay","PRY","South America","Upper middle income",13770,2019,"delta","Gamaleya Gam-COVID-Vac/Sputnik V","Vectored","2","14+","severe",NA,NA,2021-02-22,2021-12-10,NA,83.2,48.9,94.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"469",310,"Penayo",2022-06-01,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","Paraguay","PRY","South America","Upper middle income",13770,2019,"delta","Beijing/Sinopharm BBIBP-CorV","Inactivated","2","14+","severe",NA,NA,2021-02-22,2021-12-10,NA,31.8,-41.2,67.1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"470",310,"Penayo",2022-06-01,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","Paraguay","PRY","South America","Upper middle income",13770,2019,"delta","Bharat Covaxin/BBV152","Inactivated","2","14+","severe",NA,NA,2021-02-22,2021-12-10,NA,25.8,-37.1,59.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"471",310,"Penayo",2022-06-01,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","Paraguay","PRY","South America","Upper middle income",13770,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",14,371,2021-02-22,2021-12-10,NA,49.5,9.9,71.7,"yes",NA,0,49.5,9.9,71.7,0.505,0.283,0.901,-0.683196849706777,0.295423051011505
"472",310,"Penayo",2022-06-01,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","Paraguay","PRY","South America","Upper middle income",13770,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14-89","severe",NA,NA,2021-02-22,2021-12-10,NA,78,-97,97.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"473",310,"Penayo",2022-06-01,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","Paraguay","PRY","South America","Upper middle income",13770,2019,"omicron","Moderna mRNA-1273","mRNA","2","14+","severe",14,364,2021-02-22,2021-12-10,NA,42.1,-105.4,83.7,"yes",NA,0,42.1,NA,83.7,0.579,0.163,NA,-0.546452801409142,0.646710345288895
"474",310,"Penayo",2022-06-01,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","Paraguay","PRY","South America","Upper middle income",13770,2019,"omicron","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","severe",14,336,2021-02-22,2021-12-10,NA,10.1,-31,38.3,"yes",NA,0,10.1,-31,38.3,0.899,0.617,1.44927536231884,-0.106472244510517,0.217844371547852
"475",310,"Penayo",2022-06-01,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","Paraguay","PRY","South America","Upper middle income",13770,2019,"omicron","Gamaleya Gam-COVID-Vac/Sputnik V","Vectored","2","14+","severe",NA,NA,2021-02-22,2021-12-10,NA,25.7,-29.9,57.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"476",310,"Penayo",2022-06-01,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","Paraguay","PRY","South America","Upper middle income",13770,2019,"omicron","Gamaleya Gam-COVID-Vac/Sputnik V","Vectored","2","14-89","severe",NA,NA,2021-02-22,2021-12-10,NA,64.4,-44.6,92.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"477",310,"Penayo",2022-06-01,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","Paraguay","PRY","South America","Upper middle income",13770,2019,"omicron","Beijing/Sinopharm BBIBP-CorV","Inactivated","2","14+","severe",NA,NA,2021-02-22,2021-12-10,NA,40.4,-5.1,66.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"478",310,"Penayo",2022-06-01,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","Paraguay","PRY","South America","Upper middle income",13770,2019,"omicron","Bharat Covaxin/BBV152","Inactivated","2","14+","severe",NA,NA,2021-02-22,2021-12-10,NA,13,-45.8,48,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"479",311,"Monge",2022-09-02,"2022 (Jul-Dec)","Case cohort","50-59 years","included","Spain","ESP","Europe","High income",43160,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14+","infection",NA,NA,2020-12-30,2021-07-04,2021-08-31,77,76,77,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"480",311,"Monge",2022-09-02,"2022 (Jul-Dec)","Case cohort","50-59 years","included","Spain","ESP","Europe","High income",43160,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14+","symptomatic",NA,NA,2020-12-30,2021-07-04,2021-08-31,77,76,78,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"481",311,"Monge",2022-09-02,"2022 (Jul-Dec)","Case cohort","50-59 years","included","Spain","ESP","Europe","High income",43160,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",14,147,2020-12-30,2021-07-04,2021-08-31,97,97,98,"yes",NA,0,97,97,98,0.03,0.02,0.03,-3.50655789731998,0.103434976558205
"482",311,"Monge",2022-09-02,"2022 (Jul-Dec)","Case cohort","50-59 years","included","Spain","ESP","Europe","High income",43160,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14+","death",NA,NA,2020-12-30,2021-07-04,2021-08-31,97,93,99,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"483",311,"Monge",2022-09-02,"2022 (Jul-Dec)","Case cohort","50-59 years","included","Spain","ESP","Europe","High income",43160,2019,"delta","Moderna mRNA-1273","mRNA","2","14+","infection",NA,NA,2020-12-30,2021-07-04,2021-08-31,87,86,87,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"484",311,"Monge",2022-09-02,"2022 (Jul-Dec)","Case cohort","50-59 years","included","Spain","ESP","Europe","High income",43160,2019,"delta","Moderna mRNA-1273","mRNA","2","14+","symptomatic",NA,NA,2020-12-30,2021-07-04,2021-08-31,89,88,90,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"485",311,"Monge",2022-09-02,"2022 (Jul-Dec)","Case cohort","50-59 years","included","Spain","ESP","Europe","High income",43160,2019,"delta","Moderna mRNA-1273","mRNA","2","14+","severe",14,147,2020-12-30,2021-07-04,2021-08-31,98,97,99,"yes",NA,0,98,97,99,0.02,0.01,0.03,-3.91202300542815,0.28025823690513
"486",311,"Monge",2022-09-02,"2022 (Jul-Dec)","Case cohort","50-59 years","included","Spain","ESP","Europe","High income",43160,2019,"delta","Moderna mRNA-1273","mRNA","2","14+","death",NA,NA,2020-12-30,2021-07-04,2021-08-31,94,75,99,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"487",311,"Monge",2022-09-02,"2022 (Jul-Dec)","Case cohort","50-59 years","included","Spain","ESP","Europe","High income",43160,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","infection",NA,NA,2020-12-30,2021-07-04,2021-08-31,59,56,61,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"488",311,"Monge",2022-09-02,"2022 (Jul-Dec)","Case cohort","50-59 years","included","Spain","ESP","Europe","High income",43160,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","symptomatic",NA,NA,2020-12-30,2021-07-04,2021-08-31,59,55,62,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"489",311,"Monge",2022-09-02,"2022 (Jul-Dec)","Case cohort","50-59 years","included","Spain","ESP","Europe","High income",43160,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","severe",14,147,2020-12-30,2021-07-04,2021-08-31,96,93,98,"yes",NA,0,96,93,98,0.04,0.02,0.07,-3.2188758248682,0.319582389922287
"490",311,"Monge",2022-09-02,"2022 (Jul-Dec)","Case cohort","50-59 years","included","Spain","ESP","Europe","High income",43160,2019,"delta","Janssen Ad26.COV2.S","Vectored","1","14+","infection",NA,NA,2020-12-30,2021-07-04,2021-08-31,64,62,66,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"491",311,"Monge",2022-09-02,"2022 (Jul-Dec)","Case cohort","50-59 years","included","Spain","ESP","Europe","High income",43160,2019,"delta","Janssen Ad26.COV2.S","Vectored","1","14+","symptomatic",NA,NA,2020-12-30,2021-07-04,2021-08-31,56,53,59,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"492",311,"Monge",2022-09-02,"2022 (Jul-Dec)","Case cohort","50-59 years","included","Spain","ESP","Europe","High income",43160,2019,"delta","Janssen Ad26.COV2.S","Vectored","1","14+","severe",14,147,2020-12-30,2021-07-04,2021-08-31,86,83,89,"yes",NA,0,86,83,89,0.14,0.11,0.17,-1.96611285637283,0.111050528382104
"493",311,"Monge",2022-09-02,"2022 (Jul-Dec)","Case cohort","50-59 years","included","Spain","ESP","Europe","High income",43160,2019,"delta","Janssen Ad26.COV2.S","Vectored","1","14+","death",NA,NA,2020-12-30,2021-07-04,2021-08-31,89,64,97,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"494",311,"Monge",2022-09-02,"2022 (Jul-Dec)","Case cohort","50-59 years","included","Spain","ESP","Europe","High income",43160,2019,"delta","Heterologous platforms","Multiple","2","14+","infection",NA,NA,2020-12-30,2021-07-04,2021-08-31,88,85,91,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"495",311,"Monge",2022-09-02,"2022 (Jul-Dec)","Case cohort","50-59 years","included","Spain","ESP","Europe","High income",43160,2019,"delta","Heterologous platforms","Multiple","2","14+","symptomatic",NA,NA,2020-12-30,2021-07-04,2021-08-31,82,75,87,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"496",311,"Monge",2022-09-02,"2022 (Jul-Dec)","Case cohort","50-59 years","included","Spain","ESP","Europe","High income",43160,2019,"delta","Heterologous platforms","Multiple","2","14+","severe",NA,NA,2020-12-30,2021-07-04,2021-08-31,98,84,100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"497",315,"Chatzilena",2022-12-07,"2022 (Jul-Dec)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","7+","severe",7,392,2020-12-21,2021-06-04,2021-12-23,82.5,76.2,87.2,"yes",NA,0,82.5,76.2,87.2,0.175,0.128,0.238,-1.74296930505862,0.158224594324453
"498",315,"Chatzilena",2022-12-07,"2022 (Jul-Dec)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2",">=3 months","severe",NA,NA,2020-12-21,2021-06-04,2021-12-23,91.5,83.1,96.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"499",315,"Chatzilena",2022-12-07,"2022 (Jul-Dec)","Test-negative case-control","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2",">3 months","severe",NA,NA,2020-12-21,2021-06-04,2021-12-23,79.5,71.5,85.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"500",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","~47 weeks","infection",NA,NA,2020-12-13,2021-05-14,NA,37.5,36,39,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"501",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","~60 weeks","infection",NA,NA,2020-12-13,2021-05-14,NA,0.8,-1.5,3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"502",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","~47 weeks","severe",NA,329,2020-12-13,2021-05-14,NA,58.8,49.3,66.5,"yes",NA,0,58.8,49.3,66.5,0.412,0.335,0.507,-0.886731929632611,0.105709304021969
"503",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","~60 weeks","severe",NA,NA,2020-12-13,2021-05-14,NA,29.4,50.4,76.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"504",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","~47 weeks","death",NA,NA,2020-12-13,2021-05-14,NA,75.2,67.7,81,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"505",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","~60 weeks","death",NA,NA,2020-12-13,2021-05-14,NA,59.1,27.2,77,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"506",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","Moderna mRNA-1273","mRNA","2","~46 weeks","infection",NA,NA,2020-12-13,2021-05-14,NA,47.2,45.8,48.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"507",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","Moderna mRNA-1273","mRNA","2","~59 weeks","infection",NA,NA,2020-12-13,2021-05-14,NA,30.3,28.9,32.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"508",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","Moderna mRNA-1273","mRNA","2","~46 weeks","severe",NA,322,2020-12-13,2021-05-14,NA,64.7,57.2,70.9,"yes",NA,0,64.7,57.2,70.9,0.353,0.291,0.428,-1.04128722204884,0.0984183490842613
"509",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","Moderna mRNA-1273","mRNA","2","~59 weeks","severe",NA,NA,2020-12-13,2021-05-14,NA,61.5,49.6,70.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"510",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","Moderna mRNA-1273","mRNA","2","~46 weeks","death",NA,NA,2020-12-13,2021-05-14,NA,69.6,62.3,75.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"511",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","Moderna mRNA-1273","mRNA","2","~59 weeks","death",NA,NA,2020-12-13,2021-05-14,NA,48.3,22.6,65.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"512",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","Janssen Ad26.COV2.S","Vectored","2","~41 weeks","infection",NA,NA,2020-12-13,2021-05-14,NA,48.8,47.2,50.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"513",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","Janssen Ad26.COV2.S","Vectored","2","~54 weeks","infection",NA,NA,2020-12-13,2021-05-14,NA,49,46.4,51.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"514",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","Janssen Ad26.COV2.S","Vectored","2","~41 weeks","severe",NA,NA,2020-12-13,2021-05-14,NA,65.3,58.3,71.1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"515",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","Janssen Ad26.COV2.S","Vectored","2","~54 weeks","severe",NA,NA,2020-12-13,2021-05-14,NA,53.3,26.7,70.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"516",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","Janssen Ad26.COV2.S","Vectored","2","~41 weeks","death",NA,NA,2020-12-13,2021-05-14,NA,76.1,69.2,81.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"517",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","Janssen Ad26.COV2.S","Vectored","2","~54 weeks","death",NA,NA,2020-12-13,2021-05-14,NA,77.5,19.6,93.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"518",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","~25 weeks","infection",NA,NA,2020-12-13,2021-05-14,NA,54.3,53.6,55,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"519",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","~38 weeks","infection",NA,NA,2020-12-13,2021-05-14,NA,47.4,46.6,48.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"520",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","~25 weeks","severe",NA,175,2020-12-13,2021-05-14,NA,85.8,83.4,87.8,"yes",NA,0,85.8,83.4,87.8,0.142,0.122,0.166,-1.95192822138088,0.0785629448018587
"521",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","~38 weeks","severe",NA,NA,2020-12-13,2021-05-14,NA,70.9,65.3,75.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"522",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","~25 weeks","death",NA,NA,2020-12-13,2021-05-14,NA,89.6,87,91.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"523",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","~38 weeks","death",NA,NA,2020-12-13,2021-05-14,NA,77.4,70.6,82.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"524",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"delta","Moderna mRNA-1273","mRNA","2","~24 weeks","infection",NA,NA,2020-12-13,2021-05-14,NA,69.2,68.5,69.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"525",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"delta","Moderna mRNA-1273","mRNA","2","~37 weeks","infection",NA,NA,2020-12-13,2021-05-14,NA,48.4,47.5,49.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"526",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"delta","Moderna mRNA-1273","mRNA","2","~24 weeks","severe",NA,168,2020-12-13,2021-05-14,NA,89.8,88.1,91.3,"yes",NA,0,89.8,88.1,91.3,0.102,0.0870000000000001,0.119,-2.28278246569787,0.0799018812390167
"527",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"delta","Moderna mRNA-1273","mRNA","2","~37 weeks","severe",NA,NA,2020-12-13,2021-05-14,NA,72.7,67.8,77,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"528",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"delta","Moderna mRNA-1273","mRNA","2","~24 weeks","death",NA,NA,2020-12-13,2021-05-14,NA,93,91.1,94.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"529",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"delta","Moderna mRNA-1273","mRNA","2","~37 weeks","death",NA,NA,2020-12-13,2021-05-14,NA,85.1,80.1,88.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"530",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"delta","Janssen Ad26.COV2.S","Vectored","2","~20 weeks","infection",NA,NA,2020-12-13,2021-05-14,NA,59.2,57.7,60.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"531",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"delta","Janssen Ad26.COV2.S","Vectored","2","~33 weeks","infection",NA,NA,2020-12-13,2021-05-14,NA,60.5,58.9,62.1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"532",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"delta","Janssen Ad26.COV2.S","Vectored","2","~20 weeks","severe",NA,140,2020-12-13,2021-05-14,NA,77.9,72.2,82.4,"yes",NA,0,77.9,72.2,82.4,0.221,0.176,0.278,-1.50959257746438,0.116616611901144
"533",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"delta","Janssen Ad26.COV2.S","Vectored","2","~33 weeks","severe",NA,NA,2020-12-13,2021-05-14,NA,70,64.8,74.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"534",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"delta","Janssen Ad26.COV2.S","Vectored","2","~20 weeks","death",NA,NA,2020-12-13,2021-05-14,NA,83.8,76.1,89,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"535",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"delta","Janssen Ad26.COV2.S","Vectored","2","~33 weeks","death",NA,NA,2020-12-13,2021-05-14,NA,79.2,73.1,84,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"536",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"alpha","BioNTech/Pfizer BNT162b2","mRNA","2","~3 weeks","infection",NA,NA,2020-12-13,2021-05-14,NA,67.6,66.9,68.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"537",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"alpha","BioNTech/Pfizer BNT162b2","mRNA","2","~21 weeks","infection",NA,NA,2020-12-13,2021-05-14,NA,58.6,58,59.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"538",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"alpha","BioNTech/Pfizer BNT162b2","mRNA","2","~3 weeks","severe",NA,NA,2020-12-13,2021-05-14,NA,94.1,92.2,95.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"539",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"alpha","BioNTech/Pfizer BNT162b2","mRNA","2","~21 weeks","severe",NA,NA,2020-12-13,2021-05-14,NA,87.1,85,88.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"540",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"alpha","BioNTech/Pfizer BNT162b2","mRNA","2","~3 weeks","death",NA,NA,2020-12-13,2021-05-14,NA,97.1,94.7,98.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"541",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"alpha","BioNTech/Pfizer BNT162b2","mRNA","2","~21 weeks","death",NA,NA,2020-12-13,2021-05-14,NA,91.9,89.4,93.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"542",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"alpha","Moderna mRNA-1273","mRNA","2","~2 weeks","infection",NA,NA,2020-12-13,2021-05-14,NA,90.1,89.6,90.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"543",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"alpha","Moderna mRNA-1273","mRNA","2","~20 weeks","infection",NA,NA,2020-12-13,2021-05-14,NA,71.9,71.3,72.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"544",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"alpha","Moderna mRNA-1273","mRNA","2","~2 weeks","severe",NA,NA,2020-12-13,2021-05-14,NA,96.5,95.1,97.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"545",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"alpha","Moderna mRNA-1273","mRNA","2","~20 weeks","severe",NA,NA,2020-12-13,2021-05-14,NA,90.4,88.6,91.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"546",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"alpha","Moderna mRNA-1273","mRNA","2","~2 weeks","death",NA,NA,2020-12-13,2021-05-14,NA,97.2,95.1,98.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"547",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"alpha","Moderna mRNA-1273","mRNA","2","~20 weeks","death",NA,NA,2020-12-13,2021-05-14,NA,92.8,90.3,94.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"548",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"alpha","Janssen Ad26.COV2.S","Vectored","2","~2 weeks","infection",NA,NA,2020-12-13,2021-05-14,NA,70.6,68.8,72.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"549",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"alpha","Janssen Ad26.COV2.S","Vectored","2","~10 weeks","infection",NA,NA,2020-12-13,2021-05-14,NA,63,60.8,65,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"550",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"alpha","Janssen Ad26.COV2.S","Vectored","2","~2 weeks","severe",NA,NA,2020-12-13,2021-05-14,NA,67.9,56.5,76.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"551",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"alpha","Janssen Ad26.COV2.S","Vectored","2","~10 weeks","severe",NA,NA,2020-12-13,2021-05-14,NA,79.3,71.7,84.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"552",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"alpha","Janssen Ad26.COV2.S","Vectored","2","~2 weeks","death",NA,NA,2020-12-13,2021-05-14,NA,85.7,74.6,91.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"553",326,"Lin",2022-09-26,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"alpha","Janssen Ad26.COV2.S","Vectored","2","~10 weeks","death",NA,NA,2020-12-13,2021-05-14,NA,80.5,75.7,84.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"554",336,"Embi",2023-05-22,"2023 (Jan-Jun)","Test-negative case-control","immunocompetent adults","included","USA","USA","North America","High income",66120,2019,"delta","Moderna mRNA-1273","mRNA","2","14-149","symptomatic",NA,NA,2020-12-13,2021-05-14,NA,90,89,91,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"555",336,"Embi",2023-05-22,"2023 (Jan-Jun)","Test-negative case-control","immunocompetent adults","included","USA","USA","North America","High income",66120,2019,"delta","Moderna mRNA-1273","mRNA","2","150+","symptomatic",NA,NA,2020-12-13,2021-05-14,NA,84,83,85,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"556",336,"Embi",2023-05-22,"2023 (Jan-Jun)","Test-negative case-control","immunocompetent adults","included","USA","USA","North America","High income",66120,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14-149","symptomatic",NA,NA,2020-12-13,2021-05-14,NA,85,84,86,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"557",336,"Embi",2023-05-22,"2023 (Jan-Jun)","Test-negative case-control","immunocompetent adults","included","USA","USA","North America","High income",66120,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","150+","symptomatic",NA,NA,2020-12-13,2021-05-14,NA,73,72,74,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"558",336,"Embi",2023-05-22,"2023 (Jan-Jun)","Test-negative case-control","immunocompetent adults","included","USA","USA","North America","High income",66120,2019,"delta","Moderna mRNA-1273","mRNA","2","14-149","severe",14,149,2020-12-13,2021-05-14,NA,95,92,95,"yes",NA,0,95,92,95,0.05,0.05,0.08,-2.99573227355399,0.119898885011667
"559",336,"Embi",2023-05-22,"2023 (Jan-Jun)","Test-negative case-control","immunocompetent adults","included","USA","USA","North America","High income",66120,2019,"delta","Moderna mRNA-1273","mRNA","2","150+","severe",NA,NA,2020-12-13,2021-05-14,NA,89,88,90,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"560",336,"Embi",2023-05-22,"2023 (Jan-Jun)","Test-negative case-control","immunocompetent adults","included","USA","USA","North America","High income",66120,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14-149","severe",14,149,2020-12-13,2021-05-14,NA,90,88,91,"yes",NA,0,90,88,91,0.1,0.09,0.12,-2.30258509299405,0.0733882837887197
"561",336,"Embi",2023-05-22,"2023 (Jan-Jun)","Test-negative case-control","immunocompetent adults","included","USA","USA","North America","High income",66120,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","150+","severe",NA,NA,2020-12-13,2021-05-14,NA,80,79,82,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"562",336,"Embi",2023-05-22,"2023 (Jan-Jun)","Test-negative case-control","immunocompromised adults","included","USA","USA","North America","High income",66120,2019,"delta","Moderna mRNA-1273","mRNA","2","14-149","symptomatic",NA,NA,2020-12-13,2021-05-14,NA,79,64,88,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"563",336,"Embi",2023-05-22,"2023 (Jan-Jun)","Test-negative case-control","immunocompromised adults","included","USA","USA","North America","High income",66120,2019,"delta","Moderna mRNA-1273","mRNA","2","150+","symptomatic",NA,NA,2020-12-13,2021-05-14,NA,64,54,72,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"564",336,"Embi",2023-05-22,"2023 (Jan-Jun)","Test-negative case-control","immunocompromised adults","included","USA","USA","North America","High income",66120,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14-149","symptomatic",NA,NA,2020-12-13,2021-05-14,NA,62,45,73,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"565",336,"Embi",2023-05-22,"2023 (Jan-Jun)","Test-negative case-control","immunocompromised adults","included","USA","USA","North America","High income",66120,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","150+","symptomatic",NA,NA,2020-12-13,2021-05-14,NA,56,46,64,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"566",336,"Embi",2023-05-22,"2023 (Jan-Jun)","Test-negative case-control","immunocompromised adults","included","USA","USA","North America","High income",66120,2019,"delta","Moderna mRNA-1273","mRNA","2","14-149","severe",NA,NA,2020-12-13,2021-05-14,NA,81,69,88,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"567",336,"Embi",2023-05-22,"2023 (Jan-Jun)","Test-negative case-control","immunocompromised adults","included","USA","USA","North America","High income",66120,2019,"delta","Moderna mRNA-1273","mRNA","2","150+","severe",NA,NA,2020-12-13,2021-05-14,NA,73,68,77,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"568",336,"Embi",2023-05-22,"2023 (Jan-Jun)","Test-negative case-control","immunocompromised adults","included","USA","USA","North America","High income",66120,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14-149","severe",NA,NA,2020-12-13,2021-05-14,NA,68,58,75,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"569",336,"Embi",2023-05-22,"2023 (Jan-Jun)","Test-negative case-control","immunocompromised adults","included","USA","USA","North America","High income",66120,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","150+","severe",NA,NA,2020-12-13,2021-05-14,NA,64,58,69,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"570",336,"Embi",2023-05-22,"2023 (Jan-Jun)","Test-negative case-control","immunocompetent adults","included","USA","USA","North America","High income",66120,2019,"delta","Janssen Ad26.COV2.S","Vectored","1","14-149","symptomatic",NA,NA,2020-12-13,2021-05-14,NA,67,63,71,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"571",336,"Embi",2023-05-22,"2023 (Jan-Jun)","Test-negative case-control","immunocompetent adults","included","USA","USA","North America","High income",66120,2019,"delta","Janssen Ad26.COV2.S","Vectored","1","150+","symptomatic",NA,NA,2020-12-13,2021-05-14,NA,62,58,65,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"572",336,"Embi",2023-05-22,"2023 (Jan-Jun)","Test-negative case-control","immunocompetent adults","included","USA","USA","North America","High income",66120,2019,"delta","Janssen Ad26.COV2.S","Vectored","1","14-149","severe",14,149,2020-12-13,2021-05-14,NA,77,71,82,"yes",NA,0,77,71,82,0.23,0.18,0.29,-1.46967597005894,0.121664304104671
"573",336,"Embi",2023-05-22,"2023 (Jan-Jun)","Test-negative case-control","immunocompetent adults","included","USA","USA","North America","High income",66120,2019,"delta","Janssen Ad26.COV2.S","Vectored","1","150+","severe",NA,NA,2020-12-13,2021-05-14,NA,69,65,73,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"574",336,"Embi",2023-05-22,"2023 (Jan-Jun)","Test-negative case-control","immunocompromised adults","included","USA","USA","North America","High income",66120,2019,"delta","Janssen Ad26.COV2.S","Vectored","1","14-149","symptomatic",NA,NA,2020-12-13,2021-05-14,NA,9,-66,50,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"575",336,"Embi",2023-05-22,"2023 (Jan-Jun)","Test-negative case-control","immunocompromised adults","included","USA","USA","North America","High income",66120,2019,"delta","Janssen Ad26.COV2.S","Vectored","1","150+","symptomatic",NA,NA,2020-12-13,2021-05-14,NA,-6,-49,25,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"576",336,"Embi",2023-05-22,"2023 (Jan-Jun)","Test-negative case-control","immunocompromised adults","included","USA","USA","North America","High income",66120,2019,"delta","Janssen Ad26.COV2.S","Vectored","1","14-149","severe",NA,NA,2020-12-13,2021-05-14,NA,35,-3,60,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"577",336,"Embi",2023-05-22,"2023 (Jan-Jun)","Test-negative case-control","immunocompromised adults","included","USA","USA","North America","High income",66120,2019,"delta","Janssen Ad26.COV2.S","Vectored","1","150+","severe",NA,NA,2020-12-13,2021-05-14,NA,43,23,58,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"578",387,"Altarawneh",2023-07-27,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Qatar","QAT","Asia","High income",92300,2019,"alpha","BioNTech/Pfizer BNT162b2","mRNA","2","14+","symptomatic",NA,NA,2021-01-28,2021-05-31,2021-08-16,90.5,83.9,94.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"579",387,"Altarawneh",2023-07-27,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Qatar","QAT","Asia","High income",92300,2019,"alpha","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",NA,NA,2021-01-28,2021-05-31,2021-08-16,96.1,71.2,99.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"580",387,"Altarawneh",2023-07-27,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Qatar","QAT","Asia","High income",92300,2019,"beta","BioNTech/Pfizer BNT162b2","mRNA","2","14+","symptomatic",NA,NA,2021-01-28,2021-05-31,2021-08-16,80.5,79,82,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"581",387,"Altarawneh",2023-07-27,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Qatar","QAT","Asia","High income",92300,2019,"beta","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",NA,NA,2021-01-28,2021-05-31,2021-08-16,97.4,95.8,98.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"582",387,"Altarawneh",2023-07-27,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Qatar","QAT","Asia","High income",92300,2019,"beta","Moderna mRNA-1273","mRNA","2","14+","symptomatic",NA,NA,2021-01-28,2021-05-31,2021-08-16,96,91.6,98.1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"583",387,"Altarawneh",2023-07-27,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Qatar","QAT","Asia","High income",92300,2019,"beta","Moderna mRNA-1273","mRNA","2","14+","severe",NA,NA,2021-01-28,2021-05-31,2021-08-16,100,92.2,100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"584",387,"Altarawneh",2023-07-27,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Qatar","QAT","Asia","High income",92300,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14+","symptomatic",NA,NA,2021-01-28,2021-05-31,2021-08-16,58.1,54.6,61.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"585",387,"Altarawneh",2023-07-27,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Qatar","QAT","Asia","High income",92300,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",14,336,2021-01-28,2021-05-31,2021-08-16,91.1,86.3,94.2,"yes",NA,0,91.1,86.3,94.2,0.0890000000000001,0.0579999999999999,0.137,-2.41911890925,0.219269876347374
"586",387,"Altarawneh",2023-07-27,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Qatar","QAT","Asia","High income",92300,2019,"delta","Moderna mRNA-1273","mRNA","2","14+","symptomatic",NA,NA,2021-01-28,2021-05-31,2021-08-16,71,66.4,74.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"587",387,"Altarawneh",2023-07-27,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Qatar","QAT","Asia","High income",92300,2019,"delta","Moderna mRNA-1273","mRNA","2","14+","severe",14,336,2021-01-28,2021-05-31,2021-08-16,97.9,91.2,99.5,"yes",NA,0,97.9,91.2,99.5,0.0209999999999999,0.005,0.088,-3.86323284125872,0.731606862766353
"588",418,"Paternina-Caicedo",2023-09-09,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Colombia","COL","South America","Upper middle income",15530,2019,"omicron","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14-44","symptomatic",NA,NA,2021-02-17,2021-10-26,2022-07-29,36,24,47,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"589",418,"Paternina-Caicedo",2023-09-09,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Colombia","COL","South America","Upper middle income",15530,2019,"omicron","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","165+","symptomatic",NA,NA,2021-02-17,2021-10-26,2022-07-29,-8,-34,13,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"590",418,"Paternina-Caicedo",2023-09-09,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Colombia","COL","South America","Upper middle income",15530,2019,"omicron","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","severe",14,301,2021-02-17,2021-10-26,2022-07-29,10,-78,55,"yes",NA,0,10,-78,55,0.9,0.45,4.54545454545455,-0.105360515657826,0.58995801756315
"591",418,"Paternina-Caicedo",2023-09-09,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Colombia","COL","South America","Upper middle income",15530,2019,"omicron","Sinovac CoronaVac","Inactivated","2","14-44","symptomatic",NA,NA,2021-02-17,2021-10-26,2022-07-29,37,8,56,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"592",418,"Paternina-Caicedo",2023-09-09,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Colombia","COL","South America","Upper middle income",15530,2019,"omicron","Sinovac CoronaVac","Inactivated","2","165+","symptomatic",NA,NA,2021-02-17,2021-10-26,2022-07-29,-36,-48,24,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"593",418,"Paternina-Caicedo",2023-09-09,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Colombia","COL","South America","Upper middle income",15530,2019,"omicron","Sinovac CoronaVac","Inactivated","2","14+","severe",NA,NA,2021-02-17,2021-10-26,2022-07-29,7,-41,38,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"594",418,"Paternina-Caicedo",2023-09-09,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Colombia","COL","South America","Upper middle income",15530,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14-44","symptomatic",NA,NA,2021-02-17,2021-10-26,2022-07-29,59,45,70,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"595",418,"Paternina-Caicedo",2023-09-09,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Colombia","COL","South America","Upper middle income",15530,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","165+","symptomatic",NA,NA,2021-02-17,2021-10-26,2022-07-29,4,-2,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"596",418,"Paternina-Caicedo",2023-09-09,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Colombia","COL","South America","Upper middle income",15530,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",14,329,2021-02-17,2021-10-26,2022-07-29,45,1,70,"yes",NA,0,45,1,70,0.55,0.3,0.99,-0.59783700075562,0.304572058283784
"597",418,"Paternina-Caicedo",2023-09-09,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Colombia","COL","South America","Upper middle income",15530,2019,"omicron","Moderna mRNA-1273","mRNA","2","14-44","symptomatic",NA,NA,2021-02-17,2021-10-26,2022-07-29,65,54,74,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"598",418,"Paternina-Caicedo",2023-09-09,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Colombia","COL","South America","Upper middle income",15530,2019,"omicron","Moderna mRNA-1273","mRNA","2","165+","symptomatic",NA,NA,2021-02-17,2021-10-26,2022-07-29,-22,-639,80,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"599",418,"Paternina-Caicedo",2023-09-09,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Colombia","COL","South America","Upper middle income",15530,2019,"omicron","Moderna mRNA-1273","mRNA","2","14+","severe",14,175,2021-02-17,2021-10-26,2022-07-29,95,54,99,"yes",NA,0,95,54,99,0.05,0.01,0.46,-2.99573227355399,0.976694233798238
"600",418,"Paternina-Caicedo",2023-09-09,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Colombia","COL","South America","Upper middle income",15530,2019,"omicron","Janssen Ad26.COV2.S","Vectored","1","14-44","symptomatic",NA,NA,2021-02-17,2021-10-26,2022-07-29,34,11,51,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"601",418,"Paternina-Caicedo",2023-09-09,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Colombia","COL","South America","Upper middle income",15530,2019,"omicron","Janssen Ad26.COV2.S","Vectored","1","165+","symptomatic",NA,NA,2021-02-17,2021-10-26,2022-07-29,-29,-43,17,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"602",418,"Paternina-Caicedo",2023-09-09,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Colombia","COL","South America","Upper middle income",15530,2019,"omicron","Janssen Ad26.COV2.S","Vectored","1","14+","severe",NA,NA,2021-02-17,2021-10-26,2022-07-29,-5,-158,57,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"603",418,"Paternina-Caicedo",2023-09-09,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Colombia","COL","South America","Upper middle income",15530,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14-44","symptomatic",NA,NA,2021-02-17,2021-10-26,2022-07-29,-2,-32,21,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"604",418,"Paternina-Caicedo",2023-09-09,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Colombia","COL","South America","Upper middle income",15530,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","165+","symptomatic",NA,NA,2021-02-17,2021-10-26,2022-07-29,54,-177,92,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"605",418,"Paternina-Caicedo",2023-09-09,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Colombia","COL","South America","Upper middle income",15530,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","severe",14,224,2021-02-17,2021-10-26,2022-07-29,71,27,89,"yes",NA,0,71,27,89,0.29,0.11,0.73,-1.23787435600162,0.482796981721944
"606",418,"Paternina-Caicedo",2023-09-09,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Colombia","COL","South America","Upper middle income",15530,2019,"delta","Sinovac CoronaVac","Inactivated","2","14-44","symptomatic",NA,NA,2021-02-17,2021-10-26,2022-07-29,31,10,47,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"607",418,"Paternina-Caicedo",2023-09-09,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Colombia","COL","South America","Upper middle income",15530,2019,"delta","Sinovac CoronaVac","Inactivated","2","165+","symptomatic",NA,NA,2021-02-17,2021-10-26,2022-07-29,34,18,47,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"608",418,"Paternina-Caicedo",2023-09-09,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Colombia","COL","South America","Upper middle income",15530,2019,"delta","Sinovac CoronaVac","Inactivated","2","14+","severe",NA,NA,2021-02-17,2021-10-26,2022-07-29,63,35,79,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"609",418,"Paternina-Caicedo",2023-09-09,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Colombia","COL","South America","Upper middle income",15530,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14-44","symptomatic",NA,NA,2021-02-17,2021-10-26,2022-07-29,10,-20,33,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"610",418,"Paternina-Caicedo",2023-09-09,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Colombia","COL","South America","Upper middle income",15530,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","165+","symptomatic",NA,NA,2021-02-17,2021-10-26,2022-07-29,62,57,67,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"611",418,"Paternina-Caicedo",2023-09-09,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Colombia","COL","South America","Upper middle income",15530,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",14,252,2021-02-17,2021-10-26,2022-07-29,91,79,96,"yes",NA,0,91,79,96,0.09,0.04,0.21,-2.40794560865187,0.423017366480493
"612",418,"Paternina-Caicedo",2023-09-09,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Colombia","COL","South America","Upper middle income",15530,2019,"delta","Moderna mRNA-1273","mRNA","2","14-44","symptomatic",NA,NA,2021-02-17,2021-10-26,2022-07-29,52,41,61,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"613",418,"Paternina-Caicedo",2023-09-09,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Colombia","COL","South America","Upper middle income",15530,2019,"delta","Moderna mRNA-1273","mRNA","2","105-134","symptomatic",NA,NA,2021-02-17,2021-10-26,2022-07-29,89,-8,99,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"614",418,"Paternina-Caicedo",2023-09-09,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Colombia","COL","South America","Upper middle income",15530,2019,"delta","Janssen Ad26.COV2.S","Vectored","1","14-44","symptomatic",NA,NA,2021-02-17,2021-10-26,2022-07-29,7,-19,27,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"615",418,"Paternina-Caicedo",2023-09-09,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Colombia","COL","South America","Upper middle income",15530,2019,"delta","Janssen Ad26.COV2.S","Vectored","1","165+","symptomatic",NA,NA,2021-02-17,2021-10-26,2022-07-29,70,-5,92,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"616",418,"Paternina-Caicedo",2023-09-09,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Colombia","COL","South America","Upper middle income",15530,2019,"delta","Janssen Ad26.COV2.S","Vectored","1","14+","severe",14,154,2021-02-17,2021-10-26,2022-07-29,73,23,91,"yes",NA,0,73,23,91,0.27,0.09,0.77,-1.30933331998376,0.547597154213639
"617",418,"Paternina-Caicedo",2023-09-09,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Colombia","COL","South America","Upper middle income",15530,2019,"mu","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14-44","symptomatic",NA,NA,2021-02-17,2021-10-26,2022-07-29,62,26,81,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"618",418,"Paternina-Caicedo",2023-09-09,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Colombia","COL","South America","Upper middle income",15530,2019,"mu","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","severe",NA,NA,2021-02-17,2021-10-26,2022-07-29,-57,-1646,86,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"619",418,"Paternina-Caicedo",2023-09-09,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Colombia","COL","South America","Upper middle income",15530,2019,"mu","Sinovac CoronaVac","Inactivated","2","14-44","symptomatic",NA,NA,2021-02-17,2021-10-26,2022-07-29,56,46,65,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"620",418,"Paternina-Caicedo",2023-09-09,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Colombia","COL","South America","Upper middle income",15530,2019,"mu","Sinovac CoronaVac","Inactivated","2","165+","symptomatic",NA,NA,2021-02-17,2021-10-26,2022-07-29,59,-385,97,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"621",418,"Paternina-Caicedo",2023-09-09,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Colombia","COL","South America","Upper middle income",15530,2019,"mu","Sinovac CoronaVac","Inactivated","2","14+","severe",NA,NA,2021-02-17,2021-10-26,2022-07-29,68,24,86,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"622",418,"Paternina-Caicedo",2023-09-09,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Colombia","COL","South America","Upper middle income",15530,2019,"mu","BioNTech/Pfizer BNT162b2","mRNA","2","14-44","symptomatic",NA,NA,2021-02-17,2021-10-26,2022-07-29,67,61,72,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"623",418,"Paternina-Caicedo",2023-09-09,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Colombia","COL","South America","Upper middle income",15530,2019,"mu","BioNTech/Pfizer BNT162b2","mRNA","2","165+","symptomatic",NA,NA,2021-02-17,2021-10-26,2022-07-29,77,53,89,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"624",418,"Paternina-Caicedo",2023-09-09,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Colombia","COL","South America","Upper middle income",15530,2019,"mu","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",NA,NA,2021-02-17,2021-10-26,2022-07-29,88,59,96,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"625",418,"Paternina-Caicedo",2023-09-09,"2023 (Jul-Dec)","Test-negative case-control","general pop","excluded","Colombia","COL","South America","Upper middle income",15530,2019,"mu","Janssen Ad26.COV2.S","Vectored","1","14-44","symptomatic",NA,NA,2021-02-17,2021-10-26,2022-07-29,50,33,63,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"626",422,"Mimura",2023-09-23,"2023 (Jul-Dec)","Retrospective cohort",">=65 years","excluded","Japan","JPN","Asia","High income",43970,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","7+","infection",NA,NA,2021-02-17,2021-08-11,2021-10-16,78.1,65.2,87.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"627",422,"Mimura",2023-09-23,"2023 (Jul-Dec)","Retrospective cohort",">=65 years","excluded","Japan","JPN","Asia","High income",43970,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","7+","symptomatic",NA,NA,2021-02-17,2021-08-11,2021-10-16,79.1,64.6,88.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"628",422,"Mimura",2023-09-23,"2023 (Jul-Dec)","Retrospective cohort",">=65 years","excluded","Japan","JPN","Asia","High income",43970,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","7+","severe",7,154,2021-02-17,2021-08-11,2021-10-16,93.5,83.7,100,"yes",NA,1,93.5,83.7,99.9,0.0649999999999999,0.00099999999999989,0.163,-2.7333680090865,1.29942607163441
"629",426,"Hernandez-Avila",2023-10-19,"2023 (Jul-Dec)","Test-negative case-control",">=65 years","excluded","Mexico","MEX","North America","Upper middle income",19630,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","<91","symptomatic",NA,NA,2020-12-24,2021-10-18,NA,74.3,70.5,77.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"630",426,"Hernandez-Avila",2023-10-19,"2023 (Jul-Dec)","Test-negative case-control",">=65 years","excluded","Mexico","MEX","North America","Upper middle income",19630,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","141+","symptomatic",NA,NA,2020-12-24,2021-10-18,NA,66.9,62.7,70.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"631",426,"Hernandez-Avila",2023-10-19,"2023 (Jul-Dec)","Test-negative case-control",">=65 years","excluded","Mexico","MEX","North America","Upper middle income",19630,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","<91","severe",NA,91,2020-12-24,2021-10-18,NA,87.5,84.9,89.7,"yes",NA,1,87.5,84.9,89.7,0.125,0.103,0.151,-2.07944154167984,0.0975895021901245
"632",426,"Hernandez-Avila",2023-10-19,"2023 (Jul-Dec)","Test-negative case-control",">=65 years","excluded","Mexico","MEX","North America","Upper middle income",19630,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","141+","severe",NA,NA,2020-12-24,2021-10-18,NA,80.5,77.4,83.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"633",426,"Hernandez-Avila",2023-10-19,"2023 (Jul-Dec)","Test-negative case-control",">=65 years","excluded","Mexico","MEX","North America","Upper middle income",19630,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","<91","severe",NA,NA,2020-12-24,2021-10-18,NA,90.4,87.8,92.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"634",426,"Hernandez-Avila",2023-10-19,"2023 (Jul-Dec)","Test-negative case-control",">=65 years","excluded","Mexico","MEX","North America","Upper middle income",19630,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","141+","severe",NA,NA,2020-12-24,2021-10-18,NA,85.3,82.3,87.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"635",426,"Hernandez-Avila",2023-10-19,"2023 (Jul-Dec)","Test-negative case-control",">=65 years","excluded","Mexico","MEX","North America","Upper middle income",19630,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","<91","death",NA,NA,2020-12-24,2021-10-18,NA,90.3,87.7,92.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"636",426,"Hernandez-Avila",2023-10-19,"2023 (Jul-Dec)","Test-negative case-control",">=65 years","excluded","Mexico","MEX","North America","Upper middle income",19630,2019,"delta","BioNTech/Pfizer BNT162b2","mRNA","2","141+","death",NA,NA,2020-12-24,2021-10-18,NA,85.7,82.8,88.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"637",426,"Hernandez-Avila",2023-10-19,"2023 (Jul-Dec)","Test-negative case-control",">=65 years","excluded","Mexico","MEX","North America","Upper middle income",19630,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","<91","symptomatic",NA,NA,2020-12-24,2021-10-18,NA,61.2,56.9,65.1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"638",426,"Hernandez-Avila",2023-10-19,"2023 (Jul-Dec)","Test-negative case-control",">=65 years","excluded","Mexico","MEX","North America","Upper middle income",19630,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","141+","symptomatic",NA,NA,2020-12-24,2021-10-18,NA,51.8,43.5,58.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"639",426,"Hernandez-Avila",2023-10-19,"2023 (Jul-Dec)","Test-negative case-control",">=65 years","excluded","Mexico","MEX","North America","Upper middle income",19630,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","<91","severe",NA,91,2020-12-24,2021-10-18,NA,81.1,78.4,83.5,"yes",NA,1,81.1,78.4,83.5,0.189,0.165,0.216,-1.66600826392249,0.0687073810672408
"640",426,"Hernandez-Avila",2023-10-19,"2023 (Jul-Dec)","Test-negative case-control",">=65 years","excluded","Mexico","MEX","North America","Upper middle income",19630,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","141+","severe",NA,NA,2020-12-24,2021-10-18,NA,70.5,64.2,75.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"641",426,"Hernandez-Avila",2023-10-19,"2023 (Jul-Dec)","Test-negative case-control",">=65 years","excluded","Mexico","MEX","North America","Upper middle income",19630,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","<91","severe",NA,NA,2020-12-24,2021-10-18,NA,85.3,82.8,87.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"642",426,"Hernandez-Avila",2023-10-19,"2023 (Jul-Dec)","Test-negative case-control",">=65 years","excluded","Mexico","MEX","North America","Upper middle income",19630,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","141+","severe",NA,NA,2020-12-24,2021-10-18,NA,73.5,66.5,79.1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"643",426,"Hernandez-Avila",2023-10-19,"2023 (Jul-Dec)","Test-negative case-control",">=65 years","excluded","Mexico","MEX","North America","Upper middle income",19630,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","<91","death",NA,NA,2020-12-24,2021-10-18,NA,85.4,82.9,87.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"644",426,"Hernandez-Avila",2023-10-19,"2023 (Jul-Dec)","Test-negative case-control",">=65 years","excluded","Mexico","MEX","North America","Upper middle income",19630,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","141+","death",NA,NA,2020-12-24,2021-10-18,NA,73.6,66.6,79.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"645",426,"Hernandez-Avila",2023-10-19,"2023 (Jul-Dec)","Test-negative case-control",">=65 years","excluded","Mexico","MEX","North America","Upper middle income",19630,2019,"delta","Sinovac CoronaVac","Inactivated","2","<91","symptomatic",NA,NA,2020-12-24,2021-10-18,NA,47,39.6,53.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"646",426,"Hernandez-Avila",2023-10-19,"2023 (Jul-Dec)","Test-negative case-control",">=65 years","excluded","Mexico","MEX","North America","Upper middle income",19630,2019,"delta","Sinovac CoronaVac","Inactivated","2","141+","symptomatic",NA,NA,2020-12-24,2021-10-18,NA,34.9,26.2,42.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"647",426,"Hernandez-Avila",2023-10-19,"2023 (Jul-Dec)","Test-negative case-control",">=65 years","excluded","Mexico","MEX","North America","Upper middle income",19630,2019,"delta","Sinovac CoronaVac","Inactivated","2","<91","severe",NA,NA,2020-12-24,2021-10-18,NA,69.8,64.5,74.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"648",426,"Hernandez-Avila",2023-10-19,"2023 (Jul-Dec)","Test-negative case-control",">=65 years","excluded","Mexico","MEX","North America","Upper middle income",19630,2019,"delta","Sinovac CoronaVac","Inactivated","2","141+","severe",NA,NA,2020-12-24,2021-10-18,NA,57.8,51,63.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"649",426,"Hernandez-Avila",2023-10-19,"2023 (Jul-Dec)","Test-negative case-control",">=65 years","excluded","Mexico","MEX","North America","Upper middle income",19630,2019,"delta","Sinovac CoronaVac","Inactivated","2","<91","severe",NA,NA,2020-12-24,2021-10-18,NA,75.4,70.3,79.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"650",426,"Hernandez-Avila",2023-10-19,"2023 (Jul-Dec)","Test-negative case-control",">=65 years","excluded","Mexico","MEX","North America","Upper middle income",19630,2019,"delta","Sinovac CoronaVac","Inactivated","2","141+","severe",NA,NA,2020-12-24,2021-10-18,NA,59.2,51.6,65.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"651",426,"Hernandez-Avila",2023-10-19,"2023 (Jul-Dec)","Test-negative case-control",">=65 years","excluded","Mexico","MEX","North America","Upper middle income",19630,2019,"delta","Sinovac CoronaVac","Inactivated","2","<91","death",NA,NA,2020-12-24,2021-10-18,NA,75.6,70.5,79.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"652",426,"Hernandez-Avila",2023-10-19,"2023 (Jul-Dec)","Test-negative case-control",">=65 years","excluded","Mexico","MEX","North America","Upper middle income",19630,2019,"delta","Sinovac CoronaVac","Inactivated","2","141+","death",NA,NA,2020-12-24,2021-10-18,NA,59.2,51.6,65.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"653",426,"Hernandez-Avila",2023-10-19,"2023 (Jul-Dec)","Test-negative case-control",">=65 years","excluded","Mexico","MEX","North America","Upper middle income",19630,2019,"delta","Cansino Ad5-nCoV","Vectored","1","<91","symptomatic",NA,NA,2020-12-24,2021-10-18,NA,29,5.3,46.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"654",426,"Hernandez-Avila",2023-10-19,"2023 (Jul-Dec)","Test-negative case-control",">=65 years","excluded","Mexico","MEX","North America","Upper middle income",19630,2019,"delta","Cansino Ad5-nCoV","Vectored","1","141+","symptomatic",NA,NA,2020-12-24,2021-10-18,NA,43.6,32.1,53.1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"655",426,"Hernandez-Avila",2023-10-19,"2023 (Jul-Dec)","Test-negative case-control",">=65 years","excluded","Mexico","MEX","North America","Upper middle income",19630,2019,"delta","Cansino Ad5-nCoV","Vectored","1","<91","severe",NA,NA,2020-12-24,2021-10-18,NA,58.2,39,71.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"656",426,"Hernandez-Avila",2023-10-19,"2023 (Jul-Dec)","Test-negative case-control",">=65 years","excluded","Mexico","MEX","North America","Upper middle income",19630,2019,"delta","Cansino Ad5-nCoV","Vectored","1","141+","severe",NA,NA,2020-12-24,2021-10-18,NA,58.8,48.7,66.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"657",426,"Hernandez-Avila",2023-10-19,"2023 (Jul-Dec)","Test-negative case-control",">=65 years","excluded","Mexico","MEX","North America","Upper middle income",19630,2019,"delta","Cansino Ad5-nCoV","Vectored","1","<91","severe",NA,NA,2020-12-24,2021-10-18,NA,69.4,50.6,81,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"658",426,"Hernandez-Avila",2023-10-19,"2023 (Jul-Dec)","Test-negative case-control",">=65 years","excluded","Mexico","MEX","North America","Upper middle income",19630,2019,"delta","Cansino Ad5-nCoV","Vectored","1","141+","severe",NA,NA,2020-12-24,2021-10-18,NA,63.8,53.2,72,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"659",426,"Hernandez-Avila",2023-10-19,"2023 (Jul-Dec)","Test-negative case-control",">=65 years","excluded","Mexico","MEX","North America","Upper middle income",19630,2019,"delta","Cansino Ad5-nCoV","Vectored","1","<91","death",NA,NA,2020-12-24,2021-10-18,NA,69.1,50,80.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"660",426,"Hernandez-Avila",2023-10-19,"2023 (Jul-Dec)","Test-negative case-control",">=65 years","excluded","Mexico","MEX","North America","Upper middle income",19630,2019,"delta","Cansino Ad5-nCoV","Vectored","1","141+","death",NA,NA,2020-12-24,2021-10-18,NA,64.1,53.6,72.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"661",426,"Hernandez-Avila",2023-10-19,"2023 (Jul-Dec)","Test-negative case-control",">=65 years","excluded","Mexico","MEX","North America","Upper middle income",19630,2019,"delta","Gamaleya Gam-COVID-Vac/Sputnik V","Vectored","2","<91","symptomatic",NA,NA,2020-12-24,2021-10-18,NA,68.5,59.5,75.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"662",426,"Hernandez-Avila",2023-10-19,"2023 (Jul-Dec)","Test-negative case-control",">=65 years","excluded","Mexico","MEX","North America","Upper middle income",19630,2019,"delta","Gamaleya Gam-COVID-Vac/Sputnik V","Vectored","2","141+","symptomatic",NA,NA,2020-12-24,2021-10-18,NA,75.5,69.1,80.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"663",426,"Hernandez-Avila",2023-10-19,"2023 (Jul-Dec)","Test-negative case-control",">=65 years","excluded","Mexico","MEX","North America","Upper middle income",19630,2019,"delta","Gamaleya Gam-COVID-Vac/Sputnik V","Vectored","2","<91","severe",NA,NA,2020-12-24,2021-10-18,NA,90.4,85.5,93.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"664",426,"Hernandez-Avila",2023-10-19,"2023 (Jul-Dec)","Test-negative case-control",">=65 years","excluded","Mexico","MEX","North America","Upper middle income",19630,2019,"delta","Gamaleya Gam-COVID-Vac/Sputnik V","Vectored","2","141+","severe",NA,NA,2020-12-24,2021-10-18,NA,87.1,82.2,90.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"665",426,"Hernandez-Avila",2023-10-19,"2023 (Jul-Dec)","Test-negative case-control",">=65 years","excluded","Mexico","MEX","North America","Upper middle income",19630,2019,"delta","Gamaleya Gam-COVID-Vac/Sputnik V","Vectored","2","<91","severe",NA,NA,2020-12-24,2021-10-18,NA,94.8,90.5,97.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"666",426,"Hernandez-Avila",2023-10-19,"2023 (Jul-Dec)","Test-negative case-control",">=65 years","excluded","Mexico","MEX","North America","Upper middle income",19630,2019,"delta","Gamaleya Gam-COVID-Vac/Sputnik V","Vectored","2","141+","severe",NA,NA,2020-12-24,2021-10-18,NA,91.8,87.3,94.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"667",426,"Hernandez-Avila",2023-10-19,"2023 (Jul-Dec)","Test-negative case-control",">=65 years","excluded","Mexico","MEX","North America","Upper middle income",19630,2019,"delta","Gamaleya Gam-COVID-Vac/Sputnik V","Vectored","2","<91","death",NA,NA,2020-12-24,2021-10-18,NA,95.2,91,94.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"668",426,"Hernandez-Avila",2023-10-19,"2023 (Jul-Dec)","Test-negative case-control",">=65 years","excluded","Mexico","MEX","North America","Upper middle income",19630,2019,"delta","Gamaleya Gam-COVID-Vac/Sputnik V","Vectored","2","141+","death",NA,NA,2020-12-24,2021-10-18,NA,91.8,87.3,94.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"669",93,"Polinski",2022-03-17,"2022 (Jan-Jun)","Retrospective cohort","general pop","excluded","USA","USA","North America","High income",66120,2019,"alpha","Janssen Ad26.COV2.S","Vectored","1","14+","infection",NA,NA,2020-12-13,2021-05-14,NA,76,75,77,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"670",93,"Polinski",2022-03-17,"2022 (Jan-Jun)","Retrospective cohort","general pop","excluded","USA","USA","North America","High income",66120,2019,"alpha","Janssen Ad26.COV2.S","Vectored","1","14+","severe",NA,NA,2020-12-13,2021-05-14,NA,81,78,82,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"671",93,"Polinski",2022-03-17,"2022 (Jan-Jun)","Retrospective cohort","immunocompromised adults","excluded","USA","USA","North America","High income",66120,2019,"alpha","Janssen Ad26.COV2.S","Vectored","1","14+","infection",NA,NA,2020-12-13,2021-05-14,NA,64,59,68,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"672",93,"Polinski",2022-03-17,"2022 (Jan-Jun)","Retrospective cohort","immunocompromised adults","excluded","USA","USA","North America","High income",66120,2019,"alpha","Janssen Ad26.COV2.S","Vectored","1","14+","severe",NA,NA,2020-12-13,2021-05-14,NA,67,57,74,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"673",93,"Polinski",2022-03-17,"2022 (Jan-Jun)","Retrospective cohort","general pop","excluded","USA","USA","North America","High income",66120,2019,"delta","Janssen Ad26.COV2.S","Vectored","1","14+","infection",NA,NA,2020-12-13,2021-05-14,NA,74,71,77,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"674",93,"Polinski",2022-03-17,"2022 (Jan-Jun)","Retrospective cohort","general pop","excluded","USA","USA","North America","High income",66120,2019,"delta","Janssen Ad26.COV2.S","Vectored","1","14+","severe",14,98,2020-12-13,2021-05-14,NA,81,75,86,"yes",NA,0,81,75,86,0.19,0.14,0.25,-1.66073120682165,0.147912881442077
"675",267,"Lewis",2022-06-08,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"other combinations","Janssen Ad26.COV2.S","Vectored","1","14+","severe",NA,NA,2020-12-13,2021-05-14,NA,70,63,75,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"676",267,"Lewis",2022-06-08,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"other combinations","Janssen Ad26.COV2.S","Vectored","1","14-90","severe",NA,NA,2020-12-13,2021-05-14,NA,73,60,82,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"677",267,"Lewis",2022-06-08,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"other combinations","Janssen Ad26.COV2.S","Vectored","1","180+","severe",NA,NA,2020-12-13,2021-05-14,NA,70,54,81,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"678",267,"Lewis",2022-06-08,"2022 (Jan-Jun)","Test-negative case-control","immunocompromised adults","included","USA","USA","North America","High income",66120,2019,"other combinations","Janssen Ad26.COV2.S","Vectored","1","14+","severe",NA,NA,2020-12-13,2021-05-14,NA,55,31,72,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"679",267,"Lewis",2022-06-08,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"alpha","Janssen Ad26.COV2.S","Vectored","1","14+","severe",NA,NA,2020-12-13,2021-05-14,NA,68,43,83,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"680",267,"Lewis",2022-06-08,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"delta","Janssen Ad26.COV2.S","Vectored","1","14+","severe",14,276.5,2020-12-13,2021-05-14,NA,72,64,78,"yes",NA,0,72,64,78,0.28,0.22,0.36,-1.27296567581289,0.125631756402499
"681",104,"Bruxvoort",2021-12-15,"2021 (Jul-Dec)","Test-negative case-control","general pop","excluded","USA","USA","North America","High income",66120,2019,"delta","Moderna mRNA-1273","mRNA","1","14+","infection",NA,NA,2020-12-13,2021-05-14,NA,77,60.7,86.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"682",104,"Bruxvoort",2021-12-15,"2021 (Jul-Dec)","Test-negative case-control","general pop","excluded","USA","USA","North America","High income",66120,2019,"delta","Moderna mRNA-1273","mRNA","2","14+","infection",NA,NA,2020-12-13,2021-05-14,NA,86.7,84.3,88.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"683",104,"Bruxvoort",2021-12-15,"2021 (Jul-Dec)","Test-negative case-control","general pop","excluded","USA","USA","North America","High income",66120,2019,"delta","Moderna mRNA-1273","mRNA","2","14-60","infection",NA,NA,2020-12-13,2021-05-14,NA,94.1,90.5,96.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"684",104,"Bruxvoort",2021-12-15,"2021 (Jul-Dec)","Test-negative case-control","general pop","excluded","USA","USA","North America","High income",66120,2019,"delta","Moderna mRNA-1273","mRNA","2","151-180","infection",NA,NA,2020-12-13,2021-05-14,NA,80,70.2,86.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"685",104,"Bruxvoort",2021-12-15,"2021 (Jul-Dec)","Test-negative case-control","general pop","excluded","USA","USA","North America","High income",66120,2019,"delta","Moderna mRNA-1273","mRNA","2","14+","severe",14,175,2020-12-13,2021-05-14,NA,97.5,92.7,99.2,"yes",NA,0,97.5,92.7,99.2,0.025,0.00800000000000001,0.073,-3.68887945411394,0.564035178435856
"686",104,"Bruxvoort",2021-12-15,"2021 (Jul-Dec)","Test-negative case-control","general pop","excluded","USA","USA","North America","High income",66120,2019,"other combinations","Moderna mRNA-1273","mRNA","2","14-60","infection",NA,NA,2020-12-13,2021-05-14,NA,98.6,97.3,99.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"687",104,"Bruxvoort",2021-12-15,"2021 (Jul-Dec)","Test-negative case-control","general pop","excluded","USA","USA","North America","High income",66120,2019,"other combinations","Moderna mRNA-1273","mRNA","2","121-150","infection",NA,NA,2020-12-13,2021-05-14,NA,88.7,73.2,95.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"688",104,"Bruxvoort",2021-12-15,"2021 (Jul-Dec)","Test-negative case-control","general pop","excluded","USA","USA","North America","High income",66120,2019,"alpha","Moderna mRNA-1273","mRNA","1","14+","infection",NA,NA,2020-12-13,2021-05-14,NA,90.1,82.9,94.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"689",104,"Bruxvoort",2021-12-15,"2021 (Jul-Dec)","Test-negative case-control","general pop","excluded","USA","USA","North America","High income",66120,2019,"alpha","Moderna mRNA-1273","mRNA","2","14+","infection",NA,NA,2020-12-13,2021-05-14,NA,98.4,96.9,99.1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"690",104,"Bruxvoort",2021-12-15,"2021 (Jul-Dec)","Test-negative case-control","general pop","excluded","USA","USA","North America","High income",66120,2019,"gamma","Moderna mRNA-1273","mRNA","1","14+","infection",NA,NA,2020-12-13,2021-05-14,NA,74.2,43.8,88.1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"691",104,"Bruxvoort",2021-12-15,"2021 (Jul-Dec)","Test-negative case-control","general pop","excluded","USA","USA","North America","High income",66120,2019,"gamma","Moderna mRNA-1273","mRNA","2","14+","infection",NA,NA,2020-12-13,2021-05-14,NA,95.5,90.9,97.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"692",159,"Tseng",2022-02-21,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","Moderna mRNA-1273","mRNA","1","14+","infection",NA,NA,2020-12-13,2021-05-14,NA,20.4,9.5,30,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"693",159,"Tseng",2022-02-21,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","Moderna mRNA-1273","mRNA","2","14+","infection",NA,NA,2020-12-13,2021-05-14,NA,13.9,10.5,17.1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"694",159,"Tseng",2022-02-21,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","Moderna mRNA-1273","mRNA","2","14-90","infection",NA,NA,2020-12-13,2021-05-14,NA,44,35.1,51.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"695",159,"Tseng",2022-02-21,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","Moderna mRNA-1273","mRNA","2","270+","infection",NA,NA,2020-12-13,2021-05-14,NA,5.9,0.4,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"696",159,"Tseng",2022-02-21,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","Moderna mRNA-1273","mRNA","2","14+","severe",14,332.5,2020-12-13,2021-05-14,NA,84.5,23,96.9,"yes",NA,0,84.5,23,96.9,0.155,0.0309999999999999,0.77,-1.86433016206289,0.819490640398619
"697",159,"Tseng",2022-02-21,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"delta","Moderna mRNA-1273","mRNA","1","14+","infection",NA,NA,2020-12-13,2021-05-14,NA,56.7,40.7,68.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"698",159,"Tseng",2022-02-21,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"delta","Moderna mRNA-1273","mRNA","2","14+","infection",NA,NA,2020-12-13,2021-05-14,NA,63.6,59.9,66.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"699",159,"Tseng",2022-02-21,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"delta","Moderna mRNA-1273","mRNA","2","14-90","infection",NA,NA,2020-12-13,2021-05-14,NA,80.2,68.2,87.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"700",159,"Tseng",2022-02-21,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"delta","Moderna mRNA-1273","mRNA","2","270+","infection",NA,NA,2020-12-13,2021-05-14,NA,61.3,55,66.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"701",159,"Tseng",2022-02-21,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"delta","Moderna mRNA-1273","mRNA","1","14+","severe",NA,NA,2020-12-13,2021-05-14,NA,71.2,-68.7,97.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"702",159,"Tseng",2022-02-21,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"delta","Moderna mRNA-1273","mRNA","2","14+","severe",14,332.5,2020-12-13,2021-05-14,NA,99,93.3,99.9,"yes",NA,0,99,93.3,99.9,0.01,0.00099999999999989,0.0670000000000001,-4.60517018598809,1.07262566821201
"703",146,"Katikireddi",2021-12-20,"2021 (Jul-Dec)","Retrospective cohort","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14-27","severe",14,27,2020-12-21,2021-06-04,2021-12-23,83.7,79.7,87,"yes",NA,0,83.7,79.7,87,0.163,0.13,0.203,-1.81400507817538,0.113691716476073
"704",146,"Katikireddi",2021-12-20,"2021 (Jul-Dec)","Retrospective cohort","general pop","excluded","UK","GBR","Europe","High income",49370,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","140-153","severe",NA,NA,2020-12-21,2021-06-04,2021-12-23,53.6,48.4,58.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"705",247,"Kirsebom",2022-12-12,"2022 (Jul-Dec)","Test-negative case-control","40-64 years","included","UK","GBR","Europe","High income",49370,2019,"omicron","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","175+","symptomatic",NA,NA,2020-12-21,2021-06-04,2021-12-23,8,6,9.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"706",247,"Kirsebom",2022-12-12,"2022 (Jul-Dec)","Test-negative case-control","40-64 years","included","UK","GBR","Europe","High income",49370,2019,"omicron","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","175+","symptomatic",NA,NA,2020-12-21,2021-06-04,2021-12-23,19.5,11.7,26.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"707",247,"Kirsebom",2022-12-12,"2022 (Jul-Dec)","Test-negative case-control",">= 65 years","included","UK","GBR","Europe","High income",49370,2019,"omicron","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","175+","severe",175,311.5,2020-12-21,2021-06-04,2021-12-23,61,49.8,69.7,"yes",NA,1,61,49.8,69.7,0.39,0.303,0.502,-0.941608539858445,0.128792682189378
"708",247,"Kirsebom",2022-12-12,"2022 (Jul-Dec)","Test-negative case-control",">= 65 years","included","UK","GBR","Europe","High income",49370,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","175+","severe",175,311.5,2020-12-21,2021-06-04,2021-12-23,73.4,70.4,76.2,"yes",NA,1,73.4,70.4,76.2,0.266,0.238,0.296,-1.32425897020044,0.0556348930236188
"709",259,"Tsundue",2022-05-24,"2022 (Jan-Jun)","Prospective cohort","general pop","included","India","IND","Asia","Lower middle income",6820,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","infection",NA,NA,2021-01-16,2021-12-24,NA,98,85,99.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"710",259,"Tsundue",2022-05-24,"2022 (Jan-Jun)","Prospective cohort","general pop","included","India","IND","Asia","Lower middle income",6820,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","severe",14,91,2021-01-16,2021-12-24,NA,99,90,99.8,"yes",NA,0,99,90,99.8,0.01,0.002,0.1,-4.60517018598809,0.997965052405139
"711",345,"Clemens",2022-10-13,"2022 (Jul-Dec)","Test-negative case-control","18-60 years","included","Brazil","BRA","South America","Upper middle income",14890,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","infection",NA,NA,2021-01-17,2021-09-24,2022-02-05,76,49.5,87.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"712",345,"Clemens",2022-10-13,"2022 (Jul-Dec)","Test-negative case-control","18-60 years","included","Brazil","BRA","South America","Upper middle income",14890,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","severe",14,87.5,2021-01-17,2021-09-24,2022-02-05,100,44.3,100,"yes",NA,0,99.5,44.3,99.9,0.005,0.00099999999999989,0.557,-5.29831736654804,1.61289929589985
"713",345,"Clemens",2022-10-13,"2022 (Jul-Dec)","Test-negative case-control","18-60 years","included","Brazil","BRA","South America","Upper middle income",14890,2019,"gamma","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","infection",NA,NA,2021-01-17,2021-09-24,2022-02-05,81.3,-298,97.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"714",366,"Battacharya",2023-01-06,"2023 (Jan-Jun)","Test-negative case-control","general pop","included","India","IND","Asia","Lower middle income",6820,2019,"delta","Bharat Covaxin/BBV152","Inactivated","2","7+","severe",NA,NA,2021-01-16,2021-12-24,NA,74,50.5,86,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"715",366,"Battacharya",2023-01-06,"2023 (Jan-Jun)","Test-negative case-control","general pop","included","India","IND","Asia","Lower middle income",6820,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","7+","severe",7,154,2021-01-16,2021-12-24,NA,79,53.1,81,"yes",NA,0,79,53.1,81,0.21,0.19,0.469,-1.56064774826467,0.230504769460662
"716",420,"Irala",2023-09-15,"2023 (Jul-Dec)","Test-negative case-control","general pop","included","Paraguay","PRY","South America","Upper middle income",13770,2019,"omicron","Multiple or heterologous RNA","mRNA","2","14+","severe",NA,NA,2021-02-22,2021-12-10,NA,45.3,5.8,68.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"717",420,"Irala",2023-09-15,"2023 (Jul-Dec)","Test-negative case-control","general pop","included","Paraguay","PRY","South America","Upper middle income",13770,2019,"omicron","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","severe",14,364,2021-02-22,2021-12-10,NA,10,-31.3,38.2,"yes",NA,0,10,-31.3,38.2,0.9,0.618,1.45560407569141,-0.105360515657826,0.218542808235774
"718",420,"Irala",2023-09-15,"2023 (Jul-Dec)","Test-negative case-control","general pop","included","Paraguay","PRY","South America","Upper middle income",13770,2019,"omicron","Gamaleya Gam-COVID-Vac/Sputnik V","Vectored","2","14+","severe",NA,NA,2021-02-22,2021-12-10,NA,25.4,-30.2,57.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"719",420,"Irala",2023-09-15,"2023 (Jul-Dec)","Test-negative case-control","general pop","included","Paraguay","PRY","South America","Upper middle income",13770,2019,"omicron","Beijing/Sinopharm BBIBP-CorV","Inactivated","2","14+","severe",NA,NA,2021-02-22,2021-12-10,NA,42.3,-2,67.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"720",420,"Irala",2023-09-15,"2023 (Jul-Dec)","Test-negative case-control","general pop","included","Paraguay","PRY","South America","Upper middle income",13770,2019,"omicron","Bharat Covaxin/BBV152","Inactivated","2","14+","severe",NA,NA,2021-02-22,2021-12-10,NA,13,-46.1,48,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"721",420,"Irala",2023-09-15,"2023 (Jul-Dec)","Test-negative case-control","general pop","included","Paraguay","PRY","South America","Upper middle income",13770,2019,"delta","Multiple or heterologous RNA","mRNA","2","14+","severe",NA,NA,2021-02-22,2021-12-10,NA,90.4,74.3,97.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"722",420,"Irala",2023-09-15,"2023 (Jul-Dec)","Test-negative case-control","general pop","included","Paraguay","PRY","South America","Upper middle income",13770,2019,"delta","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","severe",14,259,2021-02-22,2021-12-10,NA,83.2,67.8,91.9,"yes",NA,0,83.2,67.8,91.9,0.168,0.081,0.322,-1.78379129957888,0.352066936446931
"723",420,"Irala",2023-09-15,"2023 (Jul-Dec)","Test-negative case-control","general pop","included","Paraguay","PRY","South America","Upper middle income",13770,2019,"delta","Gamaleya Gam-COVID-Vac/Sputnik V","Vectored","2","14+","severe",NA,NA,2021-02-22,2021-12-10,NA,82.9,53,95.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"724",420,"Irala",2023-09-15,"2023 (Jul-Dec)","Test-negative case-control","general pop","included","Paraguay","PRY","South America","Upper middle income",13770,2019,"delta","Beijing/Sinopharm BBIBP-CorV","Inactivated","2","14+","severe",NA,NA,2021-02-22,2021-12-10,NA,29.7,-42.6,67.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"725",420,"Irala",2023-09-15,"2023 (Jul-Dec)","Test-negative case-control","general pop","included","Paraguay","PRY","South America","Upper middle income",13770,2019,"delta","Bharat Covaxin/BBV152","Inactivated","2","14+","severe",NA,NA,2021-02-22,2021-12-10,NA,24.9,-36.9,59.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"726",179,"Chemaitelly",2022-06-02,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","Qatar","QAT","Asia","High income",92300,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","1-3 months","symptomatic",NA,NA,2021-01-28,2021-05-31,2021-08-16,46.6,33.4,57.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"727",179,"Chemaitelly",2022-06-02,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","Qatar","QAT","Asia","High income",92300,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","7+ months","symptomatic",NA,NA,2021-01-28,2021-05-31,2021-08-16,-17.8,-28.2,-8.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"728",179,"Chemaitelly",2022-06-02,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","Qatar","QAT","Asia","High income",92300,2019,"omicron","Moderna mRNA-1273","mRNA","2","1-3 months","symptomatic",NA,NA,2021-01-28,2021-05-31,2021-08-16,71,24,89,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"729",179,"Chemaitelly",2022-06-02,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","Qatar","QAT","Asia","High income",92300,2019,"omicron","Moderna mRNA-1273","mRNA","2","7+ months","symptomatic",NA,NA,2021-01-28,2021-05-31,2021-08-16,-10.2,-23.1,1.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"730",179,"Chemaitelly",2022-06-02,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","Qatar","QAT","Asia","High income",92300,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","1-3 months","symptomatic",NA,NA,2021-01-28,2021-05-31,2021-08-16,51.7,43.2,58.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"731",179,"Chemaitelly",2022-06-02,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","Qatar","QAT","Asia","High income",92300,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","7+ months","symptomatic",NA,NA,2021-01-28,2021-05-31,2021-08-16,-12.1,-19.1,5.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"732",179,"Chemaitelly",2022-06-02,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","Qatar","QAT","Asia","High income",92300,2019,"omicron","Moderna mRNA-1273","mRNA","2","1-3 months","symptomatic",NA,NA,2021-01-28,2021-05-31,2021-08-16,35.9,-5.9,61.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"733",179,"Chemaitelly",2022-06-02,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","Qatar","QAT","Asia","High income",92300,2019,"omicron","Moderna mRNA-1273","mRNA","2","7+ months","symptomatic",NA,NA,2021-01-28,2021-05-31,2021-08-16,-20.4,-30.2,1.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"734",179,"Chemaitelly",2022-06-02,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","Qatar","QAT","Asia","High income",92300,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","1-3 months","symptomatic",NA,NA,2021-01-28,2021-05-31,2021-08-16,51.7,43.2,58.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"735",179,"Chemaitelly",2022-06-02,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","Qatar","QAT","Asia","High income",92300,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","7+ months","symptomatic",NA,NA,2021-01-28,2021-05-31,2021-08-16,-9,-14.5,-3.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"736",179,"Chemaitelly",2022-06-02,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","Qatar","QAT","Asia","High income",92300,2019,"omicron","Moderna mRNA-1273","mRNA","2","1-3 months","symptomatic",NA,NA,2021-01-28,2021-05-31,2021-08-16,43.2,15,62.1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"737",179,"Chemaitelly",2022-06-02,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","Qatar","QAT","Asia","High income",92300,2019,"omicron","Moderna mRNA-1273","mRNA","2","7+ months","symptomatic",NA,NA,2021-01-28,2021-05-31,2021-08-16,-13.7,-21.3,-6.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"738",179,"Chemaitelly",2022-06-02,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","Qatar","QAT","Asia","High income",92300,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","1-6 months","severe",30,180,2021-01-28,2021-05-31,2021-08-16,70.4,45,85,"yes",NA,0,70.4,45,85,0.296,0.15,0.55,-1.21739582465808,0.331449740849556
"739",179,"Chemaitelly",2022-06-02,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","Qatar","QAT","Asia","High income",92300,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2",">=7 months","severe",NA,NA,2021-01-28,2021-05-31,2021-08-16,77.5,67.8,84.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"740",179,"Chemaitelly",2022-06-02,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","Qatar","QAT","Asia","High income",92300,2019,"omicron","Moderna mRNA-1273","mRNA","2","1-6 months","severe",30,180,2021-01-28,2021-05-31,2021-08-16,87.1,40.2,97.2,"yes",NA,0,87.1,40.2,97.2,0.129,0.028,0.598,-2.04794287462046,0.780965878514139
"741",179,"Chemaitelly",2022-06-02,"2022 (Jan-Jun)","Test-negative case-control","general pop","included","Qatar","QAT","Asia","High income",92300,2019,"omicron","Moderna mRNA-1273","mRNA","2",">=7 months","severe",NA,NA,2021-01-28,2021-05-31,2021-08-16,68.4,46.1,81.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"742",207,"Altarawneh",2022-06-15,"2022 (Jan-Jun)","Test-negative case-control","general pop","previously infected only","Qatar","QAT","Asia","High income",92300,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14+","symptomatic",NA,NA,2021-01-28,2021-05-31,2021-08-16,51.7,43.5,58.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"743",207,"Altarawneh",2022-06-15,"2022 (Jan-Jun)","Test-negative case-control","general pop","previously infected only","Qatar","QAT","Asia","High income",92300,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",NA,NA,2021-01-28,2021-05-31,2021-08-16,96.2,37.7,99.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"744",207,"Altarawneh",2022-06-15,"2022 (Jan-Jun)","Test-negative case-control","general pop","previously infected only","Qatar","QAT","Asia","High income",92300,2019,"omicron","Moderna mRNA-1273","mRNA","2","14+","symptomatic",NA,NA,2021-01-28,2021-05-31,2021-08-16,44.3,30.4,55.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"745",207,"Altarawneh",2022-06-15,"2022 (Jan-Jun)","Test-negative case-control","general pop","previously infected only","Qatar","QAT","Asia","High income",92300,2019,"omicron","Moderna mRNA-1273","mRNA","2","14+","severe",NA,NA,2021-01-28,2021-05-31,2021-08-16,100,-51.5,100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"746",207,"Altarawneh",2022-06-15,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Qatar","QAT","Asia","High income",92300,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14+","symptomatic",NA,NA,2021-01-28,2021-05-31,2021-08-16,-4.9,-16.4,5.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"747",207,"Altarawneh",2022-06-15,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Qatar","QAT","Asia","High income",92300,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",NA,NA,2021-01-28,2021-05-31,2021-08-16,96.8,71.1,99.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"748",207,"Altarawneh",2022-06-15,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Qatar","QAT","Asia","High income",92300,2019,"omicron","Moderna mRNA-1273","mRNA","2","14+","symptomatic",NA,NA,2021-01-28,2021-05-31,2021-08-16,-2.7,-16.8,9.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"749",207,"Altarawneh",2022-06-15,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Qatar","QAT","Asia","High income",92300,2019,"omicron","Moderna mRNA-1273","mRNA","2","14+","severe",NA,NA,2021-01-28,2021-05-31,2021-08-16,88.8,-1.7,98.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"750",207,"Altarawneh",2022-06-15,"2022 (Jan-Jun)","Test-negative case-control","general pop","previously infected only","Qatar","QAT","Asia","High income",92300,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14+","symptomatic",NA,NA,2021-01-28,2021-05-31,2021-08-16,55.1,50.9,58.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"751",207,"Altarawneh",2022-06-15,"2022 (Jan-Jun)","Test-negative case-control","general pop","previously infected only","Qatar","QAT","Asia","High income",92300,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",NA,NA,2021-01-28,2021-05-31,2021-08-16,97.8,82.6,99.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"752",207,"Altarawneh",2022-06-15,"2022 (Jan-Jun)","Test-negative case-control","general pop","previously infected only","Qatar","QAT","Asia","High income",92300,2019,"omicron","Moderna mRNA-1273","mRNA","2","14+","symptomatic",NA,NA,2021-01-28,2021-05-31,2021-08-16,47.9,40.8,54.1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"753",207,"Altarawneh",2022-06-15,"2022 (Jan-Jun)","Test-negative case-control","general pop","previously infected only","Qatar","QAT","Asia","High income",92300,2019,"omicron","Moderna mRNA-1273","mRNA","2","14+","severe",NA,NA,2021-01-28,2021-05-31,2021-08-16,100,55.4,100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"754",207,"Altarawneh",2022-06-15,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Qatar","QAT","Asia","High income",92300,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14+","symptomatic",NA,NA,2021-01-28,2021-05-31,2021-08-16,-1.1,-7.1,4.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"755",207,"Altarawneh",2022-06-15,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Qatar","QAT","Asia","High income",92300,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",NA,NA,2021-01-28,2021-05-31,2021-08-16,76.8,58,87.1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"756",207,"Altarawneh",2022-06-15,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Qatar","QAT","Asia","High income",92300,2019,"omicron","Moderna mRNA-1273","mRNA","2","14+","symptomatic",NA,NA,2021-01-28,2021-05-31,2021-08-16,-7.3,-15.6,0.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"757",207,"Altarawneh",2022-06-15,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Qatar","QAT","Asia","High income",92300,2019,"omicron","Moderna mRNA-1273","mRNA","2","14+","severe",NA,NA,2021-01-28,2021-05-31,2021-08-16,84.8,47.9,95.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"758",207,"Altarawneh",2022-06-15,"2022 (Jan-Jun)","Test-negative case-control","general pop","previously infected only","Qatar","QAT","Asia","High income",92300,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14+","symptomatic",NA,NA,2021-01-28,2021-05-31,2021-08-16,55.5,51.8,59,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"759",207,"Altarawneh",2022-06-15,"2022 (Jan-Jun)","Test-negative case-control","general pop","previously infected only","Qatar","QAT","Asia","High income",92300,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",NA,NA,2021-01-28,2021-05-31,2021-08-16,94.3,81.3,98.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"760",207,"Altarawneh",2022-06-15,"2022 (Jan-Jun)","Test-negative case-control","general pop","previously infected only","Qatar","QAT","Asia","High income",92300,2019,"omicron","Moderna mRNA-1273","mRNA","2","14+","symptomatic",NA,NA,2021-01-28,2021-05-31,2021-08-16,52,45.8,57.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"761",207,"Altarawneh",2022-06-15,"2022 (Jan-Jun)","Test-negative case-control","general pop","previously infected only","Qatar","QAT","Asia","High income",92300,2019,"omicron","Moderna mRNA-1273","mRNA","2","14+","severe",NA,NA,2021-01-28,2021-05-31,2021-08-16,100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"762",207,"Altarawneh",2022-06-15,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Qatar","QAT","Asia","High income",92300,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14+","symptomatic",NA,NA,2021-01-28,2021-05-31,2021-08-16,-0.2,-5.5,4.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"763",207,"Altarawneh",2022-06-15,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Qatar","QAT","Asia","High income",92300,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",14,308,2021-01-28,2021-05-31,2021-08-16,73.5,60.5,82.2,"yes",NA,0,73.5,60.5,82.2,0.265,0.178,0.395,-1.32802545299591,0.203342401685979
"764",207,"Altarawneh",2022-06-15,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Qatar","QAT","Asia","High income",92300,2019,"omicron","Moderna mRNA-1273","mRNA","2","14+","symptomatic",NA,NA,2021-01-28,2021-05-31,2021-08-16,2.2,-4.6,8.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"765",207,"Altarawneh",2022-06-15,"2022 (Jan-Jun)","Test-negative case-control","general pop","excluded","Qatar","QAT","Asia","High income",92300,2019,"omicron","Moderna mRNA-1273","mRNA","2","14+","severe",14,308,2021-01-28,2021-05-31,2021-08-16,66.3,38.3,81.6,"yes",NA,0,66.3,38.3,81.6,0.337,0.184,0.617,-1.08767234862978,0.308656445483776
"766",210,"Stowe",2022-09-30,"2022 (Jul-Dec)","Test-negative case-control","18-64 years","included","UK","GBR","Europe","High income",49370,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","1","28+","severe",NA,NA,2020-12-21,2021-06-04,2021-12-23,31.7,-3.1,54.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"767",210,"Stowe",2022-09-30,"2022 (Jul-Dec)","Test-negative case-control","18-64 years","included","UK","GBR","Europe","High income",49370,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14-174","severe",14,174,2020-12-21,2021-06-04,2021-12-23,73.8,62.5,81.7,"yes",NA,0,73.8,62.5,81.7,0.262,0.183,0.375,-1.33941077522104,0.183020375798212
"768",210,"Stowe",2022-09-30,"2022 (Jul-Dec)","Test-negative case-control","18-64 years","included","UK","GBR","Europe","High income",49370,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","175+","severe",NA,NA,2020-12-21,2021-06-04,2021-12-23,65.1,51.3,74.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"769",210,"Stowe",2022-09-30,"2022 (Jul-Dec)","Test-negative case-control",">= 65 years","included","UK","GBR","Europe","High income",49370,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","1","0-27","severe",NA,NA,2020-12-21,2021-06-04,2021-12-23,54.8,-25.3,83.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"770",210,"Stowe",2022-09-30,"2022 (Jul-Dec)","Test-negative case-control",">= 65 years","included","UK","GBR","Europe","High income",49370,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14-174","severe",14,174,2020-12-21,2021-06-04,2021-12-23,87.6,79.4,92.5,"yes",NA,1,87.6,79.4,92.5,0.124,0.075,0.206,-2.0874737133771,0.257752054911549
"771",210,"Stowe",2022-09-30,"2022 (Jul-Dec)","Test-negative case-control",">= 65 years","included","UK","GBR","Europe","High income",49370,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","1","28+","severe",NA,NA,2020-12-21,2021-06-04,2021-12-23,59.5,35.5,74.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"772",210,"Stowe",2022-09-30,"2022 (Jul-Dec)","Test-negative case-control",">= 65 years","included","UK","GBR","Europe","High income",49370,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","175+","severe",NA,NA,2020-12-21,2021-06-04,2021-12-23,65.4,56.6,72.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"773",210,"Stowe",2022-09-30,"2022 (Jul-Dec)","Test-negative case-control","18-64 years","included","UK","GBR","Europe","High income",49370,2019,"omicron","Oxford/AstraZeneca ChAdOx1-S","Vectored","1","28+","severe",NA,NA,2020-12-21,2021-06-04,2021-12-23,48.5,25.7,64.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"774",210,"Stowe",2022-09-30,"2022 (Jul-Dec)","Test-negative case-control","18-64 years","included","UK","GBR","Europe","High income",49370,2019,"omicron","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14-174","severe",14,174,2020-12-21,2021-06-04,2021-12-23,59,31.9,75.3,"yes",NA,0,59,31.9,75.3,0.41,0.247,0.681,-0.891598119283784,0.258717849367739
"775",210,"Stowe",2022-09-30,"2022 (Jul-Dec)","Test-negative case-control","18-64 years","included","UK","GBR","Europe","High income",49370,2019,"omicron","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","175+","severe",NA,NA,2020-12-21,2021-06-04,2021-12-23,53,41.7,62,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"776",210,"Stowe",2022-09-30,"2022 (Jul-Dec)","Test-negative case-control",">= 65 years","included","UK","GBR","Europe","High income",49370,2019,"omicron","Oxford/AstraZeneca ChAdOx1-S","Vectored","1","28+","severe",NA,NA,2020-12-21,2021-06-04,2021-12-23,48.1,23.5,64.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"777",210,"Stowe",2022-09-30,"2022 (Jul-Dec)","Test-negative case-control",">= 65 years","included","UK","GBR","Europe","High income",49370,2019,"omicron","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14-174","severe",14,174,2020-12-21,2021-06-04,2021-12-23,71.2,50,83.4,"yes",NA,1,71.2,50,83.4,0.288,0.166,0.5,-1.24479479884619,0.281280691343278
"778",210,"Stowe",2022-09-30,"2022 (Jul-Dec)","Test-negative case-control",">= 65 years","included","UK","GBR","Europe","High income",49370,2019,"omicron","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","175+","severe",NA,NA,2020-12-21,2021-06-04,2021-12-23,53.1,43.4,61.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"779",215,"Hansen",2022-03-30,"2022 (Jan-Jun)","Retrospective cohort","general pop","excluded","Denmark","DNK","Europe","High income",61830,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14-30","infection",NA,NA,2020-12-16,2021-07-16,2021-09-03,37,35.6,38.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"780",215,"Hansen",2022-03-30,"2022 (Jan-Jun)","Retrospective cohort","general pop","excluded","Denmark","DNK","Europe","High income",61830,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","121+","infection",NA,NA,2020-12-16,2021-07-16,2021-09-03,9.8,9.2,10.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"781",215,"Hansen",2022-03-30,"2022 (Jan-Jun)","Retrospective cohort","general pop","excluded","Denmark","DNK","Europe","High income",61830,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14-30","severe",14,30,2020-12-16,2021-07-16,2021-09-03,50.5,33.9,63,"yes",NA,0,50.5,33.9,63,0.495,0.37,0.661,-0.703197516413447,0.148023171993218
"782",215,"Hansen",2022-03-30,"2022 (Jan-Jun)","Retrospective cohort","general pop","excluded","Denmark","DNK","Europe","High income",61830,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","121+","severe",NA,NA,2020-12-16,2021-07-16,2021-09-03,51.6,47.2,55.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"783",215,"Hansen",2022-03-30,"2022 (Jan-Jun)","Retrospective cohort","general pop","excluded","Denmark","DNK","Europe","High income",61830,2019,"omicron","Moderna mRNA-1273","mRNA","2","14-30","infection",NA,NA,2020-12-16,2021-07-16,2021-09-03,37.9,34.4,41.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"784",215,"Hansen",2022-03-30,"2022 (Jan-Jun)","Retrospective cohort","general pop","excluded","Denmark","DNK","Europe","High income",61830,2019,"omicron","Moderna mRNA-1273","mRNA","2","121+","infection",NA,NA,2020-12-16,2021-07-16,2021-09-03,13.2,12.3,14.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"785",240,"Cerqueira-Silva",2023-01-11,"2023 (Jan-Jun)","Test-negative case-control","general pop","included","Brazil","BRA","South America","Upper middle income",14890,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14-59","symptomatic",NA,NA,2021-01-17,2021-09-24,2022-02-05,49.2,48.5,49.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"786",240,"Cerqueira-Silva",2023-01-11,"2023 (Jan-Jun)","Test-negative case-control","general pop","included","Brazil","BRA","South America","Upper middle income",14890,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","150+","symptomatic",NA,NA,2021-01-17,2021-09-24,2022-02-05,9.6,8.1,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"787",240,"Cerqueira-Silva",2023-01-11,"2023 (Jan-Jun)","Test-negative case-control","general pop","included","Brazil","BRA","South America","Upper middle income",14890,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14-59","severe",14,59,2021-01-17,2021-09-24,2022-02-05,82.9,80.6,85,"yes",NA,0,82.9,80.6,85,0.171,0.15,0.194,-1.76609172247948,0.0656180777977226
"788",240,"Cerqueira-Silva",2023-01-11,"2023 (Jan-Jun)","Test-negative case-control","general pop","included","Brazil","BRA","South America","Upper middle income",14890,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","150+","severe",NA,NA,2021-01-17,2021-09-24,2022-02-05,82.6,80.7,84.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"789",240,"Cerqueira-Silva",2023-01-11,"2023 (Jan-Jun)","Test-negative case-control","general pop","included","Brazil","BRA","South America","Upper middle income",14890,2019,"omicron","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14-59","symptomatic",NA,NA,2021-01-17,2021-09-24,2022-02-05,26.7,25.2,28.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"790",240,"Cerqueira-Silva",2023-01-11,"2023 (Jan-Jun)","Test-negative case-control","general pop","included","Brazil","BRA","South America","Upper middle income",14890,2019,"omicron","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","150+","symptomatic",NA,NA,2021-01-17,2021-09-24,2022-02-05,0.9,0,1.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"791",240,"Cerqueira-Silva",2023-01-11,"2023 (Jan-Jun)","Test-negative case-control","general pop","included","Brazil","BRA","South America","Upper middle income",14890,2019,"omicron","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14-59","severe",14,59,2021-01-17,2021-09-24,2022-02-05,77.1,72.9,80.6,"yes",NA,0,77.1,72.9,80.6,0.229,0.194,0.271,-1.4740332754279,0.0852705769939725
"792",240,"Cerqueira-Silva",2023-01-11,"2023 (Jan-Jun)","Test-negative case-control","general pop","included","Brazil","BRA","South America","Upper middle income",14890,2019,"omicron","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","150+","severe",NA,NA,2021-01-17,2021-09-24,2022-02-05,67.8,66.7,69,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"793",244,"Sharma",2022-04-27,"2022 (Jan-Jun)","Matched case-control","veterans","excluded","USA","USA","North America","High income",66120,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14+","infection",NA,NA,2020-12-13,2021-05-14,NA,25.3,21.8,28.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"794",244,"Sharma",2022-04-27,"2022 (Jan-Jun)","Matched case-control","veterans","excluded","USA","USA","North America","High income",66120,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",14,294,2020-12-13,2021-05-14,NA,52.9,47.8,57.6,"yes",NA,0,52.9,47.8,57.6,0.471,0.424,0.522,-0.752897184965719,0.0530444215945615
"795",244,"Sharma",2022-04-27,"2022 (Jan-Jun)","Matched case-control","veterans","excluded","USA","USA","North America","High income",66120,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14+","death",NA,NA,2020-12-13,2021-05-14,NA,50.7,37.9,61.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"796",244,"Sharma",2022-04-27,"2022 (Jan-Jun)","Matched case-control","veterans","excluded","USA","USA","North America","High income",66120,2019,"omicron","Moderna mRNA-1273","mRNA","2","14+","infection",NA,NA,2020-12-13,2021-05-14,NA,39.5,35.8,43,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"797",244,"Sharma",2022-04-27,"2022 (Jan-Jun)","Matched case-control","veterans","excluded","USA","USA","North America","High income",66120,2019,"omicron","Moderna mRNA-1273","mRNA","2","14+","severe",14,294,2020-12-13,2021-05-14,NA,66.7,61.4,71.6,"yes",NA,0,66.7,61.4,71.6,0.333,0.284,0.386,-1.09961278900169,0.0782814110468431
"798",244,"Sharma",2022-04-27,"2022 (Jan-Jun)","Matched case-control","veterans","excluded","USA","USA","North America","High income",66120,2019,"omicron","Moderna mRNA-1273","mRNA","2","14+","death",NA,NA,2020-12-13,2021-05-14,NA,65.6,52.8,76.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"799",272,"Adams",2022-10-11,"2022 (Jul-Dec)","Prospective test-negative case control","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",14,504,2020-12-13,2021-05-14,NA,36,21,48,"yes",NA,0,36,21,48,0.64,0.52,0.79,-0.446287102628419,0.106684728032039
"800",272,"Adams",2022-10-11,"2022 (Jul-Dec)","Prospective test-negative case control","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","Moderna mRNA-1273","mRNA","2","14+","severe",14,504,2020-12-13,2021-05-14,NA,41,25,54,"yes",NA,0,41,25,54,0.59,0.46,0.75,-0.527632742082372,0.124705795165106
"801",272,"Adams",2022-10-11,"2022 (Jul-Dec)","Prospective test-negative case control","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","Janssen Ad26.COV2.S","Vectored","2","14+","severe",NA,NA,2020-12-13,2021-05-14,NA,32,9,62,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"802",278,"Tartof",2022-10-07,"2022 (Jul-Dec)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","<6 months","severe",NA,180,2020-12-13,2021-05-14,NA,54,38,65,"yes",NA,0,54,38,65,0.46,0.35,0.62,-0.776528789498996,0.145863858049918
"803",278,"Tartof",2022-10-07,"2022 (Jul-Dec)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2",">=6 months","severe",NA,NA,2020-12-13,2021-05-14,NA,32,16,45,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"804",278,"Tartof",2022-10-07,"2022 (Jul-Dec)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","<6 months","symptomatic",NA,NA,2020-12-13,2021-05-14,NA,42,31,52,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"805",278,"Tartof",2022-10-07,"2022 (Jul-Dec)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2",">=6 months","symptomatic",NA,NA,2020-12-13,2021-05-14,NA,19,6,31,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"806",278,"Tartof",2022-10-07,"2022 (Jul-Dec)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","<6 months","severe",NA,180,2020-12-13,2021-05-14,NA,56,-2,81,"yes",NA,0,56,-2,81,0.44,0.19,1.02040816326531,-0.82098055206983,0.428809671974278
"807",278,"Tartof",2022-10-07,"2022 (Jul-Dec)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2",">=6 months","severe",NA,NA,2020-12-13,2021-05-14,NA,56,28,73,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"808",278,"Tartof",2022-10-07,"2022 (Jul-Dec)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","<6 months","symptomatic",NA,NA,2020-12-13,2021-05-14,NA,27,-11,52,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"809",278,"Tartof",2022-10-07,"2022 (Jul-Dec)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2",">=6 months","symptomatic",NA,NA,2020-12-13,2021-05-14,NA,12,-10,31,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"810",299,"Risk",2022-08-16,"2022 (Jul-Dec)","Retrospective cohort","immunocompromised adults","included","USA","USA","North America","High income",66120,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14+","infection",NA,NA,2020-12-13,2021-05-14,NA,13,-23,39,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"811",299,"Risk",2022-08-16,"2022 (Jul-Dec)","Retrospective cohort","immunocompetent adults","included","USA","USA","North America","High income",66120,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14+","infection",NA,NA,2020-12-13,2021-05-14,NA,-6,-16,4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"812",299,"Risk",2022-08-16,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",14,392,2020-12-13,2021-05-14,NA,67,51,78,"yes",NA,0,67,51,78,0.33,0.22,0.49,-1.10866262452161,0.204280062436814
"813",299,"Risk",2022-08-16,"2022 (Jul-Dec)","Retrospective cohort","immunocompromised adults","included","USA","USA","North America","High income",66120,2019,"omicron","Moderna mRNA-1273","mRNA","2","14+","infection",NA,NA,2020-12-13,2021-05-14,NA,57,29,74,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"814",299,"Risk",2022-08-16,"2022 (Jul-Dec)","Retrospective cohort","immunocompetent adults","included","USA","USA","North America","High income",66120,2019,"omicron","Moderna mRNA-1273","mRNA","2","14+","infection",NA,NA,2020-12-13,2021-05-14,NA,16,5,26,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"815",299,"Risk",2022-08-16,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","Moderna mRNA-1273","mRNA","2","14+","severe",14,392,2020-12-13,2021-05-14,NA,79,63,88,"yes",NA,0,79,63,88,0.21,0.12,0.37,-1.56064774826467,0.287247771136792
"816",299,"Risk",2022-08-16,"2022 (Jul-Dec)","Retrospective cohort","immunocompromised adults","included","USA","USA","North America","High income",66120,2019,"omicron","Multiple or heterologous RNA","mRNA","2","14+","severe",NA,NA,2020-12-13,2021-05-14,NA,85,62,94,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"817",299,"Risk",2022-08-16,"2022 (Jul-Dec)","Retrospective cohort","immunocompetent adults","included","USA","USA","North America","High income",66120,2019,"omicron","Multiple or heterologous RNA","mRNA","2","14+","severe",NA,NA,2020-12-13,2021-05-14,NA,68,53,78,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"818",299,"Risk",2022-08-16,"2022 (Jul-Dec)","Retrospective cohort","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","Multiple or heterologous RNA","mRNA","2","14+","severe",NA,NA,2020-12-13,2021-05-14,NA,92,66,98,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"819",301,"Yan",2022-08-18,"2022 (Jul-Dec)","Case-control","18-50 years","excluded","Hong Kong","HKG","Asia","High income",65240,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",14,364,2021-02-23,2021-08-19,2022-03-04,73.7,54.2,84.9,"yes",NA,0,73.7,54.2,84.9,0.263,0.151,0.458,-1.33560124680437,0.283058506964097
"820",301,"Yan",2022-08-18,"2022 (Jul-Dec)","Case-control","51-64 years","excluded","Hong Kong","HKG","Asia","High income",65240,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",14,364,2021-02-23,2021-08-19,2022-03-04,84.5,72.2,91.4,"yes",NA,0,84.5,72.2,91.4,0.155,0.086,0.278,-1.86433016206289,0.299304545264574
"821",301,"Yan",2022-08-18,"2022 (Jul-Dec)","Case-control",">= 65 years","excluded","Hong Kong","HKG","Asia","High income",65240,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14+","severe",14,364,2021-02-23,2021-08-19,2022-03-04,81.9,74.4,87.2,"yes",NA,1,81.9,74.4,87.2,0.181,0.128,0.256,-1.70925824771631,0.176823260346925
"822",301,"Yan",2022-08-18,"2022 (Jul-Dec)","Case-control","18-50 years","excluded","Hong Kong","HKG","Asia","High income",65240,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14+","death",NA,NA,2021-02-23,2021-08-19,2022-03-04,84.2,67.3,92.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"823",301,"Yan",2022-08-18,"2022 (Jul-Dec)","Case-control","51-64 years","excluded","Hong Kong","HKG","Asia","High income",65240,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14+","death",NA,NA,2021-02-23,2021-08-19,2022-03-04,86.9,80.3,91.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"824",301,"Yan",2022-08-18,"2022 (Jul-Dec)","Case-control",">= 65 years","excluded","Hong Kong","HKG","Asia","High income",65240,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14+","death",NA,NA,2021-02-23,2021-08-19,2022-03-04,90.6,88.5,92.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"825",301,"Yan",2022-08-18,"2022 (Jul-Dec)","Case-control","18-50 years","excluded","Hong Kong","HKG","Asia","High income",65240,2019,"omicron","Sinovac CoronaVac","Inactivated","2","14+","severe",NA,NA,2021-02-23,2021-08-19,2022-03-04,72.6,40.1,87.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"826",301,"Yan",2022-08-18,"2022 (Jul-Dec)","Case-control","51-64 years","excluded","Hong Kong","HKG","Asia","High income",65240,2019,"omicron","Sinovac CoronaVac","Inactivated","2","14+","severe",NA,NA,2021-02-23,2021-08-19,2022-03-04,67.8,48.7,79.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"827",301,"Yan",2022-08-18,"2022 (Jul-Dec)","Case-control",">= 65 years","excluded","Hong Kong","HKG","Asia","High income",65240,2019,"omicron","Sinovac CoronaVac","Inactivated","2","14+","severe",NA,NA,2021-02-23,2021-08-19,2022-03-04,56.7,47.4,64.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"828",301,"Yan",2022-08-18,"2022 (Jul-Dec)","Case-control","18-50 years","excluded","Hong Kong","HKG","Asia","High income",65240,2019,"omicron","Sinovac CoronaVac","Inactivated","2","14+","death",NA,NA,2021-02-23,2021-08-19,2022-03-04,83.7,57.9,93.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"829",301,"Yan",2022-08-18,"2022 (Jul-Dec)","Case-control","51-64 years","excluded","Hong Kong","HKG","Asia","High income",65240,2019,"omicron","Sinovac CoronaVac","Inactivated","2","14+","death",NA,NA,2021-02-23,2021-08-19,2022-03-04,78.1,69.4,84.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"830",301,"Yan",2022-08-18,"2022 (Jul-Dec)","Case-control",">= 65 years","excluded","Hong Kong","HKG","Asia","High income",65240,2019,"omicron","Sinovac CoronaVac","Inactivated","2","14+","death",NA,NA,2021-02-23,2021-08-19,2022-03-04,72.5,69.9,74.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"831",316,"Collie",2022-09-14,"2022 (Jul-Dec)","Test-negative case-control","general pop","included","South Africa","ZAF","Africa","Upper middle income",14080,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14-27","severe",14,27,2021-02-17,NA,NA,80.3,62.8,89.5,"yes",NA,0,80.3,62.8,89.5,0.197,0.105,0.372,-1.62455155024415,0.322687118396843
"832",316,"Collie",2022-09-14,"2022 (Jul-Dec)","Test-negative case-control","general pop","included","South Africa","ZAF","Africa","Upper middle income",14080,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","7-8 months","severe",NA,NA,2021-02-17,NA,NA,38.4,16.9,54.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"833",316,"Collie",2022-09-14,"2022 (Jul-Dec)","Test-negative case-control","general pop","included","South Africa","ZAF","Africa","Upper middle income",14080,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","3-4 months","severe",NA,NA,2021-02-17,NA,NA,47.4,19.9,65.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"834",316,"Collie",2022-09-14,"2022 (Jul-Dec)","Test-negative case-control","general pop","included","South Africa","ZAF","Africa","Upper middle income",14080,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","9+ months","severe",NA,NA,2021-02-17,NA,NA,19.3,6.3,30.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"835",324,"Link-Gelles",2022-10-05,"2022 (Jul-Dec)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14-159","symptomatic",NA,NA,2020-12-13,2021-05-14,NA,45,27,59,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"836",324,"Link-Gelles",2022-10-05,"2022 (Jul-Dec)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","150+","symptomatic",NA,NA,2020-12-13,2021-05-14,NA,24,19,27,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"837",324,"Link-Gelles",2022-10-05,"2022 (Jul-Dec)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","150+","severe",150,574,2020-12-13,2021-05-14,NA,17,7,27,"yes",NA,0,17,7,27,0.83,0.73,0.93,-0.186329578191493,0.0617704214298124
"838",324,"Link-Gelles",2022-10-05,"2022 (Jul-Dec)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","Moderna mRNA-1273","mRNA","2","14-159","symptomatic",NA,NA,2020-12-13,2021-05-14,NA,51,30,66,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"839",324,"Link-Gelles",2022-10-05,"2022 (Jul-Dec)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","Moderna mRNA-1273","mRNA","2","150+","symptomatic",NA,NA,2020-12-13,2021-05-14,NA,30,25,34,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"840",324,"Link-Gelles",2022-10-05,"2022 (Jul-Dec)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","Moderna mRNA-1273","mRNA","2","150+","severe",150,574,2020-12-13,2021-05-14,NA,28,17,38,"yes",NA,0,28,17,38,0.72,0.62,0.83,-0.328504066972036,0.0744148527427312
"841",324,"Link-Gelles",2022-10-05,"2022 (Jul-Dec)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","Multiple or heterologous RNA","mRNA","2","14-159","symptomatic",NA,NA,2020-12-13,2021-05-14,NA,70,52,81,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"842",324,"Link-Gelles",2022-10-05,"2022 (Jul-Dec)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","Multiple or heterologous RNA","mRNA","2","150+","symptomatic",NA,NA,2020-12-13,2021-05-14,NA,38,29,46,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"843",332,"Wan",2022-10-17,"2022 (Jul-Dec)","Case-control","60-79 years","excluded","Hong Kong","HKG","Asia","High income",65240,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14-180","infection",NA,NA,2021-02-23,2021-08-19,2022-03-04,17.3,15.2,19.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"844",332,"Wan",2022-10-17,"2022 (Jul-Dec)","Case-control","60-79 years","excluded","Hong Kong","HKG","Asia","High income",65240,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14-180","severe",14,168,2021-02-23,2021-08-19,2022-03-04,74.6,72.1,76.8,"yes",NA,1,74.6,72.1,76.8,0.254,0.232,0.279,-1.3704210119636,0.0470597985089428
"845",332,"Wan",2022-10-17,"2022 (Jul-Dec)","Case-control","60-79 years","excluded","Hong Kong","HKG","Asia","High income",65240,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14-180","severe",NA,NA,2021-02-23,2021-08-19,2022-03-04,77.5,65.7,85.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"846",332,"Wan",2022-10-17,"2022 (Jul-Dec)","Case-control","60-79 years","excluded","Hong Kong","HKG","Asia","High income",65240,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14-180","death",NA,NA,2021-02-23,2021-08-19,2022-03-04,92.1,88.7,94.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"847",332,"Wan",2022-10-17,"2022 (Jul-Dec)","Case-control",">=80 years","excluded","Hong Kong","HKG","Asia","High income",65240,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14-180","infection",NA,NA,2021-02-23,2021-08-19,2022-03-04,54.2,51.4,56.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"848",332,"Wan",2022-10-17,"2022 (Jul-Dec)","Case-control",">=80 years","excluded","Hong Kong","HKG","Asia","High income",65240,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14-180","severe",14,168,2021-02-23,2021-08-19,2022-03-04,81,78.2,83.5,"yes",NA,1,81,78.2,83.5,0.19,0.165,0.218,-1.66073120682165,0.0710585685940072
"849",332,"Wan",2022-10-17,"2022 (Jul-Dec)","Case-control",">=80 years","excluded","Hong Kong","HKG","Asia","High income",65240,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14-180","severe",NA,NA,2021-02-23,2021-08-19,2022-03-04,82.7,62.7,92,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"850",332,"Wan",2022-10-17,"2022 (Jul-Dec)","Case-control",">=80 years","excluded","Hong Kong","HKG","Asia","High income",65240,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14-180","death",NA,NA,2021-02-23,2021-08-19,2022-03-04,92.5,89.3,94.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"851",332,"Wan",2022-10-17,"2022 (Jul-Dec)","Case-control","60-79 years","excluded","Hong Kong","HKG","Asia","High income",65240,2019,"omicron","Sinovac CoronaVac","Inactivated","2","14-180","infection",NA,NA,2021-02-23,2021-08-19,2022-03-04,-23.1,-25.8,-20.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"852",332,"Wan",2022-10-17,"2022 (Jul-Dec)","Case-control","60-79 years","excluded","Hong Kong","HKG","Asia","High income",65240,2019,"omicron","Sinovac CoronaVac","Inactivated","2","14-180","severe",NA,NA,2021-02-23,2021-08-19,2022-03-04,59.4,56.6,62,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"853",332,"Wan",2022-10-17,"2022 (Jul-Dec)","Case-control","60-79 years","excluded","Hong Kong","HKG","Asia","High income",65240,2019,"omicron","Sinovac CoronaVac","Inactivated","2","14-180","severe",NA,NA,2021-02-23,2021-08-19,2022-03-04,57.7,43.8,68.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"854",332,"Wan",2022-10-17,"2022 (Jul-Dec)","Case-control","60-79 years","excluded","Hong Kong","HKG","Asia","High income",65240,2019,"omicron","Sinovac CoronaVac","Inactivated","2","14-180","death",NA,NA,2021-02-23,2021-08-19,2022-03-04,79.6,75,83.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"855",332,"Wan",2022-10-17,"2022 (Jul-Dec)","Case-control",">=80 years","excluded","Hong Kong","HKG","Asia","High income",65240,2019,"omicron","Sinovac CoronaVac","Inactivated","2","14-180","infection",NA,NA,2021-02-23,2021-08-19,2022-03-04,31.2,28.7,33.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"856",332,"Wan",2022-10-17,"2022 (Jul-Dec)","Case-control",">=80 years","excluded","Hong Kong","HKG","Asia","High income",65240,2019,"omicron","Sinovac CoronaVac","Inactivated","2","14-180","severe",NA,NA,2021-02-23,2021-08-19,2022-03-04,58.4,55.8,60.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"857",332,"Wan",2022-10-17,"2022 (Jul-Dec)","Case-control",">=80 years","excluded","Hong Kong","HKG","Asia","High income",65240,2019,"omicron","Sinovac CoronaVac","Inactivated","2","14-180","severe",NA,NA,2021-02-23,2021-08-19,2022-03-04,55,38.6,67,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"858",332,"Wan",2022-10-17,"2022 (Jul-Dec)","Case-control",">=80 years","excluded","Hong Kong","HKG","Asia","High income",65240,2019,"omicron","Sinovac CoronaVac","Inactivated","2","14-180","death",NA,NA,2021-02-23,2021-08-19,2022-03-04,69.4,65.6,72.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"859",341,"Tartof",2022-10-25,"2022 (Jul-Dec)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","<6 months","symptomatic",NA,NA,2020-12-13,2021-05-14,NA,30,-86,74,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"860",341,"Tartof",2022-10-25,"2022 (Jul-Dec)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2",">=6 months","symptomatic",NA,NA,2020-12-13,2021-05-14,NA,44,20,61,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"861",341,"Tartof",2022-10-25,"2022 (Jul-Dec)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","<6 months","symptomatic",NA,NA,2020-12-13,2021-05-14,NA,50,10,72,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"862",341,"Tartof",2022-10-25,"2022 (Jul-Dec)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2",">=6 months","symptomatic",NA,NA,2020-12-13,2021-05-14,NA,7,-11,22,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"863",341,"Tartof",2022-10-25,"2022 (Jul-Dec)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","<6 months","symptomatic",NA,NA,2020-12-13,2021-05-14,NA,30,4,49,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"864",341,"Tartof",2022-10-25,"2022 (Jul-Dec)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2",">=6 months","symptomatic",NA,NA,2020-12-13,2021-05-14,NA,19,9,29,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"865",341,"Tartof",2022-10-25,"2022 (Jul-Dec)","Test-negative case-control","general pop","included","USA","USA","North America","High income",66120,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2",">=6 months","severe",180,588,2020-12-13,2021-05-14,NA,-4,-118,50,"yes",NA,0,-4,NA,50,1.04166666666667,0.5,NA,0.0408219945202552,0.37447406891847
"866",392,"Yan",2023-05-03,"2023 (Jan-Jun)","Case-control","general pop","excluded","Hong Kong","HKG","Asia","High income",65240,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14-30","severe",14,30,2021-02-23,2021-08-19,2022-03-04,73,69.2,76.3,"yes",NA,0,73,69.2,76.3,0.27,0.237,0.308,-1.30933331998376,0.0668468474077661
"867",392,"Yan",2023-05-03,"2023 (Jan-Jun)","Case-control","general pop","excluded","Hong Kong","HKG","Asia","High income",65240,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","211-240","severe",NA,NA,2021-02-23,2021-08-19,2022-03-04,46.6,40.7,51.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"868",392,"Yan",2023-05-03,"2023 (Jan-Jun)","Case-control","general pop","excluded","Hong Kong","HKG","Asia","High income",65240,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14-30","severe",NA,NA,2021-02-23,2021-08-19,2022-03-04,69.7,50,81.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"869",392,"Yan",2023-05-03,"2023 (Jan-Jun)","Case-control","general pop","excluded","Hong Kong","HKG","Asia","High income",65240,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","211-240","severe",NA,NA,2021-02-23,2021-08-19,2022-03-04,71.8,47.2,84.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"870",392,"Yan",2023-05-03,"2023 (Jan-Jun)","Case-control","general pop","excluded","Hong Kong","HKG","Asia","High income",65240,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14-30","death",NA,NA,2021-02-23,2021-08-19,2022-03-04,89.8,83.7,93.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"871",392,"Yan",2023-05-03,"2023 (Jan-Jun)","Case-control","general pop","excluded","Hong Kong","HKG","Asia","High income",65240,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","211-240","death",NA,NA,2021-02-23,2021-08-19,2022-03-04,73.8,55.9,84.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"872",392,"Yan",2023-05-03,"2023 (Jan-Jun)","Case-control","general pop","excluded","Hong Kong","HKG","Asia","High income",65240,2019,"omicron","Sinovac CoronaVac","Inactivated","2","14-30","severe",NA,NA,2021-02-23,2021-08-19,2022-03-04,66,63.5,68.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"873",392,"Yan",2023-05-03,"2023 (Jan-Jun)","Case-control","general pop","excluded","Hong Kong","HKG","Asia","High income",65240,2019,"omicron","Sinovac CoronaVac","Inactivated","2","211-240","severe",NA,NA,2021-02-23,2021-08-19,2022-03-04,36.2,28,43.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"874",392,"Yan",2023-05-03,"2023 (Jan-Jun)","Case-control","general pop","excluded","Hong Kong","HKG","Asia","High income",65240,2019,"omicron","Sinovac CoronaVac","Inactivated","2","14-30","severe",NA,NA,2021-02-23,2021-08-19,2022-03-04,54.5,40.6,65.1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"875",392,"Yan",2023-05-03,"2023 (Jan-Jun)","Case-control","general pop","excluded","Hong Kong","HKG","Asia","High income",65240,2019,"omicron","Sinovac CoronaVac","Inactivated","2","211-240","severe",NA,NA,2021-02-23,2021-08-19,2022-03-04,67.1,34,83.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"876",392,"Yan",2023-05-03,"2023 (Jan-Jun)","Case-control","general pop","excluded","Hong Kong","HKG","Asia","High income",65240,2019,"omicron","Sinovac CoronaVac","Inactivated","2","14-30","death",NA,NA,2021-02-23,2021-08-19,2022-03-04,81.1,77.4,84.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"877",392,"Yan",2023-05-03,"2023 (Jan-Jun)","Case-control","general pop","excluded","Hong Kong","HKG","Asia","High income",65240,2019,"omicron","Sinovac CoronaVac","Inactivated","2","211-240","death",NA,NA,2021-02-23,2021-08-19,2022-03-04,76.6,60.8,86,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"878",500,"Cerqueira-Silva",2023-01-11,"2023 (Jan-Jun)","Test-negative case-control","general pop","included","UK","GBR","Europe","High income",49370,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14-59","symptomatic",NA,NA,2020-12-21,2021-06-04,2021-12-23,57.7,54.5,60.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"879",500,"Cerqueira-Silva",2023-01-11,"2023 (Jan-Jun)","Test-negative case-control","general pop","included","UK","GBR","Europe","High income",49370,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","150+","symptomatic",NA,NA,2020-12-21,2021-06-04,2021-12-23,17.8,15.1,20.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"880",500,"Cerqueira-Silva",2023-01-11,"2023 (Jan-Jun)","Test-negative case-control","general pop","included","UK","GBR","Europe","High income",49370,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","14-59","severe",14,59,2020-12-21,2021-06-04,2021-12-23,90.4,30.4,98.7,"yes",NA,0,90.4,30.4,98.7,0.096,0.013,0.696,-2.3434070875143,1.0154082405288
"881",500,"Cerqueira-Silva",2023-01-11,"2023 (Jan-Jun)","Test-negative case-control","general pop","included","UK","GBR","Europe","High income",49370,2019,"omicron","BioNTech/Pfizer BNT162b2","mRNA","2","150+","severe",NA,NA,2020-12-21,2021-06-04,2021-12-23,72.9,57.9,82.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"882",500,"Cerqueira-Silva",2023-01-11,"2023 (Jan-Jun)","Test-negative case-control","general pop","included","UK","GBR","Europe","High income",49370,2019,"omicron","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14-59","symptomatic",NA,NA,2020-12-21,2021-06-04,2021-12-23,40.7,26.6,52.1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"883",500,"Cerqueira-Silva",2023-01-11,"2023 (Jan-Jun)","Test-negative case-control","general pop","included","UK","GBR","Europe","High income",49370,2019,"omicron","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","150+","symptomatic",NA,NA,2020-12-21,2021-06-04,2021-12-23,9.6,6.3,12.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"884",500,"Cerqueira-Silva",2023-01-11,"2023 (Jan-Jun)","Test-negative case-control","general pop","included","UK","GBR","Europe","High income",49370,2019,"omicron","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","60-149","severe",60,149,2020-12-21,2021-06-04,2021-12-23,78.8,31.8,93.4,"yes",NA,0,78.8,31.8,93.4,0.212,0.0659999999999999,0.682,-1.55116900431012,0.595758907096183
"885",500,"Cerqueira-Silva",2023-01-11,"2023 (Jan-Jun)","Test-negative case-control","general pop","included","UK","GBR","Europe","High income",49370,2019,"omicron","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","150+","severe",NA,NA,2020-12-21,2021-06-04,2021-12-23,52.8,33.3,66.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"886",396,"Park",2023-05-15,"2023 (Jan-Jun)","Retrospective cohort",">=60 years","included","South Korea","KOR","Asia","High income",43780,2019,"omicron","Multiple or heterologous RNA","mRNA","2","14+","death",NA,NA,2021-02-26,2021-09-15,2021-10-25,72,70,74,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"887",396,"Park",2023-05-15,"2023 (Jan-Jun)","Retrospective cohort",">=60 years","included","South Korea","KOR","Asia","High income",43780,2019,"omicron","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","death",NA,NA,2021-02-26,2021-09-15,2021-10-25,65,62,68,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"888",396,"Park",2023-05-15,"2023 (Jan-Jun)","Retrospective cohort",">=60 years","included","South Korea","KOR","Asia","High income",43780,2019,"omicron","Heterologous platforms","Multiple","2","14+","death",NA,NA,2021-02-26,2021-09-15,2021-10-25,55,44,60,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"889",396,"Park",2023-05-15,"2023 (Jan-Jun)","Retrospective cohort",">=60 years","included","South Korea","KOR","Asia","High income",43780,2019,"omicron","Multiple or heterologous RNA","mRNA","2","14+","severe",NA,NA,2021-02-26,2021-09-15,2021-10-25,68,67,69,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"890",396,"Park",2023-05-15,"2023 (Jan-Jun)","Retrospective cohort",">=60 years","included","South Korea","KOR","Asia","High income",43780,2019,"omicron","Oxford/AstraZeneca ChAdOx1-S","Vectored","2","14+","severe",14,560,2021-02-26,2021-09-15,2021-10-25,72,70,74,"yes",NA,1,72,70,74,0.28,0.26,0.3,-1.27296567581289,0.0365053172552738
"891",396,"Park",2023-05-15,"2023 (Jan-Jun)","Retrospective cohort",">=60 years","included","South Korea","KOR","Asia","High income",43780,2019,"omicron","Heterologous platforms","Multiple","2","14+","severe",NA,NA,2021-02-26,2021-09-15,2021-10-25,61,55,67,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
